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The total synthesis of a novel diarylheptanoid isolated from a South African 
medicinal plant, Siphonochilus aethiopicus, was investigated.  S. aethiopicus 
(Indungulu in Zulu) is the only South African species of the Zingiberaceae 
plant family and is widely used in traditional medicine.  One of the compounds 
isolated from this plant is a novel diarylheptanoid.  Diarylheptanoids constitute 
a distinct group of natural plant metabolites characterized by two aromatic 
rings linked by a linear seven-carbon aliphatic chain, with varying functional 
groups on the aryl and the aliphatic chain.  The target molecule for our 
synthesis contains two highly oxygenated aryl rings linked by an aliphatic 
chain with two stereogenic centres and a trans-alkene.  
 
In this study we present our investigation of different strategies to a viable 
synthetic method that could provide material to supplement the relatively 
small quantity of product that can be isolated from the plant extract.  The 
major challenges of this synthesis were to develop procedures for the 
preparation of the homobenzylic trans-alkene, the stereogenic centres and to 
attach the electron-rich aromatic rings to the aliphatic chain. 
 
In this thesis the following aspects are described: 
•  Various types of olefination reactions (including Wittig, Julia and 
organometalic-mediated type of olefination reactions) 
•  Various types of alkylation reactions (including Grignard, Friedel-Crafts 
and organometalic-mediated type of alkylation reactions) 
•  Incorporation of the stereogenic centres (including asymmetric 
hydroxylation and use of chiral starting materials) 
 
The synthesis will not only give a viable synthetic route to the target 
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1.1 THE ROLE OF TOTAL SYNTHESIS IN NATURAL 
PRODUCT CHEMISTRY 
 
Natural products have been used by man since ancient times as remedies for 
diseases, spices, narcotics, dyes and as poisons for warfare and hunting.  People 
have used traditional remedies without a scientific rationale, but with the 
experience that they can be highly effective if taken at therapeutic doses.  Most of 
these natural products were used in crude forms and the active components were 
only isolated during and after the nineteenth century.  The broad application of 
natural biologically active compounds as antimalarial, antitumour and antiviral 
drugs, amongst others, has stimulated organic chemists to develop methods for 
the syntheses of these compounds. The contribution of organic chemists lies not 
only in their ability to produce known substances for further study but more 
important, in their capacity to create new entities which may have enhanced 
activity.1  
 
Morphine (1) can be used as a case study to illustrate how the activity of natural 











Morphine (1), first isolated from the opium poppy (Papaver somniferum and P. 
setigrum)2 in 1803, is a strong analgesic.  Opium is a sticky brown gum that 
hardens on standing that is obtained from P. somniferum by incision of the seed 
pot after the petals of the flower have dropped.3  The sticky gum contains about 
twenty alkaloids including morphine (1), codeine (2), thebaine (3) and papaverine 
(4).  Thebaine and papaverine are not analgesic but are precursors of several 

















Papaverine (4)Codeine (2) Thebaine (3)
 
Initially, synthetic studies were aimed at the preparation of some natural opium 
alkaloid derivatives but later studies resulted in the preparation of morphine 
analogues with analgesic properties.  Despite being a small molecule, morphine 
(1) has a complex structure containing five adjacent stereocenteres and five fused 
rings, two of which are heterocyclic.  Minor modifications of morphine-like 
compounds often have a drastic influence on their activity.  Methylation of the 
phenolic hydroxy group at C-3 reduces the efficacy of morphine (1) and drugs like 
codeine (2) and oxycodone (6) are mild morphine agonists while acetylation of 
both hydroxy groups of morphine increases the efficacy and yields heroin (5), 
which is a strong morphine agonist (Table 1.1). Partial agonist or antagonist 
properties are associated with replacement of the methyl substituent on the 
nitrogen atom with larger groups.  For example, in the case of nalorphine (9) and 
naloxone (10), an allyl group replaced the methyl substituent on the nitrogen atom 














































Morphine (1) Heroin (5)
Codeine (2) Oxycodone (6)
Nalbuphine (7) Buprenorphine (8)
Nalorphine (9) Naloxone (10)
Strong Agonists










However, methylcyclopropane or methylcyclobutane as the substituent renders 
nalbuphine (7) and buprenorphine (8) as mixed agonist-antagonists.  Also, 
substitution at the C-3 and C-6 hydroxy groups of morphine significantly alters the 
pharmacokinetic properties of these compounds.  Heroin (5) is regarded as a 
much more potent and fast-acting drug than morphine (1), but without the 
respiratory depression effect.  A possible reason may be that heroin (5) passes the 
blood-brain barrier much more rapidly than morphine (1) and once in the brain, it is 
hydrolysed back to morphine which is responsible for its activity.3  It has been 
clearly illustrated that synthetic chemists have an ability to tweak the structure of a 
natural product like morphine to enhance its activity. 
 
The development of antimalarial drugs also illustrates how the symbiosis between 
synthetic chemists and natural products can lead to new drugs.  Quinine (11) is an 
antimalarial agent that was isolated from the Cinchona tree (originally found in the 
high altitudes of South America).  As early as in the seventeenth century, Thomas 
Sydenman, a bachelor of medicine, prescribed a mixture of powdered bark of the 












Quinine (11) Chloroquine (12)  
 
The first total synthesis of quinine (11) was disclosed by Woodward in 1944 and 
was a major advancement in the field of organic chemistry.4  Quinine (11) was also 
used as a model for the preparation of resochin (chloroquine) (12) and sontochin 






Artemisia annua (sweet wormwood) is known by Chinese herbalists as Qinghao.  
Qinghao extracts were shown to be as effective as chloroquine (12) and quinine 
(11) in clearing the malaria parasite.5   The active principle in A. annua is 
artemisinin (13), a sesquiterpene peroxide.  Although artemisinin is effective, it 
also breaks down quickly in the body and more stable analogues are needed.  
Molecules that contain a peroxide group have been developed from the 
artemisinin such as arte-ether (14).  An attempt to improve the activity of 
artemisinin (13) led to the development of OZ277 (15), and is regarded to be more 
active than artemisinin (13).  OZ277 has sufficient solubility to be administered 
orally, it has a longer lifetime in the plasma, stays active for longer time in the body 



















Artemisinin (13) Arte-ether (14)
OZ277 (15)  
 
The examples presented above clearly illustrate the significance and richness of 
natural product synthesis.  We close this brief outline with some words penned in 
2003 by E.J. Corey:7 
•  How many challenging and worthy synthetic targets remain to be 
discovered? 
•  How many truly powerful and general new synthetic strategies and 
synthetic reactions remain to be discovered? 
 
 6 
•  Is there a prospect for the development of entirely new ways of planning or 
executing synthesis? 
 
1.2 SOUTH AFRICAN NATURAL PRODUCTS  
 
More than 30 000 species of higher plants are found in South Africa and that is 
about 10% of the total plant species of the world.8  South Africa is also blessed 
with a wealth of traditional medicines and with a rich cultural diversity which is 
reflected by the healing practices that are performed in different parts of the 
country.  In South Africa, a large part of the day-to-day medicine is still derived 
from plants and large volumes of plants or their extracts are sold in the informal 
and commercial sectors of the economy.   
 
South Africa’s contribution to world medicine includes Cape aloes (Aloe ferox, 
laxative and skin care preparations), rooibos tea (Aspalathus linearis, antioxidant 
activity), buchu (Agathosma betulina, diuretic and anti-inflammatory activities), 
devil’s claw (Harpagophytum procumbens, anti-inflammatory activity), African 
potato (Hypoxis hemerocallidea, anticancer and anti-inflammatory activities) and 
ghaap (Hoodia gordonii, appetite-suppressant activity).8   
 
1.3 AIM OF THIS STUDY 
 
The aim of this study is to synthesise a novel diarylheptanoid isolated from a 
South African medicinal plant Siphonochilus aethiopicus B.L. Burtt 
(Zingiberaceae).  S. aethiopicus, known as wild ginger or ‘ indungulu’  in Zulu, is 
the only South African species of the Zingiberaceae (ginger) plant family.  This 
rare African plant has been traditionally used for many ailments and is regarded as 
Africa’s natural anti-inflammatory. 9,10,11  Two classes of compounds have been 
isolated from this plant, diarylheptanoids (e.g. 16)12 and sesquiterpenoids [e.g. 
siphonochilon (8,12-epoxy-2,7,11-eudesmatriene-1-one), 17].12,13  The relative and 


























In view of the importance of S. aethiopicus as a medicinal plant, we aim at 
synthesising diarylheptanoid 18, as one of the possible structure of 16 with fixed 
relative and absolute stereochemistry.  The availability of this compound will assist 
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The current state of knowledge of the chemistry (structure, and total synthesis) of 
diarylheptanoids, as well as their occurrence in the plant kingdom will be reviewed 
in this chapter.  Diarylheptanoids are plant metabolites that have been isolated 
from various genera such as Acer (Aceraceae), Platycarya strobilacea 
(Juglandaceae), Myrica gale (Myricaceae) and Centrolobium (Leguminosae) but 
with the largest numbers occurring in Alpinia, Curcuma and Zingiber 
(Zingiberaceae) and Alnus and Betula (Betulaceae).1  The common structural 
feature of diarylheptanoids is two aromatic rings linked by a linear seven-carbon 
aliphatic chain, with varying functional groups on the aryl and C7-moieties (Fig. 




1 2 3 4 5 6 7
Ar1 Ar2
FGP = Functional Group  
 
FIGURE 2.1: General structural feature of a diarylheptanoid. 
 
Many diarylheptanoids possess biological activities such as anti-inflammatory, 
anti-hepatotoxic, antibacterial and antifungal activity.2  For example, curcumin (19) 
isolated from rhizomes of Curcuma longa (Zingiberaceae) (Fig. 2.2) is responsible 
for the biological activity (anti-inflammatory, anticancer, hepatoprotective, 
antiallergic, cholesterol-lowering effects and anti-HIV) of this plant.2  C. longa, also 
known as turmeric, is a tropical plant native to India and is cultivated in most 
tropical parts of the world including Africa, Madagascar as well as South and 
South-East tropical Asia.3   
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This plant has underground root-like stems and rhizomes which are commonly 
used as a spice but are also utilised for medicinal purposes in Indian Ayurvedic 


























FIGURE 2.2: The tumeric plant and its rhizomes. 
 
The constitution of this relatively simple and broadly-used compound was 
established in the nineteenth century, firstly by degradative reactions and later by 
synthesis.2  Other well-known spices and medicinal plants which also belong to the 
Zingiberaceae plant family and contain chemical constituents with similar 
structures and biological effects to curcumin are ginger (Zingiber officinale), 
cardamom (Elettaria cardamomum, Amomum subulatum) and galangal 
(Kaempferia galanga, Alpinia galanga).4 
Tumeric rhizomes, Photo: 
http://www.inmagine.com/agriculture-photos 
Tumeric plant, Photo: 
http://www.inmagine.com/agriculture-photos 
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2.2 CLASSIFICATION AND OCCURRENCE OF  
DIARYLHEPTANOIDS 
 
The diarylheptanoids can be sub-grouped into open chain linear (20) or cyclic (21, 
22, 23) compounds (Fig. 2.3).6  Oxidative coupling of the corresponding 
diarylheptanoids and their congeners may form the cyclic type that can be further 
divided into tetrahydropyrans (21) and cyclophanes, based on how the aromatic 
rings are linked through oxygen.6  The latter group is further sub-grouped into 
meta-meta bridged biphenyls (22) and meta-para diphenyl ethers (23).6  In 
addition to the above sub-groups, more complex diarylheptanoids (24), with the 
basic skeleton extended by fragments such as arylbutyl, chalcone or flavonoid 
















































FIGURE 2.3 (continued): Classification of diarylheptanoids. 
 
2.2.1 LINEAR DIARYLHEPTANOIDS 
 
Curcumin (19), the first member of the linear diarylheptanoids that was discovered, 
was isolated in the eighteenth century.2  It was not only the first linear 
diarylheptanoid to be described, but was also among the first natural organic 
compounds isolated in more or less pure state and was the only representative of 
the group until 1964.  Numerous studies published associate the anti-inflammatory 
activity of curcumin (19) and its derivatives with presence of phenolic groups in the 
molecule, which are essential for the inhibition of prostaglandin and leucotriene 
biosynthesis.1,2,8  On the other hand, some authors9 suggested that the anti-
inflammatory action is associated with the existence of the diene ketone system 
while others10,11 also describe this system for antiparasitic activity as well.   
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Recent investigations suggest that curcumin (19) has cancer-preventive properties 
as it inhibits expression of cyclooxygenase-2 in mouse skin treated with the 
tumour promoter (phorbol 12-myristate 13-acetate) through inactivation of the 
redox-sensitive eukaryotic transcription factor NF-КB.
12   To clarify structure-activity 
relationships of diarylheptanoids, curcumin and its congeners, called 
curcuminoids, and several linear diarylheptanoids from various plant species, have 
been isolated and investigated.13 
 
Recently, a novel diarylheptanoid 25 was isolated from Zingiber ottensii 
(Zingiberaceae) which is cultivated in Malaysia and used in traditional medicine for 









Diarylheptanoid 26 isolated from a Chinese medicinal herb, Alpinia officinarum 
(Zingiberaceae), inhibits nitric oxide production in lipopolysaccharide-activated 
mouse peritoneal macrophage.15  In addition, a novel diarylheptanoid 27 has been 
















In the search for anti-cancer principles from ginger, diarylheptanoid 28 was 
isolated as a novel constituent of Zingiber officinale (Zingiberaceae) and was 









A potent inhibitor of collagen-induced, arachidonic acid-induced and adenoside 
diphosphate-induced platelet aggregation of human blood is diarylheptanoid 29 






The betulapalatosides 30a and 30b were identified in Betula platyphylla var. 
japonica (Betulaceae)19 and both compounds are regarded to have 





30a  R =   -D-Glucopyranosyl β





Centrolobium species (Leguminosae) are the source of the 2H-tetrahydropyran-
type diarylheptanoids, such as the centrolobines 31a and 31b.  
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The laevorotatory enantiomers, (–)-31a and (–)-31b, occur in Centrolobium 
paraense, C. sclerophyllum and C. tomentosum, whereas the dextrorotatory 
enantiomers, (+)-32a and (+)-32b, are constituents of C. robustum.6  A 
considerable confusion concerning the stereochemistry of these compounds 
resulted mainly from the fact that they occur naturally as both enantiomers.  The 





32a R = Me




   31a R = Me
   31b R = H
 
 
Recently, the diarylheptanoids renealtin A (33a) and renealtin B (33b), featuring a 
trisubstituted tetrahydrofuran ring, have been isolated from the seeds of Brazilian 













 (33a)   H-3 α
 (33b)   H-3 β
 
 
Cyclocurcumin (34) was isolated by Kiuchi et al.21 as a novel constituent of the 
active (nematocidal activity against second stage larvae of dog ringworm) fraction 
of Curcuma longa and is a 2,6-disubstituted dihydro-2H-pyranyl-4-one.  The 
structure of 34 was elucidated on the basis of spectral data and confirmed by 
partial synthesis from curcumin (19) (by an intramolecular Michael-type addition 
reaction).2  As no specific rotation is indicated, the natural product is probably 
racemic.  A good antileishmanial activity for diarylheptanoid 35, isolated from C. 















2.2.3 BIARYL-TYPE OF DIARYLHEPTANOIDS 
 
Acerogenin E (36a), is a biaryl-type diarylheptanoid originally isolated from Acer 
nikoense (Aceraceae).23  This compound has also been isolated from Betula 
platyphylla (Betulaceae)24, and its reduced analogue, acerogenin K (36b), was 
shown to be a constituent of Acer nikoense.25  The tree is indigenous to Japan and 
has been used in folk medicine as a remedy for hepatic disorders and as an 
eyewash.1  A cyclic diarylheptanoid (37) isolated from Myrica rubra (Myricaceae) 
has been proven to be the most active antitumour promoting agent among several 
tested cyclic diarylheptanoids.26  Moreover, a novel biaryl-type diarylheptanoid, 6’-
hydroxygaruganin V (38), has been recently isolated from Garuga pinnata 
(Burseraceae) by Ara et al.27  The tree is indigenous to eastern part of Asia and is 
traditionally used to treat various diseases including asthma, opacity of cornea, 
















 36a  R = O






2.2.4 DIPHENYL ETHER-TYPE OF DIARYLHEPTANOIDS 
 
Acer nikoense (Aceraceae) is also a source of novel diphenyl ether-type 
cyclophanes such as acerogenin M (39) recently isolated by Akihisa et al.28  
Evaluation of acerogenin M for the inhibitory effects on 12-O-
tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mice (1 µg/ear) 
showed a marked anti-inflammatory effect with a 50% inhibitory dose (ID50) of 
0.26-0.81 mg per ear.  In addition, upon an evaluation against the Epstein-Barr 
virus early antigen (EBV-EA) activation induced by TPA exhibited moderate 
inhibitory effects against EBV-EA induction (IC50 values of 356-534 mol ratio/32 







The platycarynols 40a and 40b were isolated from Platycarya strobilacea29 
(Juglandaceae) and from the inner bark of Betula platyphylla,24 respectively, and 
their stereochemistry have been determined.  The structure of (+)-galeon (41a) 
isolated from Myrica gale var. tomentosa was solved with the help of X-ray 
crystallographic analysis of the corresponding p-bromobenzoate by Nagai et al.30, 
while earlier report revealed that (–)-galeon 41b is also a constituent of this plant.31  
Recent findings suggest that (+)-galeon (41a) has a potent cytotoxic activity 
against selected cancer cell lines (human colon carcinoma and human lung 
carcinoma cell lines with IC50’s ranging from 2 to 25 µg/mL).32  The absolute 






















41a 41b  
 
2.2.5 COMPLEX DIARYLHEPTANOIDS 
 
Masuda et al.33 isolated a series of novel acyclic curcuminoids, the cassumins A 
(42a), B (42b) and C (43) together with the cyclic cassumunarins A (44), B (45a) 
and C (45b) from the rhizomes of the tropical ginger (Zingiber cassumuna).34   
Interestingly, the antioxidative and anti-inflammatory activities of these compounds 
were found to be significantly stronger than those of curcumin (19).  Their 
formation is the result of an electrophilic aromatic substitution of curcumin (19) or 








42a  R = H  































45a  R = H    
45b  R = OMe    
 
 
The most complex diarylheptanoids bearing a chalcone (46) or flavanone (47) 
moiety have been isolated from the seeds of Alpinia blepharocalyx35 
(Zingiberaceae) by Prasain7,35 and his co-workers and showed inhibitory activity 
against nitric oxide production in activated murine macrophages.  Another complex 
diarylheptanoid is blepharocalyxin E (48) recently isolated from Alpinia 
blepharocalyx (Zingiberaceae) showed a particular promise as a potential drug 
candidate for the treatment of human tumours, displaying in vitro inhibitory activity 



























































These compounds combine the structural features of the aforementioned 
curcuminoids (intra- and intermolecular cyclisations, extension with non-
diarylheptanoid moieties).  To date numerous diarylheptanoids have been 
described and due to the complexity of the compounds, further structural revisions 
are in progress.  Moreover, as there are many possible reactions with potential 
precursors, even more complex diarylheptanoids can be expected to be found in 
future investigations.37  From the discussion above it can be seen that a wide 
variety of diarylheptanoids have been isolated from plants and that a large number 
of these compounds are associated with biological activities. 
 
2.3 SYNTHESIS OF DIARYLHEPTANOIDS 
 
2.3.1 SYNTHESIS OF LINEAR DIARYLHEPTANOIDS 
 
Linear diarylheptanoids have relatively simple structures that can be easily 
accessed by today’s synthetic methodologies.  In this section, linear 
diarylheptanoids will be discussed according to the oxygenation level of the tether 
chain, namely, with one oxygen functional group, two oxygen functional groups 













functional groups  
 
FIGURE 2.4: Incorporation of oxygen functions into the tether chain. 
 
Retrosynthetic methodologies of linear diarylheptanoids may be classified 
according to the efficient ways to assemble the seven carbon aliphatic chain, 
namely, C3-moiety + C4-moiety strategy, C1-moiety + C6-moiety strategy, C1-
moiety + C5-moiety + C1-moiety strategy and C2-moiety + C5-moiety strategy, 
respectively (Scheme 2.1).   
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The assembly of these synthons can be accomplished using various types of 
reactions such as nucleophilic addition to an aldehyde, alkylation of a 1,3-dithiane 
(umpolung strategy), aldol condensation and other types of condensation and 
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SCHEME 2.1: Disconnection approach of linear diarylheptanoids. 
 
a) Diarylheptanoids with one oxygen functional group 
 
For the synthesis of diarylheptanoid 53, Whiting and his co-workers38 developed 
an umpolung method based on dithiane chemistry (Scheme 2.2).  Alkylation of 
lithiated dithiane 50 by iodide 51 gave 52 in 33% yield.  Hydrolysis of the latter 
gave the diarylheptanoid 53 in 73% yield.  The C3-moiety + C4-moiety strategy 




























A Claisen-Schmidt reaction was employed for the synthesis of the two pungent 
principles of Alpinia oxyphylla (Zingiberaceae)39, namely, yakuchinone A (57) and 
yakuchinone B (56) (Scheme 2.3).40  Thus, condensation of vanillin (54) with 6-
phenyl-2-hexanone (55) gave yakuchinone B (56) in 80% yield, and hydrogenation 
then gave yakuchinone A (57).  This synthetic method is quite general and has 
been applied for the preparation of a number of analogues.40  It was found that the 
presence of the phenolic hydroxy group was responsible for a high pungency, 
while unsaturation in the aliphatic chain tends to decrease the pungency.  
Yakuchinone A (57) is reported by Kiuchi et al.41 as a potent inhibitor of 
prostaglandin synthase (IC50 = 0.51 µM) and 5-lipoxygenase and could be the 






















Diarylheptanoids containing a dienone moiety have been synthesised by a Wittig 
reaction between phosphorane 59 and cinnamaldehyde (60) in 56% yield 
(Scheme 2.4).42  Recently, a novel diarylheptanoid containing a dienone moiety 

























b) Diarylheptanoids with two oxygen functional groups 
 
The first laboratory synthesis of 1,7-diarylheptanoids with two oxygen functional 
groups was that of curcumin (19) accomplished in 1918.44  A practical industrial 
synthesis of curcumin (19) was needed due to its importance as food additives, 
dye, and its recently demonstrated chemopreventive effect.  Such syntheses were 
developed by Pavolini45 and later improved by Pabon46 (Scheme 2.5).   
 
Reaction of vanillin (54) with 2,4-pentanedione (62), pretreated with boric 
anhydride, in the presence of triisopropylborate and butylamine gave curcumin 
(19) in 80% yield.  In order to obtain a high yield of curcumin (19), the C-3 of 2,4-
pentanedione had to be protected to avoid the undesired Knoevenagel 
condensation.  This was achieved by reaction of 2,4-pentanedione with boric 
anhydride to produce the presumed boron complex 63.  The method is quite 
general and has been applied to the synthesis of other symmetrical natural and 
non-natural 1,7-diarylheptanoids.47  Recently, the same method has been 






















c) Diarylheptanoids with three oxygen functional groups 
 
Some relatively rare linear diarylheptanoids contain three oxygen functional 
groups.  Among the few examples of these diarylheptanoids are 
yashabushiketodiol A (69) and yashabushiketodiol B (70), which have been 
isolated from Alnus sieboldiana.49  An enantioselective synthesis of these 




































2.3.2 SYNTHESIS OF CYCLIC DIARYLHEPTANOIDS 
 
Macrocyclic compounds have attracted much attention by synthetic chemists due 
to their outstanding biological activity and the intrinsic challenges associated with 
their construction.51  The central issue in planning the synthesis of a macrocyclic 
compound is the ring closure.  The outcome of such a reaction depends on both 
the choice of a strategic bond and the reaction selected for its construction.  Two 
obvious strategic bond disconnections for the synthesis of cyclic diarylheptanoids 
are outlined in Scheme 2.7.  The one synthesis involves the formation of carbon-
carbon bond at the tether chain, whereas the other strategy calls for the 





























X and Y = any halide n + m = 7
 
 
SCHEME 2.7: Disconnection approach of cyclic diarylheptanoids. 
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Recently, some new powerful ring closing methods have been developed in 
addition to the well-adopted macrolactonisation reactions.52  These methods 
include intramolecular Ullmann reaction,53 Prins cyclisation strategy,54 
intramolecular Wittig-type reactions,55 intramolecular oxidative coupling,56 
intramolecular nucleophilic aromatic substitution reaction (SNAr),
57 photocyclisation 
reaction,58 asymmetric synthesis of tetrahydrofuran ring20 and transition metal-
catalysed reactions.59   In the synthesis of macrocyclic diarylheptanoids, chemists 
do not only have to find the right way to perform the cyclisation but also need to 
control the atropisomerism and that become even more challenging.   
 
2.3.2.1 Total synthesis of bridged biphenyl macrocycles 
 
(a) Ring closure via aryl-aryl bond formation 
(i) Nickel(0)-promoted intramolecular reductive coupling of arylhalide 
 
The most powerful methods for the construction of biaryl unit using transition 
metal-catalysed cross-coupling reactions are the Suzuki, Stille, Ullmann and 
Negishi reactions.60  Semmelhack61 provides a significant contribution to the field 
by introducing the zerovalent nickel-promoted intramolecular coupling of an aryl 
halide (Scheme 2.8), though this cyclisation technology fails with sterically 













n = 1, yield 81%
n = 4, yield 85%




In addition to the above synthetic strategy of Semmelhack et al.61, the total 
synthesis of alnusone (75) was developed (Scheme 2.9).  Heating a solution of 
diiodide 73 in DMF in the presence of tetrakis(triphenylphosphine)nickel afforded 
the 13-membered meta,meta-bridged biphenylmacrocycle 74 in 46% yield.  
Deprotection of the MOM ethers under acidic conditions gave the natural alnusole 















25 oC  20  min,  then 50  oC 40 h
46%
73
74  75  
SCHEME 2.9 
 
(ii) Photochemical aryl-aryl bond formation 
 
An important technique for the construction of the biaryl bond is by 
photocyclisation of an appropriate aryl halide.58  Whiting and Wood also applied 
this photolytically-induced radical cyclisation in the synthesis of dibenzylmyricanol 
(77) (Scheme 2.10).62  Thus, irradiation of the bromide 76 in ethanolic sodium 




















(iii) Intramolecular oxidative coupling 
 
Oxidation of linear diarylheptanoid 78 has also been examined.62  Utilisation of 
oxidising agents such as potassium hexacyanoferrate, silver oxide, manganese 
oxide, and vanadium oxychloride gave only tars, whereas thallium 
tris(triflouroacetate)-induced intramolecular C-O coupling afforded the 15-

















2.3.2.2 Total synthesis of m,p-cyclophanes 
 
A long-standing problem is the synthesis of biaryl ethers with sensitive 
functionalities.  Until recently, the classical Ullmann ether synthesis, using copper 
or copper salts, was regarded as less effective and required harsh conditions.53  
This was a result of the poor nucleophilicity of phenoxide and the low reactivity of 
aryl halides involved in the reaction.   
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An attempt to synthesise a biologically active (as an antibiotic) vancomycin 
complex has led to the development of a number of new powerful synthetic 
technologies such as cyclisation through aliphatic C-C bond formation and 
cyclisation through aryl-aryl ether bond formation.63   
 
(a) Formation of macrocycle via formation of aliphatic C-C bond through 
intramolecular Wittig-type reaction 
 
A developed synthesis of garuganin III (83), featuring the ring formation through 
aliphatic C-C bond formation using intramolecular Wittig reaction as a key, is 







































The addition of potassium tert-butoxide to a dilute solution of compound 80 in DMF 
produced macrocycle 81 in 67% yield.   
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Hydrogenation over platinum oxide doped with Raney nickel reduced 
simultaneously the olefin and the N-O bond leading to the enaminoketone 82.  
Garuganin III (83) was isolated from a mixture of regio- and stereoisomers after 
acidic hydrolysis and methylation of the intermediate1,3-diketone. 
 
(b) Ring formation via aryl-aryl ether bond formation 
(i) Intramolecular SNAr reaction 
 
The investigation of the cyclisation of a linear diarylheptanoid through aryl-aryl 
ether bonds has resulted in the discovery of an efficient and unified synthesis of 



















SCHEME 2.13: Retrosynthetic analysis of m,p-cyclophane. 
 
Optically active natural products containing planar chiral cyclophane, such as (R)-
(+)-galeon (40a) and (S)-(–)-galeon (40b) have been isolated and the 
enantioselective cyclisation leading to the planar chiral cyclophanes by 
intramolecular SNAr was first designed by Zhu et al.
65   
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The mechanism of cyclisation was based on utilising an achiral linear 
diarylheptanoid with an ortho fluoro nitro aryl as to create a parallel planar chirality 
(Scheme 2.14).  Potassium carbonate and caesium fluoride were previously used 
to promote cyclisation of the achiral linear diarylheptanoid and Zhu65 found that 
tetrabutylammonium fluoride and tetrabutylammonium hydroxide were also able to 
promote the cyclisation as well.  With these results Zhu and his co-workers 
investigated atropenantioselective cyclisation using chiral quaternary ammonium 
































R = H, X = OH or F
R = allyl, X = F




SCHEME 2.14: Atropenantioselective cycloetherification process. 
 
(ii) Intramolecular Ullmann reaction 
 
Parallel to the work of Islas-Gonzalez et al.66 to synthesise acerogenin A (90) and 
acerogenin C (89) by implementation of an intramolecular SNAr reaction, an 
Ullman ether synthesis has been recently employed by Jeong et al.53 for the 




84a  R1 = OH, R2 = H, R3 = OMe, R4 = Br
84b  R1 = OH, R2 = OMe, R3 = OBn, R4 = Br





















85a  X = C=O, Y = CH2, 
          A = H, B = OMe
85b  X = C=O, Y = CH2, 
          A = OMe, B = OBn
85c  X = CH2, Y = C=O, 




























Their strategy employs a substituted diarylheptanoid 84 which was subjected to an 
Ullmann67 reaction by using catalytic CuO/K2CO3 to yield the corresponding 
diphenyl ethers 85a, 85b and 85c in 49, 52 and 76% yield, respectively.   
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The O-demethylation of diarylheptanoids 85a and 85c by AlCl3 afforded 
acerogenin L (86) and acerogenin C (89) in 86 and 89% yield, respectively.  The 
selective cleavage of the benzyl ether of diarylheptanoid 85b by catalytic 
hydrogenation quantitatively yielded the desired galeon (41) as a racemic mixture 
of rotamers, which was then subjected to O-demethylation by AlCl3 to afford 
racemic pterocarine (88) in 88% yield.  Similarly, reduction of acerogenin L (86) 
and acerogenin C (89) with NaBH4 afforded the corresponding alcohols of 
acerogenin B (87) and acerogenin A (90), respectively. 
 
Methods for the synthesis of natural diarylheptanoids have set a clear view of the 
constitution and chemical properties of diarylheptanoids which enhance their 
biological activity.  This include the variation of the aryl end groups with either a 
free or protected phenolic hydroxy at both or either ends of the tether chain and 
incorporation of oxygen functions and other functional groups into the chain. 
 
2.4 SIPHONOCHILUS AETHIOPICUS 
 
Siphonochilus aethiopicus BL. Burtt (Zingiberaceae), commonly known as wild 
ginger or Natal ginger is regarded as one of the most important and threatened 
medicinal plants in South Africa.68  The generic name Siphonochilus is derived 
from the Greek word Siphono meaning tube and Chilus meaning lip in reference to 
the shape of the flower while the species name aethiopicus means from Southern 
Africa. 69  The plant originated from southern tropical Africa (South of Malawi to the 
Eastern part of South Africa).3  Wild ginger is a forest floor plant with aromatic 
rhizomatous roots, leaves that are deciduous and sprout annually from the 
underground stem in spring (Fig. 2.5).   
 
This South African wild ginger is highly prized for its medicinal value and as a 
result it has been over-harvested from the wild to a point just short of total 
extinction.  The cone shaped rhizomes and fleshy roots are dug up and sold on 
the ‘muthi’ markets around the Country because the highly aromatic roots have a 
variety of medicinal and traditional uses.   
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The rhizomes and roots are chewed fresh to treat the following ailments: 
headache, influenza, mild asthma, sinusitis and sore throat, thrush, candidiasis, 
























FIGURE 2.5: Siphonochilus aethiopicus. 
 
There is little information that gives insight on the chemical constituents of S. 
aethiopicus.  The volatile oil contains sesquiterpene 17 of the furanoid type as the 
main component but large numbers of other terpenoids are present in the 






Siphonochilon (17)  
Photo: B-E van Wyk 
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The terpenoids may be responsible for the reported beneficial effects of wild 
ginger in the treatment of colds and flu.  Like many other volatile oils these should 
have a decongestant and antiseptic action, but further research is required.  
According to Viljoen et al.75, the essential oil composition of the roots and 
rhizomes of S. aethiopicus obtained through hydrodistillation is reported to have 
the following major compounds, namely: 1,8-cineole, (E)-β-ocimene, cis-
alloocimene, together with the recently reported furanoterpenoid, which is the 
major compound in both plant organs.   
 
An interesting pharmacological report by McGaw et al.76 in which the scientist 
tested a number of Zulu medicinal plants used in the treatment of pain and 
inflammation was published.  In an assay considered to disrupt the inflammation 
process, ethanolic extracts of Siphonochilus aethiopicus were found to exhibit 
higher inhibitory activity than indomethacin, a standard pharmaceutical drug used 
as anti-inflammatory.   
 
A screening of plants used by southern African traditional healers in the treatment 
of dysmenorrhoea for prostaglandin-synthesis inhibitors and uterine relaxing 
activity, has been reported by van Lindsey et. al.77.  The highest activity was 
obtained with ethanolic extracts of S. aethiopicus.  
 
Despite the importance of S. aethiopicus as medicinal plant of South Africa, there 
is a lack of knowledge of S. aethiopicus in some aspects which includes its 
pollination biology, genetics, chemical diversity and flowering initiation as stated in 
the literature.70  Total synthesis of its natural occurring metabolites has not been 
covered yet and studies of this nature may be useful aspect that we aimed to 
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CHAPTER 3 






In the previous chapter, retrosynthetic methodologies of linear diarylheptanoids 
were classified according to the different ways to assemble the seven-carbon 
aliphatic chain, namely, the C2-moiety + C5-moiety strategy and C1-moiety + 
C6-moiety strategy were selected for this study in order to construct 
diarylheptanoid 18, a specific stereoisomer of the novel diarylheptanoid 16 
isolated from Siphonochilus aethiopicus.  The assembly of these synthons 
could be accomplished using various types of reactions such as olefination 
reactions (including Wittig, Julia and organometallic-mediated type of 
olefination reactions) as well as alkylation reactions (including Grignard, 
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Diarylheptanoid (18)  
 
Taking into account the stereochemistry in the seven-carbon aliphatic chain of 
the compound, incorporation of the stereogenic centres can be accomplished 
by asymmetric hydroxylation reaction or use of chiral starting materials to 
furnish these asymmetric centres.  In this chapter, an investigation of two 







































Structural analysis of the target compound reveals two electron-rich aromatic 
rings linked by a seven-carbon aliphatic chain with two stereogenic centres and 
a trans-alkene.  The intended homobenzylic trans-alkene can be established 
using various ways of selective E-olefination that will be discussed in this 
chapter.   
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The chirality of the vicinal diols will be generated either by the use of chiral 
starting material with stereodefined vicinal diols or by asymmetric 
dihydroxylation.  Another concern is the coupling of the highly oxygenated aryl 
rings to the aliphatic chain that can be introduced using various types of 
alkylation reactions to furnish the C-C bond formation. 
 
Based on the retrosynthetic analysis outlined in Scheme 3.1, a synthetic 
strategy was developed as depicted in Scheme 3.2 which made use of a 






































3.2.1 Synthesis of phenacetaldehydes 91 and 95 
 
The first target was to obtain precursor 91, which was required for the 
stereocontrolled olefination.  Vanillin (54) was chosen as the readily available 
starting material (Scheme 3.3).   
 
A convenient method described by Yang et al.1 was followed for the synthesis 
of 3-bromovanillin (96) in excellent yield of about 95%.  Copper-catalysed base 
hydrolysis of 3-bromovanillin (96) was performed as described by Ellis and 























The next step was the selective methylation of 3,4-dihydroxy-5-
methoxybenzaldehyde (97) at the 4-position.  The differentiation in the reaction 
rate between the two hydroxy groups of the compound 97 is not sufficient to 
get selective methylation at the 4-position in a reaction with K2CO3 and MeI, 
even though the presence of the para electron–withdrawing aldehyde function 
causes the 4-OH to be more reactive than the 3-hydroxy group.  Therefore, a 
method developed by Zhu et al.3,4and Pearson and Bruhn5 on selective 
protection of the 4-position of gallic acid was followed.  The proposed pathway 
for this step is outlined in Scheme 3.4 (97→98→99→100). 
 
On the other hand, Ellis and Lenger2 developed another method for the 
selective methylation at the 4-position where they utilised a weak base like 
Na2CO3 to abstract the reactive proton of the 4-OH followed by Me2SO4 as the 




































The first reaction involved the heating of the di-acetate 98 in DMF at 40 oC in 
the presence of K2CO3 and MeI to give exclusively the 4-methoxylated 
compound 100.  The selectivity of this reaction may be explained by the trace 
of water present in the reaction medium that may selectively hydrolyse the 
reactive 4-acetyl group leading to the formation of the intermediate 99, which is 
stabilised by the conjugation effect of the aldehyde function.  Subsequent 
methylation gave the desired product 101 in 80% yield.  Alternatively, when 
compound 97 was subjected to selective methylation in the presence of 
Na2CO3 and Me2SO4 the desired product was furnished in 65% yield along 
with the presence of the other regioisomeric by-product (4-hydroxy-3,5-
dimethoxybenzaldehyde) in trace amounts and about 10% of the over-
methylated by-product (3,4,5-trimethoxybenzaldehyde).  The 1H NMR 
spectrum of the di-methoxylated compound 101 displayed the expected signals 
including two methoxy groups (δH 3.82 and 3.91), the sharp singlet of the free 
hydroxy group (δH 6.36) and another sharp singlet of an aldehyde proton (δH  
9.79).   
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A carbonyl signal (aldehyde), two methoxy signals and six aromatic carbon 
signals were observed in the 13C NMR spectrum.  The MS spectrum revealed 
an [M+H]+ base peak of 183.1812 corresponding to the mass of the desired 
compound 101.  Subsequently, the free hydroxy group of compound 101 was 
protected as an isopropyl ether to eliminate the formation of side products 
when subjecting the compound to further synthetic steps.  The protected 
compound 102 was homologated by the Wittig-reaction following a convenient 
method described by Treu and Jordis.6  Subsequent hydrolysis of the enol 
ether 103, isolated as the mixture of cis/trans isomers (67:33, E:Z ratio), gave 

































The structure of compound 91 was confirmed by 1H NMR which displayed the 
expected signals including the aldehyde as a triplet (δH 9.71), isopropyl ether 
signals [δH 4.49 (CH) and 1.31 (2 x CH3), α-CH2 of acetaldehyde (δH 3.57) and 
the two methoxy signals (δH 3.83).  In the 13C NMR, all the expected signals 
were observed including the carbonyl peak of an aldehyde (δC 199.3) and the 
molecular formula of the compound was confirmed by MS.   
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The next step was to synthesise precursor 95.  Vanillin (54) was again chosen 
as the starting material for the synthesis (Scheme 3.6).  Protection of the free 
hydroxy group of vanillin (54) as an isopropyl ether gave compound 104 in 
good yield.  Subsequently, compound 104 was homologated by Wittig reaction 
followed by acid hydrolysis employing the above-mentioned method of Treu 
and Jordis6 to furnish the desired precursor 95 in 75% yield.   
 
The presence of the compound was confirmed by 1H NMR which displayed the 
expected signals including the aldehyde as a triplet (δH 9.23), the isopropyl 
ether signals [δH 4.04 (CH) and 0.98 (2xCH3)], the α-CH2 of the acetaldehyde 
(δH 3.05) and the methoxy signals (δH 3.45).  In the 13C NMR all the expected 


























The synthesis of precursor 94 (see Scheme 3.2) was performed in a one-step 
reaction where the free hydroxy group of the readily available 3-bromopropanol 
was protected as the tetrahydropyranyl ether to obtain the desired compound 




3.2.2 SELECTIVE E-OLEFINATION STRATEGIES 
 
The next step was to develop a selective E-olefination reaction that could link 
two precursors in the construction of the target molecule.  Different approaches 
followed towards the olefination reaction will be discussed in this section. 
 
3.2.2.1 Wittig olefination 
 
Initially, propyltriphenylphosphonium bromide (106) was used in a model 
reaction to develop reaction conditions for the Wittig reaction with precursor 91 
(Scheme 3.7).  Though several attempts were made using different bases and 

















base = NaH or KOtBu or BuLi or LDA




Another attempt to the Wittig reaction used the precursor 91 and the 
commercially available (3-bromopropyl)triphenylphosphonium bromide (108) 
with the intention to form compound 109 which, when subsequently subjected 
to further reactions, should furnish precursor 105 in a shorter way (Scheme 
3.8).  However, the desired alkene (109) was not obtained.  Instead compound 
108 underwent an intramolecular nucleophilic substitution reaction on 
successive treatment with two equivalents of base to furnish the 
cyclopropyltriphenylphosphonium salt (110) as described by Utimoto et al.7 
When compound 110 is subjected further to Wittig reaction conditions, it failed 


































Solvent = THF or Diethyl Ether
base = BuLi or LDA or NaH or KO tBu  





3.2.2.2 Julia olefination 
 
It was therefore decided to carry out the preparation of the trans-alkene by 
Julia8 olefination.  A model reaction was utilised in an attempt to form an E-
alkene by Julia olefination.  This process began by the reaction between the 
sodium salt of benzenethiol (112) with butyl bromide (113) to form thioether 
114 (Scheme 3.9).  Subsequent oxidation of thioether 114 gave the sulfone 
115 which was condensed with phenylacetaldehyde (116) in the presence of 
the base to furnish the diastereomers of β-hydroxy sulfones (117).  Protection 
of the resultant hydroxy group with benzoyl chloride converted the mixture of 
alcohols into a mixture of β-benzoloxy sulfones (118).   
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The intended elimination reaction was performed on the mixture of β-
benzoyloxy sulfones (118) using sodium amalgam but the reaction led to the 
formation of two undesired products (Scheme 3.9).  Firstly, compound 119 was 
isolated when the reaction was performed using a solvent mixture of 
THF/MeOH (3:1) while compound 121 was isolated in 70% yield in the 
































THF, -20 oC, 70%
1. Na(Hg), Na2HPO4, THF, -20 oC






The presence of compound 119 shows the reductive cleavage of a sulfone 
functional group and hydrolysis of an ester functional group to yield the 
undesired alcohol.  On the other hand, the formation of the undesired alkene 
121 highlights the high reactivity of the benzylic protons.  The structure of 
compound 119 was confirmed by the 1H NMR spectrum which displayed the 
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proton signals of the CH with an attached hydroxy group as a doublet of triplet 
(δH 3.8), the expected aromatic protons signals and the aliphatic chain protons 
with the protons signals of the terminal CH3 as triplet (δH  0.93).  The 13C NMR 
spectrum was in agreement with structure 119. The distinctive carbon signal of 
a CH with an attached hydroxy group (δC 72.7), was present in the spectrum.  
Also, the structure of compound 121 was confirmed by 1H NMR spectroscopy 
which reveals the presence of a trans double bond proton signals as doublet of 
doublet and a doublet [δH 5.88 (J = 15.6 and 9.6 Hz) and 6.24 (J = 15.6 Hz)].  
The 13C NMR spectrum of 121 was in agreement with the proposed structure. 
 
In another attempt to achieve this elimination, procedure described by Lee et 
al.9 was followed whereby the substrate was treated with magnesium in 
ethanol.  However, only starting material was recovered in this reaction. 
 
3.2.2.3 β-Nitro xanthates as olefin precursors 
 
Upon failing to perform elimination in the Julia reaction, other types of 
elimination procedures were investigated including radical elimination of 
nitrogen dioxide to form olefins.  This approach reported by Zard10 required β-
nitro xanthates, which undergo elimination to give the corresponding olefins in 
good E-selectivity in the presence of a source of reactive radicals.  The 
process begins with addition of potassium O-ethyl xanthate to α,β-unsaturated 
nitro compounds to give stable β-nitro xanthates which upon heating with 
lauroyl peroxide as source of reactive radical give the trans-alkene in good 
selectivity.10  In order to ascertain the feasibility of this approach, compound 
104 was transformed to the α,β-unsaturated nitro compound 122 by treatment 
with nitromethane and 5% KOH (Scheme 3.10).11  Reduction of the α,β-
unsaturated nitro compound 122 with borohydride exchange resin (BER) 
afforded the saturated nitro derivative 125 in 90% yield.12,13   
 
Addition of the nitro compound 125 to the aliphatic aldehyde 124 gave the β-
hydroxy nitro compound 126 in good yield.  3-Benzoyloxypropanal (124) was 
obtained by selective protection of 1,3-propanediol followed by oxidation of the 
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free hydroxy group with Dess-Martin reagent.  Acetylation of compound 126 





























1. CH3NO2, 5%  aq. KOH










The next step was to prepare the β-nitro xanthate 128 from the acetylated 
adduct 127.  This compound was obtained in a very poor yield of about 30% as 
a mixture of diastereomers that were also observed by Zard.10  Upon 
subjecting the β-nitro xanthate 128 to radical elimination using lauroyl peroxide 
as a reactive radical in refluxing 1,2-dichloroethane, no desired olefination was 
observed.  The structure of the β-nitro xanthate 128 was confirmed by 1H NMR 
and 13C NMR with all the expected signals present.  From the reactions 
described above, it is clear that the approach to a diarylheptanoid described in 
Scheme 3.2, is not feasible due to the extreme reactivity of the benzylic 





















SCHEME 3.10 (continued) 
 
3.3 THE ALTERNATIVE ROUTE TO THE CONNECTION 
OF PRECURSORS 
 
Upon failing to use the previous strategy as a way to link the fragments of the 
target molecule, another way of connecting the precursors was devised.  In this 
strategy, the aldehyde functional group was positioned on the aliphatic chain 
as to avoid the highly reactive aryl-acetaldehyde bearing an α-carbon which 
may undergo self condensation.  With this in mind, a strategy was developed 
to use carbohydrates as chiral starting materials.  Carbohydrates are naturally-
occurring organic compounds with readily available aldehyde functional group 
and gifted with a wealth of stereodefined attributes.  Their advantage is that 
they are available in a variety of cyclic and acyclic forms, in a variety of chain 
length and lastly some of them are relatively cheap.  The only disadvantage 
with them is that some are easily decomposed at certain elevated 
temperatures and need to be handled with care.  Besides that, one can be able 
to modify their chains either by chain elongation or cleavage and to create or 




3.3.1 Retrosynthetic Analysis 
 
The alternative retrosynthetic analysis of the target molecule is based on two 
highly oxygenated aromatic rings that are linked to a 2-deoxypentose as the 
readily available aliphatic aldehyde (Scheme 3.11).  The process will use the 
modified selective E-olefination methods to introduce the desired trans-alkene 
that will serve as the connection to the other side of the highly oxygenated 
aromatic ring.  The modified olefination methods include an improved Julia 
olefination, an improved Wittig reaction and organometallic-mediated 
olefination reactions.  Various C-C bond formation methods will be investigated 
in order to couple the other aromatic ring to the aliphatic chain.  These various 
C-C coupling reactions are Friedel-Crafts acylation or alkylation, Grignard 
reaction and organometallic-mediated alkylation reactions.   
 
In order to synthesise enantiomerically pure vicinal diols, the 2-deoxypentose 
was a key principle of the synthetic plan with an easy access to erythro and 
threo diols.  The 2-deoxypentose was intended to serve not only as a chiral 
starting material but also as a locus for attaching the highly oxygenated 
aromatic rings.  The 2-deoxypentose was prepared from D-xylose while D-
arabinose and the readily available 2-deoxy-D-ribose were also investigated to 
elaborate the synthesis of other enantiomers. 
 
The synthesis was planned as outlined in Scheme 3.12. Two pathways were 
investigated for the assembly of the precursors where path (a) begins the 
construction of the molecule with a selective E-olefination reaction while path 













































































































3.3.2 Synthesis of precursors 
 
Synthesis of 130, a coupling partner for chiral aliphatic aldehyde 132, was 
prepared from 101 using a methodology developed by Fernandes et al.15  The 
first step was the protection of the free hydroxy group of compound 101 as a 
benzyl ether to form 138 in 85% yield (Scheme 3.13). The subsequent Wittig 
olefination furnished compound 140 in 90% yield, which upon 
hydroboration/oxidation, afforded the alcohol 141 in quantitative yield.  The 
primary hydroxy group of compound 141 was converted into the tosylate 142, 
which underwent nucleophilic displacement with sodium iodide in refluxing 























2. NaOH in EtOH/H2O (2:1)






















The structure of compound 130 was confirmed by the 1H NMR spectrum which 
reveals a CH2 signal shifted to a higher field by 0.89 ppm as compared to that 
of tosylate compound 142, indicating replacement of the tosylate group.  In the 
13C NMR spectrum all the expected signals were observed and the molecular 
formula of the compound was confirmed by MS. 
 
The next step was to convert 130 into useful coupling adducts, namely, Wittig 
reagent16 143 and Julia olefination adduct17,18,19 146 (Scheme 3.14).  Firstly, 
compound 130 was converted into the essential Wittig reagent 143 that may 
undergo selective E-olefination as one of the fragment linkage methodologies.  
Compound 130 was reacted with excess triphenylphosphine in refluxing xylene 
to form the desired Wittig reagent 143 in almost 100% yield (Scheme 3.14).  
The presence of a phosphonium salt was confirmed by the high melting point. 
The solubility in different solvents also indicated that the precipitate consisted 




































1. NaH, THF, 0 oC
SCHEME 3.14 
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The Julia olefination adduct was also prepared from precursor 130 in a two-
step reaction as illustrated in Scheme 3.14.  The process begins with 
nucleophilic substitution of compound 130 with 144 to furnish the desired 
thioether 145 in a good yield which upon subsequent oxidation with oxone 
(2KHSO5.KHSO4.K2SO4) gave the desired Julia olefination adduct 146 in 91% 
yield.  The presence of the compound was confirmed by the 1H NMR spectrum 
which reveals a CH2 signal shift to a lower field by 0.29 ppm as compared to 
that of thioether 145 indicating oxidation of the thiol group. The 13C NMR 
spectrum was in agreement with the proposed structure and the molecular 
formula of the compound was confirmed by high-resolution mass spectrometry. 
 
Synthesis of precursor 133 was accomplished in a two-step reaction where the 
commercially available guaiacol (135) was subjected to selective bromination 
at the position para to the free hydroxy group to obtain the bromo guaiacol 147 
in 90% yield (Scheme 3.15).20  The position of the bromo substituent was 
confirmed by performing a NOE experiment.  The results showed a clear NOE 
effect between the methoxy protons and the aromatic proton with a meta-
coupling only, thereby confirming the position of the bromine.  Compound 135 
was further protected as a benzyl ether to obtain the desired precursor 133 in 



















The chiral aldehyde 132 required for olefination reactions with the Wittig 
reagent 143 or Julia olefination adduct 146 was prepared from D-xylose (148) 
as outlined in Scheme 3.16.  Thus, using literature precedent,21,22,23 D-xylose 
(148) was first converted into known dithioacetal 149, which was protected as 






















































Base-promoted elimination led to dithioketene acetal 151 in 75% yield 
(Scheme 3.16).  The free hydroxy group of dithioketene acetal 151 directed a 
hydride reduction to give the 2-deoxysugar derivative (153) in 60% yield.  To 
determine whether the free C-3 hydroxy group of dithioketene acetal 151 is 
required for reduction of the compound, the 3-O-benzyl ether of the 
dithioketene acetal 151 was prepared to give compound 152.  Attempted 
reduction of this derivative 152 with lithium aluminium hydride failed.  A simple 



















































These results demonstrated that reduction proceeds via hydride transfer at C-
2, with water serving as the proton donor at C-1.24 
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Because of the obligatory requirement for the free C-3 hydroxy group, the 
reaction is envisaged to proceed via directed hydride transfer through the 
alkoxyaluminium hydride salt 154 to yield the stabilised carbanion 155 or the 
cyclic alkoxy aluminium salt 156.  Hydrolysis of the latter salt during work-up 
would then result in the observed incorporation of the solvent hydrogen to 
obtain compound 153 in 60% yield.   
 
The next step was the mild aqueous acid hydrolysis of 2-deoxysugar derivative 
153 to yield the 2-deoxy-D-threo-pentose diethyl dithioacetal (157) in almost 
75% yield (Scheme 3.18).  The high solubility of compound 157 in water led to 
difficulties in extraction of the compound.  Therefore, the water was removed 
by the additional of ethanol and the resulting azeotrope was removed under 
vacuum.  This was to eliminate removal of water at elevated temperatures as 







































The primary hydroxy group of compound 157 was converted into the tosylate 
158 in 60% isolated yield.  Subsequent protection of 158 as the acetonide gave 
compound 159 which underwent nucleophilic displacement with sodium iodide 
in refluxing acetone to form 160 in 90% yield.  The next step was to perform 
hydrolysis of the diethyl dithioacetal in order to obtain the desired aldehyde 
132.  However, this step was postponed as it was planned to link the first two 
fragments through path b (Scheme 3.12) and the presence of an unprotected 
aldehyde would pose difficulties.  The structures of all prepared sugar 
compounds were confirmed by 1H NMR and 13C NMR spectroscopy, and 
where required COSY, HSQC, HMBC and DEPT spectroscopy were employed 
to determine the position of substituents.  Confirmation of the molecular 
formulae of these compounds was done on high-resolution MS. 
 
The synthesis of 2-deoxy-D-erythro-pentose diethyl dithioacetal 157 was also 
investigated to give access to other enantiomers.  The process used D-
arabinose as the starting material23,24,25 (161), which was converted to bis-
acetonide 163 in 80% yield (Scheme 3.19).  Treatment of the latter with 
potassium tert-butoxide followed by reduction of the intermediate ketene 
diethyl dithioacetal with LiAlH4 or Red-Al as before, gave 2-deoxy-4,5-O-
isopropylidene-D-erythro-pentose (165) in 60% yield.  Hydrolysis of the 
acetonide protecting group under similar conditions described above for the 
threo isomer gave the 2-deoxy-D-erythro-pentose (166) in 70% yield.  The 
primary hydroxy group of compound 166 was converted into the tosylate 167 in 
60% yield.  The next two steps towards the synthesis of the required chiral 
aldehyde were suspended until the coupling conditions of the threo isomer 
were met.  
 
In the preparation of the threo isomer 167 (Scheme 3.19), the structures of all 
prepared carbohydrate derivatives were confirmed by 1H NMR and 13C NMR 
spectroscopy, and where required COSY, HSQC, HMBC and DEPT 
spectroscopy were employed to determine the position of substituents.  




























































3.3.3 The assembly of precursors through path (b) (Scheme 
3.12) 
 
Various organometallic C-C bond forming reactions were investigated in an 
attempt to assemble the two precursors 133 and 160.  The first attempt was 
the reaction between the organolithium adduct 168, prepared from compound 
133, and compound 160 (Scheme 3.20).   
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Several reaction conditions were investigated, which include different lithiating 
agents (n-BuLi, LDA, and Li metal), different solvents (THF and diethyl ether), 
different activating catalysts (CuI and CuBr) and lastly different temperatures 
(from -78 oC to room temperature) but the desired coupling was not 


















Solvent = THF or Ether
Catalyst = CuI or CuBr
-78 oC to rt
169





Another investigation involved the use of Grignard reagent 170 which was also 
prepared from 133 (Scheme 3.21).  Similar reaction conditions were also 
investigated which include different solvents (THF and diethyl ether), different 
activating catalysts (FeCl3, CeCl3 and CuI) and lastly different temperatures 
(from -78 oC to room temperature and elevated temperature) but once again 
the desired product was not obtained.  The failure of the coupling reactions can 
be attributed to the electron-rich aromatic compound.  It is known that halogen-
metal exchange can be slow for electron-rich aromatic substrates.  Therefore, 



















Solvent = THF or Ether
Catalyst = FeCl3 or CeCl3 or CuI








Transforming one terminal part of sugar moiety 160 into an acyl chloride which 
should be highly reactive under Friedel-Crafts acylating conditions could be a 
solution.  The process began with 2-deoxy-D-threo-pentose diethyl dithioacetal 
(157), which upon selective protection of the primary alcohol gave the silylated 
compound 171 in 80% yield (Scheme 3.22).  Subsequent protection of the diol 
as the acetonide gave compound 172 in good yield which upon conversion of 
its diethyl dithioacetal to dimethyl acetal furnish compound 173 also in 
reasonable yield.  Removal of the silyl protecting group afforded compound 
174 in 90% yield.  The reaction worked well on small scale, but on larger scale 
(gram quantities), a much reduced yield was obtained.  The next step planned 
was an oxidation of the primary alcohol to an acid, which could be transformed 
to the acyl chloride, but, due to limited amount of product 174, those two steps 












































HgCl2, HgO, MeOH 
 PPTs, 2,2-dimethoxypropane
90%
THF, 80%, 0 oC
CH2Cl2, 90% 






1. TBDMSCl, imidazole, DMF




The structures of all prepared sugar compounds were based on 1H NMR and 
13C NMR spectroscopy.  The molecular formulae of these compounds were 
confirmed by high-resolution MS.   
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The problems encountered with the synthesis of the acylated terminal part of 
the carbohydrate, other alternative ways of transforming the terminal carbon 
into a reactive electrophile needed to be investigated. An reactive epoxide was 
considered as a viable precursor. The synthesis was planned is outlined in 
Scheme 3.23 where 2-deoxy-4,5-O-isopropylidene-D-threo-pentose diethyl 
dithio acetal (153) was utilised as starting material.  The process began with 
the protection of compound 153 as its tert-butyl diphenylsilyl ether (177) in 90% 
yield.  The identity of the compound was confirmed by 1H NMR and 13C NMR 
spectroscopy which reveals all the expected signals and the molecular formula 





































It was planned to perform mild hydrolysis of the acetonide group to yield 
compound 178 that could be subjected to a selective primary tosylation 
reaction.  Treatment of the tosylated compound 179 with a base under 
methanolic solution should give the desired epoxide (180) (Scheme 3.23). 
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A model reaction was performed to study the reaction conditions for the ring-
opening of epoxides, particularly with carbon-based nucleophiles (Scheme 
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Lewis acid-catalysed epoxide ring-opening as well as the ferric chloride and 
cerium chloride-catalysed Grignard epoxide ring opening were investigated.  
Though the epoxides are known to be highly reactive to nucleophilic attack, in 
this reaction they reacted sluggishly and no efficient addition took place.  The 
results of the model reaction are illustrated in Scheme 3.24.   
 
 
The assembling of the precursors through path (b) relied on having a reactive 
electrophile that could react with the aryl nucleophile.  The failure to obtain 
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reactive electrophile led us to develop a practical route for large scale 
synthesis of these reactive electrophiles.   
 
A great deal of effort had been devoted to the use of D-ascorbic acid as an 
alternative to the naturally occurring carbohydrate starting material.  Looking at 
the synthetic strategies disclosed by Cho et al.30 and Dahlgren et al.31 it was 
considered that D-ascorbic acid (189) could be transformed into the reactive 
electrophiles 186 and 187 that were needed.  With this in mind another 
retrosynthetic pathway was devised (Scheme 3.25), in which organometallic-
mediated olefination reaction and alkylation reaction were the key steps. 
 
Lipshutz et al.32 devised a strategy of generating aromatics bearing a 
disubstituted allylic moiety with E-geometry by using the reaction between 
hydrozirconated terminal alkynes with benzylic chlorides at room temperature 
in the presence of catalytic amount of Ni(0). This method could be used to 
couple the benzylic chloride as it has been proven to be equally successful for 
both electron-rich and electron-poor benzylic chlorides.   
 
Based on the retrosynthetic pathway (Scheme 3.25), the synthesis was 
planned as illustrated in Scheme 3.26 following a strategy of Lipshutz.32  
Firstly, it was planned to couple compound 186 and 188 by Friedel-Crafts 
acylation to yield compound 190.  Subjecting compound 190 to Wolff-Kishner 











































































































































Substitution of the tosylate in 192 with iodide will form compound 193, which 
can be extended further with two carbons by nucleophilic substitution with 
trimethylsilylethynyllithium followed by removal of the silyl group under basic 
conditions to yield the terminal alkyne 185.  The resulting alkyne 185 was to be 
treated with zirconocene chloride hydride in THF under argon atmosphere to 
form vinyl hydrozirconocene 184.  It was therefore intended to couple the vinyl 
hydrozirconocene 184 with benzylic chloride 183 using nickel as a catalyst in 
order to obtain the desired target molecule 18 after acetylation reaction. 
 
Synthetic procedures30,31 were followed for the synthesis of compound 186 as 
outlined in Scheme 3.27.  D-Ascorbic acid was converted to its acetonide 194 
in 95% yield.  Oxidation of the latter with hydrogen peroxide produced threonic 
acid sodium salt (195) which was then transformed to methyl ester 197 with 
dimethyl sulfate and sodium bicarbonate in water.  Methylation was attempted 
in situ without isolating the oxidation product 195 by slow addition of dimethyl 
sulfate to maintain the basic condition which is said to increase the yields 
according to literature30 but the product 197 could not be isolated. 
 
At this point, the known procedure30 was slightly altered and an acidic workup 
attempted of threonic acid sodium salt (195) into its corresponding acid 196 as 
described by Dahlgren and his co-workers.31  Difficulties arose in extracting the 
acid from the aqueous layer.  This is due to the acetonide protecting group 
becoming susceptible to the mild acidic washings and cause compound 196 to 
have a large number of unprotected hydroxy groups.  These conditions may 
cause compound 196 to have a higher solubility in water layer than in organic 
layer and posing difficulties in isolating it from aqueous layer.  This led on to 
reconsider the synthesis of electrophiles using this method as difficulties arose 
on isolating the acid which is needed for further transformation into 













































         95% 
30% aq. NaOH, 
H2O2, NaHCO3









    imidazole,







A model reaction was performed to illustrate the coupling conditions of the vinyl 
hydrozirconocene 184 with the benzylic chloride 183 (Scheme 3.28).  The 
benzylic chloride 183 was prepared in two steps starting from compound 138.   
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Thus, 138 was reduced to the corresponding benzyl alcohol using sodium 
borohydride in methanol and then treated with thionyl chloride to form the 
benzyl chloride (183) (Scheme 3.28).   
 
1-Octyne (200) was the one of the readily available alkynes converted to its 
vinyl hydrozirconocene (201) as described by Lipshutz and his coworkers.32  In 
an argon atmosphere, the freshly prepared vinyl hydrozirconocene (201) was 
subjected to a cross-coupling reaction in situ in the presence of catalytic 
amount of tetrakis(triphenylphosphine)nickel with benzylic chloride 183.  
Though the reaction procedure seems to be simple and straightforward, the 
reaction conditions were complicated and because of the high moisture 
sensitivity associated with these organozirconocene compounds, after several 










































3.3.4 The assembly of precursors through path (a) 
 
The synthetic pathway designed for path (a) (Scheme 3.12) is based on the E-
olefination methodology to generate aromatics bearing a disubstituted allylic 
moiety of E-olefin geometry.  Two olefination strategies were investigated 
namely, the improved Julia-Kocienski olefination17 and the E-selective Wittig33 
reaction of nonstabilised ylides. 
 
The process begins with converting compound 177 into a useful coupling agent 
for the olefination reaction.  This was done by treating the compound 177 with 
mercuric oxide and mercuric chloride in a warm mixture of acetonitrile, acetone 
and water to obtain the desired aldehyde 203 in 90% yield (Scheme 3.29).  
The presence of the compound was confirmed by 1H NMR spectroscopy which 
displays an aldehyde proton resonating at low field (δH 9.6) as a triplet.  In the 
13C NMR all the expected signals were observed and the molecular formula of 



















The improved Julia olefination is outlined in Scheme 3.31 where the tert-
butyltetrazole (TBT) alkyl sulfone 146 was treated with a base to form a 
reactive nucleophile that can attack the threonic aldehyde (203) (Scheme 
3.31).  According to Aϊssa et al.17 and Kocienski et al.18, tert-butyltetrazole 
(TBT)-alkyl sulfones (146a) are regarded as more stable than n-alkyl 
phenyltetrazole (PT) sulfones (204) and n-alkyl benzothiazole (BT) sulfones 




























Even with sterically divergent substituents on the sulfone, self-condensation 
occurs even at low temperatures.  The alkyl phenyltetrazole (PT) sulfones 
(204) is regarded as more stable than the alkyl benzothiazole (BT) sulfones 
(205) though they also decompose especially when a base like potassium 
bis(trimethylsilyl)amide (KHMDS) is used.  The stability of the sulfones is 
enhanced by increasing the steric bulk of the substituent on the tetrazole ring 
hence the tert-butyltetrazole (TBT)-alkyl sulfones (146) is reasoned as the 
most stable sulfone.18  The mechanism of the degradation of the n-alkyl 
benzothiazole (BT) sulfones (205) is outlined in Scheme 3.30.  As described by 
Kocienski et al.18 when the sulfone 205 is treated with lithium diisopropyl amide 
(LDA) in THF at -60 oC for 1 h followed by warming to -20 oC over 1.5 h, the 
condensation product 210 was obtained in 54% yield together with a further 
7% of n-alkyl benzothiazole (BT) sulfones (205) (Scheme 3.30). 
 
With this information in mind, tert-butyltetrazole (TBT)-alkyl sulfone (146) was 
utilised as Julia olefination reagent.  Several attempts were made to synthesise 
the E-olefin 211 (Scheme 3.31).  A number of different bases, solvent systems 
and different reaction temperatures were investigated.  The desired olefin 211 




























































1. LDA, THF, -60 oC, 1 h
2. warm to -20 oC,









At this stage, it could not be concluded whether the (TBT)-alkyl sulfone (146) 
undergoes decomposition or self-condensation reactions (Scheme 3.31).  
When using Aϊssa’s16a alternate procedure for Julia-olefination which includes 
the use of Cs2CO3 and a mixture of THF/DMF at 70 
oC, sulfone 146 
decomposed.  In the reaction, the starting material 146 was no longer 
























base = KHMDS, BuLi, LDA
solvent = 1,2-dimethoxyethane,




An E-selective Wittig reaction was attempted using a procedure described by 
Oh et al.33 who demonstrated that E-alkenes could be produced as the major 
product by simply quenching the reaction with a large excess of methanol at -
78 oC in the Wittig reaction with nonstabilised ylides of a linear alkyl chain.  
These conditions were found to work even under the salt-free conditions 
required by nonstabilised ylides for Wittig olefination reactions.  Without the 
addition of methanol the usual Z-alkene will be obtained.  The mechanism of 
enhanced selectivity for E-olefination is illustrated in Scheme 3.32.  According 
to Oh et al.33, the well-established oxaphosphetane intermediate 212 opens up 
under the salt free conditions with addition of methanol to give the acyclic 
intermediate 213 that is in equilibrium with the β-hydroxyphosphonium 
methoxide salt 214.  The betaine intermediate 216 is formed after the 
deprotonation step and the protonation step 217 would decompose to give the 




































































With the above information in hand, a plan was to investigate the reaction 
described by Oh et al.33 using unstabilised ylide 143 and aliphatic aldehyde 
203 (Scheme 3.33).  Several attempts were made using different bases, 
different solvents and different temperatures for screening the reaction 
conditions for reagents.  No alkene formation was observed, even when the 
lithium salt was added.  The problem may be associated with poor 
nucleophilicity of ylide 143 which may need an activator to speed up the 
reaction.  To check the procedure, a Wittig reaction with benzyl bromide and 
benzaldehyde was performed, and no problems with these reagents were 
observed.  Therefore, the failure of the reaction can be attributed to the low 





















base = KHMDS, BuLi, LDA, KOtBu







Diarylheptanoids are natural products with a variety of biological activities and 
total synthesis of these compounds, which often occur in minute quantities in 
nature, is important.  Two general strategies for executing the synthesis of 
diarylheptanoid 18 were investigated, namely: C2-moiety + C5-moiety and C1-
moiety + C6-moiety as illustrated in Scheme 3.11 and 3.12.   
 
The challenges were: 
 To prepare suitable aromatic precursors. 
 To prepare a linear fragment containing a diol with the required 
stereochemistry. 




An achievement was to prepare the aromatic rings with the correct substitution 
pattern and to prepare the linear fragment with the required stereochemistry of 
the diol functionality. Carbohydrates were used as the starting material for the 
linear fragment.  The advantages are that the pentose starting materials (D-
xylose and D-arabinose) are available in both enantiomeric forms and these 
two pentoses gave access to both the threo and erythro stereochemistry of the 
diol.  The last steps were the attachment of the linear chain to the aryl 
precursor and the formation of the E-alkene.  Unfortunately, reaction conditions 
for these reactions could not be established.  The electron-rich nature of both 
aromatic rings is responsible for the problems associated with these reactions 
and a substantial amount of research will be needed to solve this problem. 
 
It is clear that organometallic-type reactions, which are often used for Ar-C 
coupling reactions, are very difficult with electron-rich aromatic rings.  Friedel-
Crafts reactions, which are enhanced by electron-rich aromatic rings, should 
be investigated for the arylation reaction.  The formation of the E-alkene in the 
homobenzylic position from two bulky, relatively unstable precursors also 
needs further investigation.  The solution may be to use a completely different 
approach such as a Grubbs metathesis reaction. 
 
Although the final product was not prepared, significant advances towards the 
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4.1 GENERAL EXPERIMENTAL PROCEDURES 
 
4.1.1 PURIFICATION OF SOLVENTS AND REAGENTS 
 
All the required chemicals or reagents were obtained from Fluka, Sigma-Aldrich or 
Merck and used without further purification unless otherwise specified.  All 
solvents used for reactions and chromatography were purified and distilled prior to 
use.  All reactions requiring anhydrous solvents were performed under a positive 
nitrogen pressure in oven-dried or flamed-out glass apparatus, unless otherwise 
mentioned.  Anhydrous solvents were obtained from appropriate drying agents as 
follows:1 tetrahydrofuran, diethyl ether, toluene and benzene were distilled under 
nitrogen from sodium wire and benzophenone; pyridine and dichloromethane were 
refluxed over calcium hydride; chloroform and carbon disulfide were refluxed over 
phosphorus(V) oxide.  N,N-Dimethylformamide and acetone were stored over 
sodium  and distilled.  Dimethyl sulfoxide was dried over two consecutive batches 
of 4Å molecular sieves and then distilled under reduced pressure.  When 





Thin-layer chromatography (TLC) was performed on aluminum-backed 0.2 mm 
silica gel plates (Merk silica gel 60 F254 or Machery-Nagel silica gel 60 UV254).  
Normal and flash chromatography were performed using Merck Kieselgel 60 (230 
- 400 mesh) and on columns with 4 cm or 1 cm diameters.  Centrifugal 
chromatography was performed on a Harrison Research Chromatotron Model 
7924T on glass plates coated with Merck silica gel 60 with particle size 0.040-
0.063 mm, 2 - 4 mm thick.   
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The mobile phase comprised of different ratios of hexane - ethyl acetate.  
Detection of the developed TLC plate was accomplished using UV254 light or by 
using spraying reagents. 
 
4.1.3 SPECTROSCOPIC AND PHYSICAL DATA 
 
All melting points were obtained on a Reichert Kofler hot-stage microscope and 
are uncorrected. 
 
Nuclear magnetic resonance spectroscopy (NMR) of the isolated compounds was 
performed on Varian Unity Inova 300 MHz or 500 MHz and Bruker Avance III 400 
MHz or 500 MHz spectrometers.  All NMR spectra were recorded at 25 oC (Varian) 
and 30 oC (Bruker) in deuterated solvents and the chemical shifts were referenced 
to the solvent shift.  Where required, nuclear Overhauser effect (NOE), HMBC, 
HMQC, COSY and DEPT spectroscopy were employed to assign spectra and 
determine structures.  Coupling constants were calculated as observed in the 1H 
NMR spectrum.  The following abbreviations are used for designated splitting 
patterns: 
 
 s singlet   br broadened 
 d doublet  dd doublet of doublets 
 t triplet   ddd doublet of doublet of doublets 
 q quartet  m multiplet 
 
Mass spectra were obtained with a Waters LCT Premier mass spectrometer using 
both positive and negative electrospray ionisation.  Optical rotations were 
measured in an appropriate spectroscopic grade solvent on a Perkin-Elmer 241 







4.1.4 OTHER GENERAL EXPERIMENTAL PROCEDURES 
 
The term “removal of solvent under reduced pressure” refers to the use of 
aspirator pressure (ca. 25 Torr) with a rotavapor at 40-50 oC.  The term “in vacuo” 
refers to the removal of solvent by rotary evaporation, followed by removal of the 
residual solvent at oil pump pressure (ca. 0.1-1.0 Torr) at ambient temperature 
until constant mass was achieved. 
 
4.2 SYNTHETIC PROCEDURES 
 













To a solution of vanillin (54) (1.00 g, 7 mmol) in glacial acetic acid (50 ml), 
bromine (1.05 g, 7 mmol) in glacial acetic acid (20 ml) was added dropwise at 
room temperature over a period of 1 h and stirred for 1 h at the same 
temperature.  The reaction was quenched by addition of water (50 ml) and the 
resulting solid was filtered off.  The crude product was recrystallised from 
ethanol to afford white crystals of 3-bromovanillin (96) (0.95 g, 95%).   
 
Mp:    163-164 oC from ethanol (lit.2 163-164 oC)  
 
1H NMR (300 MHz, DMSO-d6) δH:  
3.90 (3H, s, OCH3), 7.41 (1H, d, J=1.8 Hz, H-6) and 
7.71 (1H, d, J=1.8 Hz, H-2), 9.76 (1H, s, CHO), 




13C NMR (75 MHz, DMSO-d6) δC:  
56.3 (OCH3), 109.1 (C-6), 109.4, (C-2), 128.7 (C-3), 
128.8 (C-1), 148.5 (C-4), 149.7 (C-5), 190.3 (CHO). 
 
HRESIMS m/z  [M+H]+ 230.9669 
    (calc. for C8H7 
79BrO3+H, 230.9657) 
IR νmax (cm-1):  3229, 2717, 1672. 
 







3-Bromovanillin (96) (5.00 g, 22 mmol), sodium hydroxide (6.13 g, 153 mmol) 
and copper powder (0.03 g, 0.4 mmol) were stirred in 100 ml water.  The 
reaction mixture was heated at reflux for 24-27 h.  Sodium hydrogen phosphate 
(0.11 g, 0.6 mmol) was added during the last half hour of reflux.  The reaction 
was then cooled to less than 50 oC, filtered to remove a precipitate of cupric 
hydrogen phosphate and acidified with 6 M HCl (9.6 ml).  The reaction mixture 
was extracted with ethyl acetate (3 x 50 ml).  The ethyl acetate extract was 
stirred with activated carbon and filtered.  The filtrate was washed with 
saturated EDTA solution followed by brine (25 ml).  The organic solution was 
then dried over anhydrous magnesium sulfate, filtered and concentrated in 
vacuo.  The crude product was dissolved in boiling toluene (50 ml), treated with 
activated carbon, filtered and cooled to crystallise.  The product, 3,4-dihydroxy-
5-methoxybenzaldehyde (97) (3.00 g, 60%) was afforded as brownish 
crystals. 
 
Mp:    132-133 oC from toluene (lit.3 132-134 oC)  
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1H NMR (300 MHz, DMSO-d6) δH:  
3.81 (3H, s, OCH3), 6.99 (1H, d, J=1.2 Hz, H-6), 7.01 
(1H, d, J=1.5 Hz, H-2), 9.48 (2H, 2xs, OH), 9.68 (1H, 
s, CHO). 
 
13C NMR (75 MHz, d6-DMSO) δC:  
55.9 (OCH3), 104.8 (C-6), 110.8 (C-2), 127.2 (C-1), 
140.9 (C-5), 145.8 (C-3), 148.4 (C-4), 191.1 (CHO). 
 
HRESIMS m/z  [M+H]+ 169.0504 
    (calc. for C8H8O4+H, 169.0501) 
IR νmax (cm-1):  3487, 2844, 1655. 
 







Method : 14 
 
To a solution of 3,4-dihydroxy-5-methoxybenzaldehyde (97) (5.00 g, 29 mmol) 
in acetic anhydride (75 ml), triethyl amine (8 ml, 59 mmol) was added slowly at 
0 oC.  After stirring for 2 h at room temperature, the excess of acetic anhydride 
was destroyed by careful addition of EtOH (10 ml) at 0 oC.  The reaction mixture 
was diluted with water and extracted with ethyl acetate, the organic phase was 
washed with brine, dried over anhydrous magnesium sulfate and concentrated 
in vacuo.  The crude mixture was recrystallised from 70% ethyl acetate/hexane 
mixture to furnish compound 98 in 100% yield.  To the acetylated compound 98 
(5.0 g, 19 mmol) in DMF was added potassium carbonate (3.00 g, 19 mmol) 
and MeI (1.23 ml, 19 mmol).  The resulting mixture was heated at 40 oC for 3 h.   
The inorganic salt was removed by filtration and the filtrate was diluted with 
ethyl acetate (20 ml) and cold water (20ml).   
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The two layers were separated and the aqueous layer was extracted with ethyl 
acetate (3 x 20 ml).  The combined organic layers were washed with water (20 
ml), brine (20 ml), dried over magnesium sulfate, filtered and concentrated in 
vacuo.  Compound 100 was obtained in 70% yield after recrystallisation from 
90% heptane/ethyl acetate mixture.  Then a solution of compound 100 (5.00 g, 
22 mmol) in MeOH (100 ml) was added to a solution of potassium carbonate 
(16.00 g, 132 mmol) in water (50 ml).  After stirring for 20 min at room 
temperature, the volatiles were evaporated and the aqueous solution acidified 
to pH of 2 and extracted with ethyl acetate.  The organic phase was washed 
with brine, dried over anhydrous magnesium sulfate and concentrated in vacuo.  
The crude residue was recrystallised from 90% heptane/ethyl acetate to furnish 
off-white crystals of 3-hydroxy-4,5-dimethoxybenzaldehyde (101) (4.00 g, 
80%).   
 
Mp:   63-64 oC from 90% heptane/EtOAc (lit.4 64-65 oC)  
 
1H NMR (300 MHz, CDCl3) δH:  
3.82 (3H, s, OCH3), 3.91 (3H, s, OCH3), 6.36 (1H, s, OH), 
6.99 (1H, d, J=1.5 Hz, H-6), 7.07 (1H, d, J=1.2 Hz, H-2), 
9.79 (1H, s, CHO). 
 
13C NMR (75 MHz, CDCl3) δC:  
56.0 (OCH3), 61.0 (OCH3), 103.7 (C-6), 111.5 (C-2), 131.9 
(C-1), 140.8 (C-5), 149.5 (C-4), 152.6 (C-3), 191.2 (CHO). 
 
HRESIMS m/z [M+H]+ 183.0650 
   (calc. for C9H10O4+H, 183.0657) 
 






Method : 23 
 
3,4-Dihydroxy-5-methoxybenzaldehyde (97) (5.00 g, 30 mmol), dimethyl sulfate 
(3 ml, 3.75 g, 30 mmol) and sodium carbonate (3.50 g, 29 mol) were stirred into 
acetone.  The reaction mixture was heated at reflux for 4-6 h and then cooled to 
room temperature.  The inorganic salts were removed by filtering, and then 
acetone was removed by concentrating in vacuo and replaced by toluene.  The 
toluene solution was stirred at room temperature for 1 h and filtered to remove 
an insoluble tar.  The product was extracted with a dilute sodium hydroxide 
solution.  The aqueous layer was acidified with 3 M HCl to a pH of 1-2 and 
extracted with toluene.  The organic layer was dried over anhydrous 
magnesium sulfate, then treated with activated carbon and filtered.  The 
chromatographic purification on silica (elution with 70% hexane/ethyl acetate) 
followed by recrystallisation with toluene afforded off-white crystals of 3-
hydroxy-4,5-dimethoxybenzaldehyde (101) (3.00 g, 60%). 
 
Mp:   63-64 oC from 90% heptane/EtOAc (lit.4 64-65 oC)  
 
1H NMR (300 MHz, CDCl3) δH:  
3.82 (3H, s, OCH3), 3.91 (3H, s, OCH3), 6.36 (1H, s, OH), 
6.99 (1H, d, J=1.5 Hz, H-6), 7.08 (1H, d, J=1.8 Hz, H-2), 
9.79 (1H, s, CHO). 
 
13C NMR (75 MHz, CDCl3) δC:  
55 (OCH3), 60. (OCH3), 103.7 (C-6), 111.5 (C-2), 131.9 (C-
1), 140.8 (C-5), 149.5 (C-4), 152.6 (C-3), 191.2 (CHO). 
 
HRESIMS m/z [M+H]+ 183.0650 
   (calc. for C9H10O4+H, 183.0657) 














The 3-hydroxy-4,5-dimethoxybenzaldehyde (101) (1.00 g, 5 mmol), 2-
bromopropane (1.50 ml, 2.00 g, 16 mmol) and K2CO3 (1.50 g, 10 mmol) were 
stirred in acetonitrile (30 ml) at 60 oC for 24 h.  The reaction mixture was filtered 
and concentrated in vacuo.  The residue was dissolved in diethyl ether (50 ml) and 
washed with water (3 x 30 ml).  The aqueous layer was extracted with diethyl ether 
(2 x 50 ml), the combined organic extracts were washed with water (2 x 50 ml) 
followed by brine (1 x 50 ml) and dried over anhydrous magnesium sulfate.  The 
chromatographic purification on silica (elution with 80% hexane/ethyl acetate) 
afforded as a yellowish oil of 3-isopropoxy-4,5-dimethoxybenzaldehyde (102) 
(0.85 g, 85%).   
 
1H NMR (300 MHz, CDCl3) δH:  
1.30-1.36 [6H, 2xs, OCH(CH3)2], 3.84-3.85 (3H, s, CH3O), 
3.88-3.89 (3H, s, OCH3), 4.58 [1H, sept, OCH(CH3)2] 6.99 
(1H, d, J=1.5 Hz, Ar-H6), 7.08 (1H, d, J=1.8 Hz, Ar-H2), 9.78 
(1H, s, CHO). 
 
13C NMR (75 MHz, CDCl3) δC:  
22.1 [OCH(CH3)2], 22.1 (OCH(CH3)2), 56.2 (OCH3), 60.8 
(OCH3), 71.7 [OCH(CH3)2], 105.9 (C-6), 110.50 (C-2), 
131.5 (C-1), 143.8 (C-5), 151.7 (C-3), 153.8 (C-4), 190.9 
(CHO). 
 
HRESIMS m/z [M+H]+ 225.1128 
   (calc. for C12H16O4+H, 225.1120) 
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IR νmax (cm-1): 2727, 1689. 
 













To a suspension of (methoxymethyl)triphenylphosphonium chloride (2.30 g, 65 
mmol) in dry THF (20 ml), potassium tert-butoxide (1.00 g 85 mmol) was added 
at 0 oC and stirred for 15 min.  The 3-isopropoxy-4,5-dimethoxy-benzaldehyde 
(102) (1.00 g, 44 mmol) was added and stirred for another 15 min.  The reaction 
mixture was concentrated in vacuo and partitioned between water (10 ml) and 
diethyl ether (30 ml).  The aqueous layer was extracted with diethyl ether (2 x 
30 ml) and the combined organic layer was washed with water (2 x 30 ml) and 
brine (30 ml), dried over anhydrous magnesium sulfate, filtered and 
concentrated in vacuo.  The purification on silica (elution with 90% hexane/ethyl 
acetate) afforded a yellowish oil of 1-isopropoxy-2,3-dimethoxy-5-(2-
methoxyvinyl)benzene (103) (0.75 g, 75%) as a mixture of cis/trans isomers 
(67%:33%, E:Z ratio).   
 
1H NMR (300 MHz, CDCl3) δH:  
1.38 [6H, 2xs, OCH(CH3)2], 3.50-3.73 (9H, 3xs, 3xOCH3), 
4.04 [1H, sept, OCH(CH3)2], 5.20 (1H, d, J=6.9 Hz, CHα, 
cis), 5.56 (1H, d, J=13.2 Hz, CHα, trans), 6.20 (1H, d, J=7.2 
Hz, -CHβ, cis) 6.83 (1H, d, J=12.6 Hz, CHβ, trans), 





13C NMR (75 MHz, CDCl3) δC:  
22.6 [OCH(CH3)2], 56.0 (OCH3), 56.5 (OCH3), 60.7 (OCH3), 
71.4 [2 X OCH(CH3)2], 102.3 (CHα) 105.0 (C-6), 105.5 (C-
2), 105.6 (C-1), 106.4 (C-4), 109.5 (C-3), 147.3 (CHβ) 148.4 
(C-5),  
 
HRESIMS m/z [M+H]+ 253.1441 
   (calc. for C14H20O4+H, 253.1440) 
 









The 1-isopropoxy-2,3-dimethoxy-5-(2-methoxy-vinyl)-benzene (103) (1.00 g, 4 
mmol) was stirred in THF (20 ml) and 2 M HCl (5 ml) under argon and reflux for 
3 h.  The mixture was concentrated in vacuo and the residue was partitioned 
between water (10 ml) and diethyl ether (20 ml).  The aqueous layer was 
extracted with diethyl ether (3 x 20 ml) and the combined organic layers were 
washed with water (2 x 10 ml), saturated NaHCO3 (2 x 20 ml) and brine (10 ml), 
the organic layer dried over anhydrous magnesium sulfate and concentrated in 
vacuo to afford a yellowish oil of (3-isopropoxy-4,5-
dimethoxyphenyl)acetaldehyde (91) (0.75 g, 75%) after chromatographic 
purification on silica (elution with 90% hexane/ethyl acetate).   
 
1H NMR (300 MHz, CDCl3) δH:  
1.27-1.35 [6H, 2xs, OCH(CH3)2], 3.57 (2H, s, CH2CHO), 
3.81-3.83 (6H, 2xs, OCH3), 4.49 (1H, sept, OCH(CH3)2), 




13C NMR (75 MHz, CDCl3) δC:  
22.2 [OCH(CH3)2], 50.0 (CH2CHO), 56.1 (OCH3), 60.6 
(OCH3), 71.5 [OCH(CH3)2], 106.5 (C-6), 110.6 (C-2), 126.9 
(C-1), 141.8 (C-4), 151.8 (C-3), 153.8 (C-5), 199.3 (CHO). 
 
HRESIMS m/z [M+H]+ 239.1285 
   (calc. for C13H18O4+H, 239.1283) 
 
IR νmax (cm-1): 2789, 1670. 
 













Compound 104 was prepared according to the procedure described for the 
synthesis of compound 102 starting with vanillin (54) (2.00 g, 13 mmol).  The 
residue was dissolved in diethyl ether (50 ml) and washed with water (3 x 30 
ml).  The aqueous layer was extracted with diethyl ether (2 x 50 ml), the 
combined organic extracts were washed with water (2 x 50 ml) followed by brine 
(1 x 50 ml) and dried over anhydrous magnesium sulfate.  The chromatographic 
purification on silica (elution with 70% hexane/ethyl acetate) afforded as a 
colourless oil of 4-isopropoxy-3-methoxybenzaldehyde (104) (1.70 g, 85%). 
 
1H NMR (300 MHz, CDCl3) δH:  
1.37 [6H, 2xs, OCH(CH3)2], 3.86 (6H, s, OCH3), 4.64 [1H, 
sept, OCH(CH3)2], 6.92 (1H, d, J=8 Hz, H-5), 7.37 (2H, dd, 





13C NMR (75 MHz, CDCl3) δC:  
22.7 [OCH(CH3)2], 55.9 (OCH3), 71.2 [OCH(CH3)2], 109.4 
(C-2), 112.7 (C-5), 126.5 (C-6), 129.6 (C-1), 150.2 (C-3), 
153.0 (C-4), 190.7 (CHO). 
 
HRESIMS m/z [M+H]+ 195.1022 
   (calc. for C11H14O3+H, 195.1020) 
IR νmax (cm-1): 2889, 1650. 
 











Compound (105) was prepared according to the procedure described for 
synthesis of compound (103) starting with 4-isopropoxy-3-methoxy-
benzaldehyde (104) (2.30 g, 2 mmol).  The reaction mixture was concentrated 
in vacuo and partitioned between water (10 ml) and diethyl ether (30 ml).  The 
aqueous layer was extracted with diethyl ether (2 x 30 ml) and the combined 
organic layer was washed with water (2 x 30 ml) and brine (30 ml), dried over 
anhydrous magnesium sulfate, filtered and concentrated in vacuo.  The 
purification on silica (elution with 90% hexane/ethyl acetate) afforded a 
yellowish oil of 1-isopropoxy-2-methoxy-4-(2-methoxyvinyl)benzene (105) 







1H NMR (300 MHz, CDCl3) δH:  
1.38 [6H, 2xs, OCH(CH3)2], 3.50 (3H, s, OCH3 cis) 3.69 
(3H, s, OCH3 trans) 3.73 (3H, s, OCH3), 4.41 [1H, sept, 
OCH(CH3)2], 5.20 (1H, d, J=6.9 Hz, CHα, cis), 5.56 (1H, d, 
J=13.2 Hz, CHα, trans), 6.20 (1H, d, J=7.2 Hz, CHβ, cis) 
6.83 (1H, d, J=12.6 Hz, CHβ, trans), 6.70 (1H, d, J=8 Hz, 
Ar-H5), 6.83 (2H, 2xdd, J=1.8 Hz, Ar-H2,6). 
 
13C NMR (75 MHz, CDCl3) δC:  
22.1 [OCH(CH3)2], 55.8 (OCH3 cis), 56.4 (OCH3 trans), 60.5 
(OCH3), 71.6 (OCH(CH3)2), 104.8 (CHα) 108.9 (C-2), 112.1 
(C-5), 115.8 (C-6), 116.5 (C-1), 120.7 (C-4), 146.4 (CHβ) 
147.6 (C-3). 
 
HRESIMS m/z [M+H]+ 223.1335 
   (calc. for C13H18O3+H, 223.1333) 
 







Compound 95 was prepared according to the procedure described for synthesis 
of compound 91 starting with 1-isopropoxy-2-methoxy-4-(2-methoxy-vinyl)-
benzene (105) (2.00 g, 8 mmol).  The mixture was concentrated in vacuo and 






The aqueous layer was extracted with diethyl ether (3 x 20 ml) and the 
combined organic layer washed with water (2 x 10 ml), saturated NaHCO3 (2 x 
20 ml) and brine (10 ml), the organic layer dried over anhydrous magnesium 
sulfate and concentrated in vacuo to afford a yellowish oil of (4-isopropoxy-3-
methoxyphenyl)acetaldehyde (95) (1.50 g, 75%) after purification on silica 
(elution with 90% hexane/ethyl acetate). 
 
1H NMR (300 MHz, CDCl3) δH:  
0.98 [6H, dt, OCH(CH3)2], 3.05 (3H, s, OCH3), 3.45 (2H, d, 
J=2.2 Hz, CH2CHO), 4.04 [1H, sept, OCH(CH3)2], 6.05 (1H, 
d, J=8 Hz, H-5), 6.55 (2H, dd, J=2.1 Hz, H-2 and H-6), 9.23 
(1H, t, CHO). 
 
13C NMR (75 MHz, CDCl3) δC:  
21.9 [OCH(CH3)2], 50.1 (CH2CHO), 56.00 (OCH3), 70.8 
[OCH(CH3)2], 106.3 C-2, 109.6 (C-5), 128.0 (C-6), 134.6 
(C-1), 146.5 (C-4), 150.3 (C-5), 199.4 (CHO). 
 
HRESIMS m/z [M+H]+ 209.1179 
   (calc. for C12H16O3+H, 209.1170) 
IR νmax (cm-1): 2889, 1640. 
 







To a stirred solution of the 3-bromopropanol (3 ml, 33 mmol) in dichloromethane 
was added p-toluenesulfonic acid (3.16 g, 33 mmol) under nitrogen 
atmosphere.   
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The mixture was cooled to below 10 oC and 3,4-dihydro-2H-pyran (3.6 ml, 39 
mmol) was added slowly.  Upon completion of the reaction by TLC monitoring 
for consumption of starting material, the reaction mixture was quenched with 
saturated aqueous sodium bicarbonate (5 ml) and extracted with ethyl acetate 
(3 x 20 ml).  The combined organic extracts were washed with water (20 ml), 
brine (20 ml) and dried over anhydrous magnesium sulfate followed by 
concentration in vacuo.  Purification of the residue on silica (elution with 90% 
hexane/ethyl acetate) afforded 2-(3-bromopropoxy)tetrahydropyran (94) 
(4.39 g, 95%) as a colourless oil. 
 
1H NMR (300 MHz, CDCl3) δH:  
1.41-1.73 (6H, m, CH2-THP), 1.99-2.04 (2H, m, 
OCH2CH2CH2Br), 3.38-3.44 (4H, m, OCH2CH2CH2Br and 
CH2-THP), 3.74-3.77 (2H, m, OCH2CH2CH2Br), 4.49 (1H, 
m, CH-THP). 
 
13C NMR (75 MHz, CDCl3) δC:  
19.3, 25.3, 30.4, 64.6, 98.5 (5xC-THP), 30.5 
(OCH2CH2CH2Br), 32.7 (OCH2CH2CH2Br), 61.9 
(OCH2CH2CH2Br). 
 
HRESIMS m/z [M+H]+ 223.0330 
   (calc. for C8H15 
79BrO2+H, 223.0334) 
 
4.2.11 Preparation of propyltriphenylphosphonium bromide (106)7 
 
Triphenylphosphine (1.00 g, 4 mmol) was added to 1-bromopropane (0.35 ml, 0.47 
g, 4 mmol) in benzene (50 ml) and the mixture was refluxed for 2 h until formation 
of the salt was complete.  The reaction was cooled to room temperature and the 
salt was then filtered off and dried in high vacuum pressure (ca. 22 Torr) to obtain 
a pure white salt which upon recrystallisation from EtOH gave pure crystals of 
propyltriphenylphosphonium bromide (106) (0.50 g, 100%) with a melting point 
range of 233-237 oC (lit.6 235-238 oC). 
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To a suspension of propyltriphenylphosphonium bromide (106) (2.20 g, 8 mmol) 
in dry THF (20 ml) was added at 0 oC KOtBu (0.8 g, 8 mmol) and the mixture 
was stirred for 15 min.  Then (3-isopropoxy-4,5-dimethoxy-phenyl)-
acetaldehyde (91) (1.00 g, 4 mmol) in dry THF (5 ml) was added and the stirring 
was continued for another 15 min.  The reaction mixture was concentrated in 
vacuo and partitioned between water (20 ml) and diethyl ether (30 ml).  The 
aqueous layer was extracted with diethyl ether (2 x 20 ml).  The combined 
organic layer was washed with water (20 ml), brine (20 ml), dried over 
magnesium sulfate and concentrated in vacuo to afford an orange yellow crude 
which was purified on silica (elution with 90% hexane/ethyl acetate) and no 
desired product was obtained. 
 








Compound 109 was prepared according to the procedure described for 
synthesis of compound 107 starting with a suspension of (3-
bromopropyl)triphenylphosphonium bromide (108) (1.00 g, 2 mmol) in dry THF 
(20 ml) was added at 0 oC KOtBu (0,20 g, 2 mmol) and the mixture was stirred 
for 15 min.   
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Then (4-isopropoxy-3-methoxyphenyl)acetaldehyde (95) (0.20 g, 1 mmol) in dry 
THF (5 ml) was added and the stirring was continued for another 15 min.  The 
reaction mixture was concentrated in vacuo and partitioned between water (20 
ml) and diethyl ether (30 ml).  The aqueous layer was extracted with diethyl 
ether (2 x 20 ml).  The combined organic layers were washed with water (20 
ml), brine (20 ml), dried over magnesium sulfate and concentrated in vacuo to 
afford an orange yellow crude which upon purification on silica (elution with 90% 
hexane/ethyl acetate), no desired product was obtained. 
 








Compound 111 was prepared according to the procedure described for 
synthesis of compound 109. Cyclopropyltriphenylphosphonium bromide (1.00 g, 
2 mmol) in dry THF (20 ml) [prepared from 2 equivalents of KOtBu (0,20 g, 2 
mmol)] was added at 0 oC (4-isopropoxy-3-methoxy-phenyl)acetaldehyde (95) 
(0.20 g, 1 mmol) in dry THF (5 ml) and the mixture was stirred for 15 min.  The 
reaction mixture was concentrated in vacuo and partitioned between water (20 
ml) and diethyl ether (30 ml).  The aqueous layer was extracted with diethyl 
ether (2 x 20 ml).  The combined organic layers were washed with water (20 
ml), brine (20 ml), dried over magnesium sulfate and concentrated in vacuo to 
afford an orange yellow crude which upon purificatio on silica (elution with 90% 
hexane/ethyl acetate), no desired (2-cyclopropylidenethyl)-1-isopropoxy-2-

















To a suspension of NaH (2.82 g, 0.1 mmol) in dry THF under argon atmosphere at 
0 oC, was added dropwise benzenethiol (112) (5 ml, 0.1 mmol) at 0 oC.  The 
resulting solution was allowed to stir at room temperature for 3 h.  Bromobutane (5 
ml, 0.1 mmol) was added and the reaction mixture was allowed to stir for another 3 
h with TLC monitoring for the consumption of the starting material.  The reaction 
mixture was cooled to 0 oC and quenched with ice cold water.  The resulting 
precipitate was filtered off and the solvent was removed in vacuo.  The remaining 
aqueous layer was extracted with ethyl acetate (3 x 20 ml) and the organic phase 
was washed with water (20 ml) and brine (20 ml) followed by drying over 
magnesium sulfate and concentrated in vacuo.  The chromatographic purification 
of the residue (elution with 90% hexane/ethyl acetate) afforded butyl phenyl 
sulfide (114) (3.80 g, 90%) as a colourless oil. 
 
1H NMR (300 MHz, CDCl3) δH:  
0.94 [3H, t, S(CH2)3CH3], 1.48 [2H, m, S(CH2)2CH2CH3], 
1.65 (2H, m, SCH2CH2CH2CH3), 2.95 [2H, m, 
SCH2(CH2)2CH3], 7.27-7.35 (5H, m, Ar-H). 
 
13C NMR (75 MHz, CDCl3) δC:  
13.6 [S(CH2)3CH3] 21.9 [S(CH2)2CH2CH3], 31.2 
(SCH2CH2CH2CH3), 33.2 [SCH2(CH2)2CH3], 125.4 (C-4), 
126.6 (2C, C-2 and C-6), 128.7 (2C, C-3 and C-5), 136.9 
(C-1). 
 
HRESIMS m/z [M+H]+ 167.0901 
   (calc. for C10H14S+H, 167.0904) 
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To a stirred solution of butyl phenyl sulfide (114) (4.00 g, 24 mmol) in methanol 
(30 ml) was added a solution of oxone (29.60 g, 48 mmol) in ice cold water of 0-
10 oC (10 ml).  After stirring for 3 h at temperature below 20 oC, the reaction 
was monitored by TLC for consumption of starting material and the mixture was 
concentrated in vacuo.  The residue was partitioned between water (20 ml) and 
ethyl acetate (20 ml).  The organic phase was washed with water (20 ml) and 
brine (20 ml) followed by drying over magnesium sulfate and concentrated in 
vacuo.  The chromatographic purification of the residue (elution with 90% 
hexane/ethyl acetate) afforded colourless oil of (butane-1-sulfonyl)benzene 
(115) (3.20 g, 80%). 
 
1H NMR (300 MHz, CDCl3) δH:  
0.97 [3H, t, SO2(CH2)3CH3], 1.48 (2H, m, 
SO2(CH2)2CH2CH3), 1.65 (2H, m, SO2CH2CH2CH2CH3), 
3.40 [2H, m, SO2CH2(CH2)2CH3], 7.35-7.80 (5H, m, Ar-H). 
 
13C NMR (75 MHz, CDCl3) δC:  
13.2 [SO2(CH2)3CH3], 21.2 [SO2(CH2)2CH2CH3], 24.3 
(SO2CH2CH2CH2CH3), 55.6 [SO2CH2(CH2)2CH3], 127.6 
(2C, C-2 and C-6), 129.5 (2C, C-3 and C-5), 133.5 (C-4), 
138.8 (C-1). 
 
HRESIMS m/z [M+H]+ 199.0800 




















To a solution of (butane-1-sulfonyl)benzene (115) (1.00 g, 5 mmol) in dry 
dichloromethane under argon atmosphere was added dropwise a solution of 
lithium bis(trimethylsilyl)amide (LHMDS) (1.70 g, 10 mmol) in dichloromethane 
(5 ml) at room temperature.  The solution was stirred for 10 min and the solution 
of phenylacetaldehyde (116) (0.6 ml, 5 mmol) in dichloromethane (3 ml) was 
added dropwise.  The reaction mixture was stirred for 1 h at room temperature 
and the consumption of starting material was monitored by TLC and when the 
reaction is complete, the reaction mixture was added a solution of saturated 
aqueous NH4Cl (10 ml) and the solvent was removed in vacuo.  The residue 
was partitioned between water (20 ml) and diethyl ether (20 ml).  The combined 
organic solvents were washed with saturated aqueous NaHCO3 (20 ml), brine 
(20 ml), dried over anhydrous magnesium sulfate and concentrated in vacuo.   
The chromatographic purification of the residue (elution with 90% hexane/ethyl 
acetate) afforded a yellowish oil of 3-benzenesulfonyl-1-phenylhexan-2-ol 
(117)) (0.75 g, 75%). 
 
1H NMR (300 MHz, CDCl3) δH:  
0.96 (3H, t, CH3), 1.33-1.40 (2H, m, CH2), 1.81-1.93 (2H, 
m, CH2), 2.0 (1H, s, OH), 2.70-2.93 (2H, m, CH2), 3.06 (1H, 





13C NMR (75 MHz, CDCl3) δC:  
14.0 (CH3), 19.8 (CH2), 22.2 (CH2), 39.8 (CH2), 64.2 
(CHSO2Ph), 67.8 (CHOH), 125.0 (C-4), 126.5 (2C, C-2’ 
and C-6’), 128.3 (4C, C-2, C-3, C-5 and C-6), 129.5 (2C, C-
3’ and C-5’), 133.5 (C-4’), 137.5 (C-1’), 138.5 (C-1). 
 
HRESIMS m/z [M+H]+ 319.1382 
   (calc. for C18H22O3S+H, 319.1385) 
 
IR νmax (cm-1): 3430. 
 
























The 3-benzenesulfonyl-1-phenyl-2-hexanol (117) (1.00 g, 3 mmol) in 
dichloromethane (20 ml) was treated with Et3N (0.4 ml, 3 mmol), DMAP (0.4 g, 
3 mmol) and benzoylchloride (0.4 ml, 3 mmol) and stirring was continued at 
room temperature for 20 h.  The reaction was added saturated aqueous NH4Cl 
(10 ml) and the solvent was removed in vacuo.  The residue was partitioned 
between water (20 ml) and ethyl acetate (20 ml).  The combined organic 
solvents were washed with brine (20 ml), dried over anhydrous magnesium 
sulfate and concentrated in vacuo.   
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The chromatographic purification of the residue (elution with 90% hexane/ethyl 
acetate) afforded a yellowish oil of benzoic acid 2-benzenesulfonyl-1-
benzylpentyl ester (118) (0.95 g, 95%). 
 
1H NMR (300 MHz, CDCl3) δH:  
0.96 (3H, t, CH3), 1.33-1.40 (2H, m, CH2), 1.81-1.93 (2H, 
m, CH2), 2.0 (1H, s, OH), 2.70-2.93 (2H, m, CH2), 3.06 (1H, 
m, CHSO2Ph), 4.20 (1H, m, CHOH), 7.08-7.93 (15H, m, Ar-
H). 
 
13C NMR (75 MHz, CDCl3) δC:  
13.6 (CH3), 20.6 (CH2), 26.7 (CH2), 36.5 (CH2), 64.4 
(CHSO2Ph), 72.1 (CHOH), 121.4 (C-2’’ and C-6’’), 125.3 
(C-4’’), 125.7 (C-4), 126.7 (2C, C-2’ and C-6’), 128.3 (4C, 
C-2, C-3, C-5 and C-6), 128.9 (2C, C-3’’ and C-5’’), 129.5 
(2C, C-3’ and C-5’), 133.5 (C-4’), 136.5 (C-1’), 137.7 (C-1), 
153.1 (C-1’’). 
 
HRESIMS m/z [M+H]+ 423.1650 
   (calc. for C25H26O4S+H, 423.1652) 
 
IR νmax (cm-1): 1620. 
 





In a three-necked flask containing mercury (15 ml) under argon atmosphere 
was inserted piece of Na (1.00 g, 43 mmol) in ~0.20 g portions per 3 min time 
intervals.   
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After the amalgation is complete, the flask was cooled to -20 oC and a solution 
of benzoic acid 2-benzenesulfonyl-1-benzyl-pentyl ester (118) (1.00 g, 23 mmol) 
in a mixture of THF/MeOH (3:1, 20 ml) was transferred to the sodium amalgam 
via cannula followed by addition of Na2HPO4 (0.30 g, 23 mmol) in solution of 3:1 
mixture of THF/MeOH (5 ml).  The resulting mixture was stirred for 1 h at -20 oC 
followed by 2 h stirring at room temperature.  The reaction was added with ice-
cold water (10 ml) and elimination of the mercury residue was done by 
decanting the top solution.  The resultant solution was extracted with diethyl 
ether (2 x 30 ml).  The combined organic extracts were washed with aqueous 
NH4Cl (20 ml), brine (20 ml), dried over magnesium sulfate and concentrated in 
vacuo.  The chromatographic purification of the residue (elution with 80% 
hexane/ethyl acetate) afforded a yellowish oil of 1-phenyl-2-hexanol (119) 
(0.75 g, 75%). 
 
1H NMR (300 MHz, CDCl3) δH:  
0.93 (3H, t, CH3), 1.34-1.58 (6H, m, 3xCH2), 2.67-2.84 (2H, 
2xdd, J=4.2 Hz and 8.4 Hz, CH2), 3.80 (1H, m, CHOH), 
7.25-7.33 (5H, m, Ar-H). 
 
13C NMR (75 MHz, CDCl3) δC:  
14.2 (CH3), 22.8 (CH2), 28.0 (CH2), 36.6 (CH2), 44.1 (CH2), 
72.7 (CHOH), 126.4 (C-4), 128.3 (4C, C-2, C-3, C-5 and C-
6), 139.4 (C-1). 
 
 
HRESIMS m/z [M+H]+ 179.14452 
   (calc. for C12H18O+H, 179.14456) 
 










A mixture of benzoic acid 2-benzenesulfonyl-1-benzylpentyl ester (118) (1.00 g, 
23 mmol), magnesium powder (-50 mesh) (80 mg, 23 mmol) and catalytic 
amount of HgCl2 (0.12 g, 0.5 mmol) in dry ethanol (20 ml) were stirred for 2 h at 
room temperature.  The reaction mixture was poured into cold (5 oC) 0.5 N HCl 
and extracted with diethyl ether (2 x 30 ml).  The combined organic extracts 
were washed with saturated aqueous NaHCO3 solution (20ml), water (20 ml), 
brine (20 ml), dried over magnesium sulfate and concentrated in vacuo.  The 
chromatography of the residue (elution with 80% hexane/ethyl acetate) afforded 
the starting material benzoic acid 2-benzenesulfonyl-1-benzylpentyl ester 
(118) in high yield without the presence of the desired compound (120). 
 

















Compound (121) was prepared following exactly the same procedure and 
reagents [(mercury (15 ml), Na (1.00 g, 43 mmol), compound (118) (1.00 g, 23 
mmol) and Na2HPO4 (0.30 g, 23 mmol)] utilised for the preparation of 
compound (119) but using only dry THF (20 ml) as the solvent.   
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The resulting mixture was stirred for 1 h at -20 oC followed by 2 h stirring at 
room temperature.  The reaction was added with ice-cold water (10 ml) and 
elimination of the mercury residue was done by decanting the top solution.  The 
resultant solution was extracted with diethyl ether (2 x 30 ml).  The combined 
organic extracts were washed with aqueous NH4Cl (20 ml), brine (20 ml), dried 
over magnesium sulfate and concentrated in vacuo.  The chromatographic 
purification of the residue (elution with 80% hexane/ethyl acetate) afforded a 
yellowish oil of 3-benzenesulfonyl-1-phenyl-hexene (121) (0.70 g, 70%). 
 
1H NMR (300 MHz, CDCl3) δH:  
0.92 (3H, t, CH3), 1.28-2.19 (4H, m, 2xCH2), 3.61-3.68 (1H, 
m, CHSO2Ph), 5.89 (1H, dd, J= 15.6 and 9.6 Hz, CH, 
trans), 6.24 (1H, d, J= 15.6 Hz, CH, trans), 7.23-7.80 (10H, 
m, Ar-H). 
 
13C NMR (75 MHz, CDCl3) δC:  
13.6 (CH3), 20.0 (CH2), 29.2 (CH2), 29.4 (CHSO2Ph), 121.2 
(α-CH), 126.4 (β-CH), 126.6 (2C, C-2 and C-6), 126.8 (2C, 
C-2’ and C-6’), 128.5 (C-4), 128.9 (C-3 and C-5), 130.5 (C-
3’ and C-5’), 135.4 (C-4’), 136.3 (C-1), 137.9 (C-1’). 
 
HRESIMS m/z [M+H]+ 301.1274 
   (calc. for C18H20O2S+H, 301.1278) 
 













To a solution of 4-isopropoxy-3-methoxybenzaldehyde (104) (1.00 g, 5 mmol) 
and nitromethane (1.3 ml, 30 mmol) in EtOH (25 ml) at 0 oC was added 5% 
aqueous potassium hydroxide solution (10 ml).  After stirring for 1 h at the same 
temperature, the reaction mixture was poured into 15% aqueous HCl solution 
(20 ml) and a yellow precipitate formed which was filtered and dried in vacuo.  
The crude product was recrystallised from hexane to afford yellow crystals of 1-
isopropoxy-2-methoxy-4-(2-nitrovinyl)benzene (122) (0.90 g, 90%). 
 
Mp:   90-93 oC from hexane  
 
1H NMR (300 MHz, CDCl3) δH:  
1.39 [6H, 2xs, OCH(CH3)2], 3.88 (3H, s, OCH3), 4.63 [1H, 
sept, OCH(CH3)2], 6.89 (1H, d, J=8.4 Hz, H-5) 6.99 (1H, d, 
J=2.4 Hz, H-2), 7.11 (1H, dd, J=2.1 Hz, H-6), 7.50 (1H, d, 
J=13.5 Hz, CHα, trans) 7.94 (1H, d, J=13.5 Hz, CHβ, trans). 
 
13C NMR (75 MHz, CDCl3) δC:  
21.8 [OCH(CH3)2], 56.0 (OCH3), 71.3 [OCH(CH3)2], 109.8 
(C-2), 111.0 (C-5), 114.1 (C-6), 122.5 (C-1), 124.5 (C-4), 
135.0 (CH), 139.5 (CH), 150.4 (C-3). 
 
HRESIMS m/z [M+H]+ 239.1168 
   (calc. for C12H16NO4+H, 239.1170) 
 
IR νmax (cm-1): 1625,1488. 
 










Potassium bromate (15.00 g, 90 mmol) was added over a 0.5 h period to a 
vigorously stirred mixture of 2-iodobenzoic acid (17.00 g, 68 mmol) and sulfuric 
acid (146 ml, 0.7 M) at 55 oC.  The mixture was warmed to 65 oC and stirred for 
3.6 h.  Then it was cooled to 0 oC, filtered off and washed with 1 L of water and 
ethanol (2 x 50 ml) to give 2-iodoxybenzoic acid in 98%.  Then 2-iodoxybenzoic 
acid (5.00 g, 18 mmol) was stirred as slurry in acetic anhydride (17.00 g, 0.8 
mol), acetic acid (70 ml) and heated to 100 oC.  All the solids were dissolved 
approximately after 40 minutes and the solvent was removed under vacuum at 
room temperature until thick slurry remained.  The slurry was filtered in an inert 
atmosphere and washed with diethyl ether (180 ml) to give the Dess-Martin 
periodinane (7.00 g, 87%) which was utilised without further purification. 
 












The compound was prepared in two steps, firstly selective protection of 1,3-
propanediol followed by oxidation of the free hydroxy group.  A solution of 1,3-
propanediol (3.00 g, 42 mmol) in THF (5 ml) was added at 0 oC to a suspension 
of sodium hydride (2.39 g, 50 mmol) in THF(20 ml) and the mixture was stirred 
at room temperature for 1 h.  Benzoyl chloride (5 ml, 42 mmol) in THF (5 ml) 
was slowly added at 0 oC to the mixture and continue stirring at room 
temperature for 2 h.  The 10% potassium carbonate was added and the two-
phase mixture was stirred at room temperature for 1 h.  The mixture was 
extracted with diethyl ether (3 x 25 ml) and the combined organic extracts were 
washed with brine (25 ml), dried over magnesium sulfate and concentrated in 
vacuo.  The crude product was subjected further to oxidation reaction without 
further purification.   
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A solution of crude material (1.00 g, 6 mmol) in dry dichloromethane (20 ml) 
was added Dess-Martin periodinane (4.00 g, 8 mmol) in dry dichloromethane 
(10 ml) and the mixture was stirred for 3 h at room temperature.  The mixture 
was filtered off and the remaining organic filtrate was washed with brine, dried 
over magnesium sulfate and concentrated in vacuo.  The chromatographic 
purification of the residue (elution with 80% hexane/ethyl acetate) afforded a 
colourless oil of 3-oxopropyl benzoate (124) (2.40 g, 80%). 
 
1H NMR (300 MHz, CDCl3) δH:  
2.83 (2H, 2xt, CHOCH2CH2OBz), 4.58 (2H, t, 
CHOCH2CH2OBz), 7.33-7.96 (5H, m, Ar-H), 9.78 (1H, t, 
CHO). 
 
13C NMR (75 MHz, CDCl3) δC:  
42.5 (CHOCH2CH2OBz), 58.3 (CHOCH2CH2OBz), 128.2 
(2C, C-3 and C-5), 129.2 (2C, C-2 and C-6), 129.6 (C-1), 
133.0 (C-4), 166.2 (CO2Ar), 199.4 (CHO). 
 
HRESIMS m/z [M+H]+ 179.07178 
   (calc. for C10H10O3+H, 179.07180) 
 
IR νmax (cm-1): 2773, 1643. 
 
4.2.25 Preparation of borohydride exchange resin (BER)15,16 
 
CH2N(CH3)3BH4





An aqueous solution of NaBH4 (1 M, 200 ml) was stirred with wet chloride-form 
resin (Amberlite IRA 400) (40.00 g) for 1 h.  The resulting resin was thoroughly 
washed with distilled water until free of excess NaBH4.  The borohydride 
exchange resin was then dried in vacuo at 60 oC for 6 h.  The dried resin (40.00 
g) was stored under nitrogen in a refrigerator. 
 













To the solution of 1-isopropoxy-2-methoxy-4-(2-nitro-vinyl)-benzene (122) (1.00 
g, 4 mmol) in mixture of methanol/dichloromethane (10:1, 20 ml) was added 
BER (1.5 g, 4 mmol).  The reaction mixture was stirred at room temperature for 
2 h.  The resin was filtered off and the filtrate was concentrated in vacuo.  The 
chromatographic purification of the residue (elution with 80% hexane/ethyl 
acetate) afforded a yellowish oil of 1-isopropoxy-2-methoxy-4-(2-
nitroethyl)benzene (125) (0.90 g, 90%). 
 
1H NMR (300 MHz, CDCl3) δH:  
1.30 [6H, 2xs, OCH(CH3)2], 3.21 (2H, t, CH2CH2NO2), 3.80 
(3H, s, OCH3), 4.45 [1H, sept, OCH(CH3)2], 4.55 (2H, t, 
CH2CH2NO2), 6.67 (2H, d, J=6.3 Hz, Ar-H), 6.80 (1H, d, 
J=9 Hz, Ar-H). 
 
13C NMR (75 MHz, CDCl3) δC:  
21.9 [OCH(CH3)2], 32.9 (CH2CH2NO2), 55.8 (OCH3), 71.3 
[OCH(CH3)2], 76.4 (CH2CH2NO2), 112.3 (C-2), 115.9 (C-5), 
120.5 (C-6), 128.4 (C-1), 146.5 (C-4), 150.5 (C-3). 
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HRESIMS m/z [M+H]+ 241.13266 
   (calc. for C12H18NO4+H, 241.13269) 
 
4.2.27 Preparation of 3-hydroxy-5-(4-isopropoxy-3-methoxyphenyl)-4-nitro-






















To a solution of tetrabutylammonium fluoride (0.22 g, 0.8 mmol) in THF was 
added 1-isopropoxy-2-methoxy-4-(2-nitroethyl)benzene (125) (0.5 g, 2 mmol) at 
0 oC.  The 3-oxopropyl benzoate (124) (0.4 g, 2 mmol) and triethylamine (0.3 
ml, 2 mmol) were added to the bright red solution.  To this solution was added a 
solution of tert-butyldimethylsilyl chloride (0.5 g, 3 mmol) in THF (5 ml) at 0 oC.  
The reaction mixture was allowed to warm up to room temperature for 30 
minutes.  The mixture was filtered off and the remaining filtrate was diluted with 
water (20 ml) and extracted with diethyl ether (3 x 25 ml).   
The combined organic layers were washed with water (20 ml), brine (20 ml), 
dried over magnesium sulfate and concentrated in vacuo.  The chromatographic 
purification of the residue (elution with 80% hexane/ethyl acetate) afforded a 
yellowish oil of 3-hydroxy-5-(4-isopropoxy-3-methoxyphenyl)-4-nitro-pentyl 








1H NMR (300 MHz, CDCl3) δH:  
1.29 [6H, 2xs, OCH(CH3)2], 1.98 (2H, m, CH2), 3.18 (2H, m, 
CH2), 3.74 (3H, s, OCH3), 4.14 [1H, sept, OCH(CH3)2], 4.47 
(3H, m, CH2 and CHOH), 4.73 (1H, m, CHNO2), 6.64 (2H, 
d, J=6.3 Hz, Ar-H), 6.71 (1H, d, J=9 Hz, Ar-H), 7.38-7.97 
(5H, m, Ar-H). 
 
13C NMR (75 MHz, CDCl3) δC:  
21.8 [OCH(CH3)2], 32.7 (CH2), 35.7 (CH2), 55.7 (OCH3), 
61.0 (CH2), 68.7 (CHOH), 71.3 (OCH(CH3)2), 93.4 
(CHNO2), 112.5 (C-2), 115.7 (C-5), 120.9 (C-6), 123.8 (C-
1), 128.4 (2C, C-3’ and C-5’), 129.5 (2C, C-2’ and C-6’), 
130.5 (C-1’), 133.2 (C-4’), 146.9 (C-4), 150.3 (C-3). 
 
HRESIMS m/z [M+H]+ 419.19655 
   (calc. for C22H28NO7+H, 419.19658) 
 
IR νmax (cm-1): 3320, 16.30, 1456. 
 
4.2.28 Preparation of 3-acetoxy-5-(4-isopropoxy-3-methoxyphenyl)-4-nitro-






















The 3-Hydroxy-5-(4-isopropoxy-3-methoxyphenyl)-4nitro-pentyl benzoate (126) 
(1.50 g, 4 mmol) was dissolved in dichloromethane (20 ml) and acetic anhydride 
(7 ml, 7 mmol) and DMAP (0.40 g, 4 mmol) were added sequentially at room 
temperature.  After stirring for 2 h at the same temperature, the reaction was 
added water (20 ml) and extracted with dichloromethane (3 x 20 ml).   
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The combined organic layers were washed with water (20 ml), brine (20 ml), 
dried over magnesium sulfate and concentrated in vacuo.  The yellow solid of 5-
3-acetoxy-5-(4-isopropoxy-3-methoxyphenyl)-4-nitro-pentyl benzoate (127) 
(1.43 g, 95%) obtained and was utilised in the next step without further 
purification and characterisation. 
 
4.2.29 Preparation of 3-ethoxythiocarbonylsulfanyl-5-(4-isopropoxy-3-






















To a solution of 3-acetoxy-5-(4-isopropoxy-3-methoxyphenyl)-4-nitropentyl 
benzoate (127) (1.50 g, 3 mmol) in a 9/1 mixture of acetonitrile and acetic acid 
(20 ml) was added potassium O-ethylxanthate (0.60 g, 4 mmol) at 0 oC under 
nitrogen atmosphere.  The reaction was stirred at room temperature until 
complete consumption of the starting material.  The reaction was added a 
saturated solution of citric acid (20 ml) and extracted with dichloromethane (3 x 
20 ml).  The combined organic layers were washed with water (20 ml), 
saturated solution of sodium hydrogen carbonate, brine (20 ml), dried over 
magnesium sulfate and concentrated in vacuo.  The chromatographic 
purification of the residue (elution with 80% hexane/ethyl acetate) afforded a 
pale yellow oil of 3-ethoxythiocarbonylsulfanyl-5-(4-isopropoxy-3-








1H NMR (300 MHz, CDCl3) δH:  
1.20 (3H, t, CH2CH3), 1.32 (6H, 2xs, OCH(CH3)2), 1.99-
2.31 [3H, m, CH2 and CHSC(S)OEt], 3.18 (2H, m, CH2), 
3.83 (3H, s, OCH3), 4.06 (2H, q, J=7.2 Hz and 7.5 Hz, 
CH2CH3), 4.14 [1H, sept, OCH(CH3)2], 4.48 (3H, m, CHNO2 
and CH2), 6.85 (1H, d, J=8.4 Hz, Ar-H), 6.95 (1H, d, J=2.1 
Hz, Ar-H), 7.00 (1H, dd, J=1.5 Hz and 1.8 Hz, Ar-H), 7.39-
8.07 (5H, m, Ar-H). 
 
13C NMR (75 MHz, CDCl3) δC:  
13.9 (CH2CH3), 21.8 [OCH(CH3)2] 29.3 (CH2), 31.6 (CH2), 
35.6 [CHSC(S)OEt], 55.9 (OCH3), 60.2 (CH2CH3), 62.7 
(CH2), 71.1 [OCH(CH3)2], 80.6 (CHNO2), 111.2 (C-2), 114.5 
(C-5), 120.9 (C-6), 123.8 (C-1), 128.3 (2C, C-3’ and C-5’), 
129.3 (C-1’), 130.0 (2C, C-2’ and C-6’), 133.6 (C-4’), 149.0 
(C-4), 150.4 (C-3), 171.5 [SC(S)OEt]. 
 
HRESIMS m/z [M+H]+ 523.17251 
   (calc. for C25H32NO7S2+H, 523.17254) 
 
IR νmax (cm-1): 1650, 1420. 
 
4.2.30 Attempted preparation of 5-(4-isopropoxy-3-methoxyphenyl)-3-












To a solution 3-ethoxythiocarbonylsulfanyl-5-(4-isopropoxy-3-methoxyphenyl)-4-
nitropentyl benzoate (128) (2.50 g, 5 mmol) in refluxing degassed 1,2-
dichloroethane (25 ml) was added dilauroyl peroxide (DLP) (2.90 g, 7 mmol) 
under nitrogen atmosphere.  The reaction was stirred at refluxed for 90 minutes 
and DLP (2.90 g, 7 mmol) was added once again.  After a further 90 minutes at 
reflux, the reaction was cooled to room temperature and concentrated under 
reduced pressure.  The residue was partitioned between water (20 ml) and 
dichloromethane (20 ml) and the aqueous layer was extracted with 
dichloromethane (3 x 15 ml).  The combined organic extracts were washed with 
water (20 ml), brine (20 ml), dried over magnesium sulfate and concentrated in 
vacuo.  The chromatography of the residue (elution with 90% hexane/ethyl 
acetate) afforded the starting material 3-ethoxythiocarbonylsulfany-5-(4-
isopropoxy-3-methoxyphenyl)-4-nitropentyl benzoate (128) in high yield 
(2.3 g, 90%) without the presence of the desired compound (129). 
 



















The 3-hydroxy-4,5-dimethoxybenzaldehyde (101) (2.00 g, 11 mmol), and K2CO3 
(3.03 g, 22 mmol) were stirred in acetonitrile (30 ml) under argon.  Benzyl bromide 
(1.60 ml, 2.25 g, 13 mmol) was added and the mixture heated at 60 oC for 12 h.  
The reaction mixture was filtered and concentrated in vacuo.  The residue was 
dissolved in ethyl acetate (50 ml) and washed with water (3 x 30 ml).  The 
aqueous layer was extracted with ethyl acetate (2 x 50 ml), the combined organic 
extracts were washed with water (2 x 50 ml) solution followed by brine (1 x 50 ml) 
and dried over anhydrous magnesium sulfate and concentrated in vacuo to afford 
a yellowish oil.   
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The chromatographic purification on silica (elution with 80% hexane/ethyl acetate) 
afforded 3-benzyloxy-4,5-dimethoxybenzaldehyde (138) (1.7 g, 85%) as white 
solid.  
 
Mp:   43-45 oC from hexane 
1H NMR (500 MHz, CDCl3) δH:  
3.90-3.95 (6H, 2xs, 2xOCH3), 5.16 (2H, s, OCH2Bn), 7.12 
(1H, d, J=1.5 Hz, Ar-H), 7.16 (1H, d, J=1.5 Hz, Ar-H), 7.30-
7.45 (5H, m, Ar-H), 9.81 (1H, s, CHO). 
 
13C NMR (125 MHz, CDCl3) δC:  
56.1 (OCH3), 71.1 (OCH2Bn), 106.5 (C-6), 109.1 (C-2), 
127.4 (2C, C-2’ and C-6’), , 128.3 (2C, C-3’ and C-5’), 
129.9 (C-4’), 131.5 (C-1), 136.29 (C-4), 144.2 (C-1’), 152.5 
(C-3), 153.7 (C-5), 190.9 (CHO). 
 
HRESIMS m/z [M+H]+ 273.1133 
   (calc. C16H16O4+H, 273.1127) 
 
IR νmax (cm-1): 1622. 
 
4.2.32 Preparation of methyltriphenylphosphonium iodide (139)7 
 
Triphenylphosphine (1.00 g, 4 mmol) was added to iodomethane (0.20 ml, 0.50 g, 
4 mmol) in benzene (50 ml) and the mixture was refluxed for 2 h until formation of 
the salt.  The reaction was cooled to room temperature and the salt was then 
filtered off and dried in high vacuum pressure (ca. 22 Torr) to obtain a pure white 
salt which upon recrystallisation from EtOH gave pure crystals of 
methyltriphenylphosphonium iodide (139) (0.50 g, 100%) with a melting point 












To a suspension of methyltriphenylphosphonium iodide (139) (3.00 g, 7 mmol) in 
dry THF (50 ml), potassium tert-butoxide (0.80 g, 7 mmol) was added at 0 oC and 
stirred for 15 minutes.  Then the above mixture was added to a solution of 3-
benzyloxy-4,5-dimethoxybenzaldehyde (138) (1.00 g, 4 mmol) in dry THF using a 
syringe.  The combined mixture was stirred at room temperature for another 15 
minutes.  The consumption of starting material was monitored by TLC and when 
the reaction is complete, the mixture was concentrated in vacuo and partitioned 
between water and diethyl ether.  The organic layer was washed with water (2 x 
50 ml) followed by brine (1 x 50 ml), dried over magnesium sulfate and finally 
concentrated in vacuo to afford a yellowish oil.  The chromatographic purification 
on silica (elution with 90% hexane/ethyl acetate) afforded 1-benzyloxy-2,3-
dimethoxy-5-vinylbenzene (140) (0.90 g, 90%) as a yellow oil. 
 
1H NMR (500 MHz, CDCl3) δH:  
3.88-3.89 (6H, 2xs, 2xOCH3), 5.14 (2H, s, OCH2Bn), 5.19 
(1H, d, J=10.9 Hz, β1-CH), 5.61 (1H, d, J=17.5 Hz, β2-CH), 
6.57-6.63 (1H, dd, J=10.8 Hz and 6.7 Hz, α-CH) 6.65-6.68 
(2H, 2 x d, J=1.8 Hz, Ar-H), 7.30-7.47 (5H, m, Ar-H). 
 
13C NMR (125 MHz, CDCl3) δC:  
56.1 (OCH3), 60.9 (OCH3), 71.2 (OCH2Bn), 103.7 (C-6), 
105.8 (C-2), 113.2 (β-CH), 127.2 (2C, C-2’ and C-6’), 127.8 
(C-4’), 127.9 (2C, C-3’ and C-5’), 133.2 (α-CH), 136.7 (C-
1), 137.1 (C-4), 138.8 (C-1), 152.5 (C-3), 153.5 (C-5). 
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HRESIMS m/z [M+H]+ 271.1333 
   (calc. for C17H18O3+H, 271.1334) 
 








To a solution of 1-benzyloxy-2,3-dimethoxy-5-vinylbenzene (140) (1.00 g, 3.6 
mmol) in dry THF (50 ml) at 0 oC under argon atmosphere was added 
BH3.(CH3)2S (0.70 ml, 3.6 mmol, 5 M solution in diethyl ether) and stirred for 4 h 
at room temperature.  The reaction flask was cooled to 0 oC and then a solution 
of NaOH (0.30 g, 7 mmol) in ethanol/water ratio 2:1 (20 ml) followed by 
hydrogen peroxide (0.30 ml, 11 mmol, 30% w/v solution in H2O) were added 
dropwise over 30 minutes.  The mixture was then allowed to stir at room 
temperature for 3 h.  The product was taken up in ethyl acetate and the 
aqueous layer extracted twice with ethyl acetate (3 x 30 ml).  The combined 
organic layers were washed with water (50 ml), brine (50ml), dried over 
magnesium sulfate and concentrated in  vacuo to yield a crude product which 
upon chromatographic purification on silica (elution with 50% hexane/ethyl 
acetate) afforded 2-[(3-benzyloxy)-4,5-dimethoxyphenyl]ethanol (141) (0.85 
g, 85%) as colourless oil. 
 
1H NMR (500 MHz, CDCl3) δH:  
2.77 (2H, t, J=6.4 Hz, CH2CH2OH), 3.81 (2H, t, J=6.4 Hz 
and 6.3 Hz, CH2CH2OH), 3.86 (6H, 2xs, 2xOCH3), 5.13 
(2H, s, OCH2Bn), 6.45 (2H, 2xd, J=1.7 Hz and 1.8 Hz, Ar-
H), 7.31-7.44 (5H, m, Ar-H). 
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13C NMR (125 MHz, CDCl3) δC:  
39.4 (CH2CH2OH), 56.1 (OCH3), 60.9 (OCH3), 63.5 
(CH2CH2OH), 71.1 (OCH2Bn), 106.3 (C-6), 108.3 (C-2), 
127.3 (2C, C-6’ and C-2’), 127.9 (C-4’), 128.5 (2C, C-3’ and 
C-5’), 134.0 (C-1), 137.2 (C-4), 137.4 (C-1’), 152.4 (C-3), 
153.5 (C-5). 
 
HRESIMS m/z [M+H]+ 289.1451 
   (calc. for C17H20O4+H, 289.1440) 
 
IR νmax (cm-1): 3410. 
 



























To a solution of 2-[(3-benzyloxy)-4,5-dimethoxyphenyl]ethanol (141) (1.00 g, 4 
mmol) in dry CH2Cl2 (30 ml) at 0 
oC under argon atmosphere was triethyl amine 
(0.60 ml, 4 mmol) followed by para-toluenesulfonyl chloride (0.80 g, 4 mmol) 
and the reaction mixture was stirred at room temperature for 30 minutes to 2 h.  
Upon completion of the reaction by TLC monitoring for consumption of starting 
material, the reaction mixture was quenched with aqueous HCl (5 ml, 5 M).   
The resulting aqueous phase was extracted with dichloromethane (3 x 20 ml).  
The combined organic extracts were dried over anhydrous magnesium sulfate 
and concentrated in vacuo.  The chromatography of the residue on silica 
(elution with 70% hexane/ethyl acetate) afforded 3-(benzyloxy)-4,5-
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dimethoxyphenethyl 4-methylbenzenesulfonate (142) (0.90 g, 90%) as a 
white solid. 
Mp:   35-37 oC from hexane 
 
1H NMR (500 MHz, CDCl3) δH:  
2.41 (3H, s, OTs-CH3), 2.84-2.87 (2H, t, J=6.9 Hz and 8.05 
Hz, CH2CH2OTs), 3.79-3.84 (6H, 2xs, 2xOCH3), 4.17-4.20 
(2H, t, J=7.05 Hz and 6.9 Hz, CH2CH2OTs), 5.05 (2H, s, 
OCH2Bn), 6.31-6.36 (1H, 2xd, J=1.7 Hz and 1.6 Hz, Ar-H), 
7.26 (1H, d, J=2.9 Hz, Ar-H), 7.27-7.44 (5H, m, Ar-H). 
 
13C NMR (125 MHz, CDCl3) δC:  
21.6 (OTs-CH3), 35.9 (CH2CH2OTs), 56.0 (OCH3), 60.9 
(OCH3), 70.5 (CH2CH2OTs), 71.1 (OCH2Bn), 106.2 (C-6), 
108.1 (C-2), 127.3 (2C, C-2’ and C-6’), 127.8 (2C, C-3’ and 
C-5’), 127.9 (2C, C-2’’ and C-6’’), 128.5 (2C, C-3’’ and C-
5’’), 129.7 (C-4’), 130.2 (C-1’’), 131.8 (C-1), 132.9 (C-4), 
137.1 (C-4’’), 137.2 (C-1’), 144.7 (C-3), 152.3 (C-5). 
 
HRESIMS m/z [M+Na]+ 465.1083 
   (calc. for C24H26O6+Na, 465.1080) 
 












A solution of 3-(benzyloxy)-4,5-dimethoxyphenethyl 4-methylbenzenesulfonate 
(142) (1.00 g, 2 mmol) in acetone (50 ml) containing NaI (1.70 g, 11 mmol) was 
refluxed for 24 h.  Upon completion of the reaction by TLC monitoring for 
consumption of starting material, the reaction mixture was cooled to room 
temperature and precipitated sodium para-toluenesulfonate was filtered off.  
The filtrate was concentrated in vacuo.  The residue was partitioned between 
water (50 ml) and chloroform (25 ml).  The organic layer was washed with 
aqueous Na2S2O3 (50 ml), water (50 ml) and brine (50 ml) followed by drying 
over magnesium sulfate and concentrated in vacuo.  The chromatography of 
the residue on silica (elution with 80% hexane/ethyl acetate) afforded 1-
benzyloxy-5-(2-iodoethyl)-2,3-dimethoxybenzene (130) (0.90 g, 90%) as 
white solid. 
 
Mp:   60-63 oC from hexane 
 
1H NMR (500 MHz, CDCl3) δH:  
2.84-2.87 (2H, t, J=8 Hz CH2CH2I), 3.29 (2H, t, J=8 Hz, 
CH2CH2I), 3.85-3.86 (6H, 2xs, 2xOCH3), 5.13 (2H, s, 
OCH2Bn), 6.41 (1H, d, J=1.8 Hz, Ar-H), 6.44 (1H, d, J=1.8 
Hz, Ar-H), 7.31-7.45 (5H, m, Ar-H). 
 
13C NMR (125 MHz, CDCl3) δC:  
5.3 (CH2CH2I), 40.7 (CH2CH2I), 56.1 (OCH3), 60.9 (OCH3), 
71.2 (OCH2Bn), 105.8 (C-6), 107.7 (C-2), 127.3 (2C, C-2’ 
and C-6’), 127.9 (C-4’), 128.5 (2C, C-3’ and C-5’), 136.2 (C-
1), 137.1 (C-4), 137.9 (C-1’), 152.4 (C-3), 153.5 (C-5). 
 
HRESIMS m/z [M+H]+ 399.0452 
















To a solution of 1-benzyloxy-5-(2-iodoethyl)-2,3-dimethoxybenzene (130) (1.00 
g, 2 mmol) in xylene (50 ml) was added triphenylphosphine (1.30 g, 5 mmol) 
and the reaction mixture was refluxed under argon for 24 h or until the formation 
of the salt.  Then the solution was cooled to 50 oC and filter the solution to 
afford the milky white solid of 1-benzyloxy-2,3-
dimethoxyphenethyltriphenylphosphonium iodide (143) (1.00 g, 100%) 
after successive drying in high vacuum (ca. 22 Torr).  The salt was utilised 
without further purification and characterisation. 
 










To a solution of NaN3 (5.60 g, 86.8 mmol) in warm water (27 ml) was added tert-
butyl isothiocyanate (10.00 g, 86.8` mmol) as an i-PrOH (21 ml) solution via 
dropping funnel over a period of 30 minutes.  At the end of the addition, the 
mixture was refluxed for 16 h, then cooled in ice-bath and concentrated HCl (13 
ml) was added carefully.  The mixture was concentrated under reduced pressure 
and stored at 0 oC for overnight.   
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The yellow solid obtained was filtered off and washed once with ice-cooled water, 
then dried under high vacuum pressure (ca. 22 Torr) to obtain a pale yellow 
powder of 1-tert-butyl-1,4-dihydrotetrazol-5-thione (144) (10.00 g , 100%) with a 
melting point of 88-90 oC (lit.10 90-92 oC) from cyclohexane.  The salt was utilised 
without further purification and characterisation. 
 











A solution of 1-tert-butyl-1,4-dihydrotetrazol-5-thione (144) (1.00 g, 6.7 mmol) in 
anhydrous THF (5 ml) was added via a canula at 0 oC into a suspension of NaH 
(0.30 g, 8 mmol) in anhydrous THF (20 ml).  After an hour stirring at 0 oC, 1-
benzyloxy-5-(2-iodo-ethyl)-2,3-dimethoxy-benzene (130) (2.70 g, 6.7 mmol) in 
anhydrous THF (5 ml) was added via with a syringe.  The mixture was stirred 
overnight at room temperature.  Upon completion of the reaction by TLC 
monitoring for consumption of starting material, the reaction mixture was cooled to 
0 oC and quenched with ice cold water.  The resulting precipitate was filtered off 
and the solvent was removed in vacuo.  The remaining aqueous layer was 
extracted with ethyl acetate (3 x 20 ml) and the organic phase was washed with 
water (20 ml) and brine (20 ml) followed by drying over magnesium sulfate and 
concentrated in vacuo.  The chromatography of the residue (elution with 70% 
hexane/ethyl acetate) afforded 5-[2-(3-benzyloxy-4,5-dimethoxyphenyl)-




1H NMR (400 MHz, CDCl3) δH:  
1.73, [9H, s, C(CH3)3], 3.06 (2H, t, J=7.4 Hz and 7.8 Hz, 
CH2CH2S), 3.60 (2H, t, J=7.8 Hz and 7.4 Hz, CH2CH2S), 
3.87 (6H, s, 2xOCH3), 5.14 (2H, s, OCH2Bn), 6.49 (1H, d, 
J=1.7 Hz, Ar-H), 6.54 (1H, d, J=1.7 Hz, Ar-H), 7.28-7.48 
(5H, m, Ar-H). 
 
13C NMR (100 MHz, CDCl3) δC:  
28.7 [C(CH3)3], 34.9 (CH2CH2S), 35.8 (CH2CH2S), 56.2 
[C(CH3)3], 60.9/61.0 (2xOCH3), 71.3 (OCH2Bn), 106.2 (C-
6), 108.1 (C-2), 127.4 (2C, C-2’ and C-6’), 127.9 (C-4’), 
128.1 (SCN2), 128.5 (C-3’), 128.5 (C-5’), 134.9 (C-1), 137.2 
(C-4), 137.7 (C-1’), 152.4 (C-3), 153.5 (C-5 ). 
 
HRESIMS m/z [M+H]+ 429.1963 
   (calc. for C22H28N4O3S+H, 429.1960) 
 














A solution of oxone (0.12 g, 0.2 mmol) in H2O2 (2 ml) was added at 0 
oC to a 
stirred solution of 5-[2-(3-benzyloxy-4,5-dimethoxyphenyl)-ethylsulfanyl]-1-tert-
butyl-4,5-dihydro-1H-tetrazole (145) (1.00 g, 2.3 mmol) in ethanol (25 ml).  The 
mixture was stirred for few hours at room temperature.   
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Upon completion of the reaction by TLC monitoring for consumption of starting 
material, the mixture was concentrated in vacuo.  The residue was partitioned 
between water (20 ml) and dichloromethane (20 ml).  The organic phase was 
washed with water (20 ml) and brine (20 ml) followed by drying over magnesium 
sulfate and concentrated in vacuo.  The chromatography of the residue (elution 
with 70% hexane/ethyl acetate) afforded 5-[2-(3-benzyloxy-4,5-
dimethoxyphenyl)-ethanesulfonyl]-1-tert-butyl-4,5-dihydro-1H-tetrazole (146) 
(0.91 g, 91%) as a yellow oil. 
 
1H NMR (400 MHz, CDCl3) δH:  
1.87, [9H, s, C(CH3)3] 3.14 (2H, t, J=7.6 Hz and 7.5 Hz, 
CH2CH2SO2), 3.84 - 3.94 (8H, s and m, 2xOCH3 and 
CH2CH2SO2), 5.14 (2H, s, OCH2Bn), 6.52 (1H, d, J=7 Hz, 
Ar-H), 6.56 (1H, d, J=7 Hz, Ar-H), 7.28-7.52 (5H, m, Ar-H). 
 
13C NMR (100 MHz, CDCl3) δC:  
29.8 (CH2CH2SO2), 30.2 [C(CH3)3], 54.5 [C(CH3)3], 56.3 
(CH2CH2SO2), 60.9/64.1 (2xOCH3), 71.3 (OCH2Bn), 106.2 
(C-6), 108.1 (C-2), 127.3 (SO2CN2), 127.3 (2C, C-2’ and C-
6’), 127.9 (C-4’), 128.5 (2C, C-3’ and C-5’), 133.2 (C-1), 
137.0 (C-4), 137.3 (C-1’), 152.7 (C-3), 153.8 (C-5). 
 
HRESIMS m/z [M+H]+ 461.1855` 
   (calc. for C22H28N4O5S+H, 461.1859) 
 

















A mixture of bromine (5.4 ml, 105 mmol) in carbon disulfide (5 ml) was added 
dropwise to the solution of guaiacol (135) (11.2 ml, 105 mmol) and carbon 
disulfide (30 ml).  The solution was stirred at 0 oC for 18 h, and then partitioned 
between water (20 ml) and carbon disulfide (20 ml).  The organic extracts were 
washed with water (3 x 20 ml), brine (20 ml), dried over anhydrous magnesium 
sulfate and concentrated in vacuo.  The chromatography of the residue (elution 
with 70% hexane/ethyl acetate) afforded 4-bromo-2-methoxyphenol (147) 
(11.38 g, 90%) as a brownish oil. 
 
1H NMR (500 MHz, CDCl3) δH:  
3.87 (3H, s, OCH3), 5.61 (1H, s, OH), 6.81 (1H, d, J=10 Hz, 
H-6), 6.97 (1H, d, J=2.2 Hz, H-3), 7.99 (1H, dd, J=2.2 Hz, 
H-5). 
 
13C NMR (175 MHz, CDCl3) δC:  
56.1 (OCH3), 71.2 [OCH(CH3)2], 114.1 (C-4), 115.7 (2C, C-
3 and C-6), 124.1 (C-5), 144.8 (C-1), 147.2 (C-2). 
 
HRESIMS m/z [M+H]+ 203.0720 
   (calc. for C7H7 
79BrO2+H, 203.0723) 
IR νmax (cm-1): 3509. 
 






















The 4-Bromo-2-methoxyphenol (147) (1.00 g, 5 mmol) and anhydrous 
potassium carbonate were added to acetonitrile (20 ml) under nitrogen 
atmosphere.   
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Benzyl bromide (0.7 ml, 6 mmol) was added and the mixture was heated for 20 
h at 50 oC.  After cooling, the mixture was filtered to remove inorganic material 
and the filtrate was concentrated in vacuo.  The residue was partitioned 
between water (20 ml) and chloroform (20 ml).  The aqueous layer was 
extracted with chloroform (3 x 20 ml).  The combined organic extracts were 
washed with water (20 ml), brine (20 ml), dried over magnesium sulfate and 
concentrated in vacuo.  The chromatography of the residue (elution with 80% 
hexane/ethyl acetate) afforded 1-benzyloxy-4-bromo-2-methoxybenzene 
(133) (0.85 g, 85%) as a white solid. 
 
Mp:   40-46 oC from hexane 
 
1H NMR (400 MHz, CDCl3) δH:  
3.89 (3H, s, OCH3), 5.18 (2H, s, OCH2Bn), 6.77 (1H, d, 
J=8.5 Hz, H-6), 6.99 (1H, dd, J=2.8 Hz, H-3), 7.03 (1H, d, 
J=2.8 Hz, H-5), 7.31-7.49 (5H, m, Ar-H). 
 
13C NMR (100 MHz, CDCl3) δC:  
56.2 (OCH3), 71.2 (OCH2Bn), 113.4 (C-4), 115.3 (C-6), 
115.5 (C-3), 127.3 (2C, C-2’ and C-6’), 127.5 (C-4’), 128.0 
(2C, C-3’ and C-5’), 136.8 (C-1’), 147.4 (C-1), 150.6 (C-2). 
 
HRESIMS m/z [M+H]+ 293.0190 
   (calc. for C14H14 
79BrO2+H, 293.0177) 
 












To a stirred solution of D-xylose (148) (10.00 g, 67 mmol) in 6 M hydrochloric 
acid (100 ml) was added dropwise ethyl mercaptan (10 ml, 135 mmol) over 20 
minutes.  The mixture was stirred for 2,5 h at room temperature, diluted with 
water (10 ml) and neutralised with 25% ammonium hydroxide solution (5 ml).  
The aqueous solution was extracted twice with petroleum ether (20 ml) and the 
organic phase containing excess of ethane thiol being discarded.  
Concentration of the aqueous phase under vacuum gave a crystalline residue 
which was suspended in a mixture of acetone and ethyl acetate (30 ml, 2:1 
ratio).  The resulting suspension was filtered over a layer of celite and the 
insoluble mineral material was washed with acetone.   
 
The collected filtrate was concentrated in vacuo to obtain syrup (8.00 g, 80%) 
which crystallised on standing in the cold.  The D-xylose diethyl dithioacetal 
(149) was utilised without further purification. 
 
Mp:   39–42 oC from hexane (lit.27. 40–43 oC) 
 
1H NMR (300 MHz, DMSO-d6) δH:  
1.16 (6H, t, J=7.2 Hz and 7.5 Hz, 2xSCH2CH3), 2.08 (1H, s, 
OH), 2.56-2.66 (4H, m, 2xSCH2CH3), 3.56-4.00 (6H, m, 
CH-1, CH-2, CH-3, CH-4 and CH2-5), 4.29/4.42 (2H, 2xs, 
OH), 4.721 (1H, s, OH). 
 
13C NMR (75 MHz, d6-DMSO) δC:  
14.3 (2xSCH2CH3), 24.1/25.0 (2xSCH2CH3), 
54.7/63.6/70.5/73.3/73.5 (CH-1, CH-2, CH-3, CH-4 and 
CH2-5). 
 
HRESIMS m/z [M-H]-  255.0737 
   (calc. for C9H20O4S2-H, 255.0725) 
 
IR νmax (cm-1): 3328. 
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To a suspension of D-xylose diethyl dithioacetal (149) (6.00 g, 23 mmol) in 
anhydrous acetone (100 ml) at 0 oC was added concentrated sulfuric acid (1 
ml).  The resulting solution was warmed to room temperature and was stirred 
for 16 h and then neutralised by addition of calcium hydroxide (4.00 g).  The 
precipitated solid was removed by filtration and washed with acetone (50 ml).  
The filtrate was concentrated in vacuo to leave brown oil which was taken up in 
diethyl ether and washed with a saturated solution of sodium bicarbonate (50 
ml), and then brine (50 ml).  The organic extract was dried over magnesium 
sulfate and concentrated in vacuo.  The chromatography of the residue on silica 
(elution with 90% hexane/ethyl acetate) afforded 2,3:4,5-di-O-isopropylidene-
D-xylose diethyl dithioacetal (150) (5.70 g, 95%) as a yellowish oil. 
 
[ ]25Dα    -64° ( c 2.6, acetone) [lit.27,28,29 -67.0° ( c 2.8, acetone)] 
 
1H NMR (300 MHz, CDCl3) δH:  
1.07-1.12 (6H, dt, J=7.2 Hz and 7.5 Hz, 2xSCH2CH3), 1.19-
1.28 [12H, 4xs, 2xOC(CH3)2] 2.52-2.63 (4H, m, 
2xSCH2CH3), 3.74 (2H, m, CH2-5), 3.87-4.19 (4H, m, CH-1, 
CH-2, CH-3, CH-4). 
 
13C NMR (75 MHz, CDCl3) δC:  
13.9/14.0 (2xSCH2CH3), 24.4/24.8/25.2/25.7/26.7/26.9 
(2xSCH2CH3 and 2xOC(CH3)2), 




HRESIMS m/z [M+H]+ 337.1502 
   (calc. for C15H28O4S2+H, 337.1507) 
 
4.2.45 Preparation of 2-deoxy-4,5-O-isopropylidene-D-threo-pent-1-enose 









To a solution of potassium tert-butoxide (3.00 g, 27 mmol) in tetrahydrofuran 
(70 ml) and dimethyl sulfoxide (25 ml) at rt was added dropwise over 15 
minutes a solution of 2-deoxy-4,5-O-isopropylidene-D-threo-pent-1-enose 
diethyl dithioacetal (150) (4.5 g, 13 mmol) in tetrahydrofuran (5 ml).  The 
mixture was stirred for 1hr and was poured on to ice (500 g).  The aqueous 
mixture was extracted with chloroform (3 x 25 ml), and the combined extracts 
were washed with cold water (3 x 20 ml), dried over anhydrous magnesium 
sulfate.  Removal of the solvent in vacuo followed by chromatography of the 
residual oil on silica (elution with 80% hexane/ethyl acetate) afforded 2-deoxy-
4,5-O-isopropylidene-D-threo pent-1-enose diethyl dithioacetal (151) (2.25 
g, 75%) as a pale yellow oil.   
 
[ ]25Dα    -50.5° ( c 2.4, CHCl3) [lit.27,28,29 -48.5° ( c 2.4, CHCl3)] 
 
1H NMR (300 MHz, CDCl3) δH:  
1.14-1.19 (6H, dt, J=7.2 Hz and 7.5 Hz, 2xSCH2CH3), 1.28-
1.37 [6H, 2xs, OC(CH3)2], 2.60-2.85 (5H, m, 2xSCH2CH3 
and OH), 3.69-3.87 (2H, 2xdd, J=8.1 Hz and 8.4 Hz, CH2-
5), 3.99 (1H, dd, J=6.6 Hz, CH-4), 4.68 (1H, m, CH-3), 5.81 
(1H, d, J=8.1 Hz, CH-2). 
 
 136
13C NMR (75 MHz, CDCl3) δC:  
13.6/14.8 (2xSCH2CH3), 25.1/26.4/26.8/27.3 [2xSCH2CH3 
and OC(CH3)2], 65.5 (CH-5), 70.4 (CH-4), 78.6 (CH-3), 
109.6 [OC(CH3)2], 132.5 (CH-2), 135.7 (CH-1). 
 
HRESIMS m/z [M-H]-  277.0941 
   (calc. for C12H22O3S2-H, 277.0932) 
 
IR νmax (cm-1): 3474. 
 
4.2.46 Preparation of 3-O-(benzyl)-2-deoxy-4,5-O-isopropylidene-D-threo-















Potassium tert-butoxide (0.50 g, 4 mmol) was added in one portion to a stirred 
solution of 2-deoxy-4,5-O-isopropylidene-D-threo pent-1-enose diethyl 
dithioacetal (151) (1.00 g, 4 mmol) in THF (30 ml) at -20 oC for 1 h, and then 
catalytic amount of tetrabutylammonium iodide (0.1 g, 0.4 mmol) followed by a 
solution of benzyl bromide (0.5 ml, 4 mmol) in THF (5 ml) were added.  The 
suspension was allowed to warm to room temperature and stirring was 
continued for 15 h.  Saturated ammonium chloride solution (15 ml) was added 
and the solvent removed in vacuo.  The residue was portioned between ethyl 
acetate (20 ml) and water (20 ml) and the aqueous phase was extracted with 
ethyl acetate (3 x 20 ml).  The combined organic extracts were washed with 
water (20 ml), brine (20 ml), dried over anhydrous magnesium sulfate and 
concentrated in vacuo.   
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The chromatography of the residual oil on silica (elution with 80% hexane/ethyl 
acetate) afforded 3-O-(benzyl)-2-deoxy-4,5-O-isopropylidene-D-threopent-1-
enose diethyl dithioacetal (152) (0.70 g, 70%) as a pale yellow oil in 70% 
yield.   
 
[ ]25Dα    +40.5° ( c 2.4, CHCl3)  
 
1H NMR (500 MHz, CDCl3) δH:  
1.21-1.27 (6H, dt, J=7.2 Hz and 7.5 Hz, 2xSCH2CH3), 
1.36/1.41 [6H, 2xs, OC(CH3)2] 2.69-2.91 (4H, m, 
2xSCH2CH3), 3.77/3.94 (2H, 2xdd, J=1.8 Hz and 15.3 Hz, 
CH2-5), 4.22 (1H, dd, J=6.6 Hz and 19.7 Hz, CH-4), 
4.49/4.62 (2H, 2xd, J=12.2 Hz, CH2Bn), 4.71 (1H, dd, J=2.7 
Hz and 15.7 Hz, CH-3), 5.84 (1H, d, J=9.2 Hz, CH-2), 7.24-
7.36 (5H, m, Ar-H). 
 
13C NMR (175 MHz, CDCl3) δC:  
14.0/15.2 (2xSCH2CH3), 25.4/26.4/27.0/27.5 [2xSCH2CH3 
and OC(CH3)2], 65.7 (CH-5), 70.5 (CH-4), 77.8 (CH-3), 
109.7 [OC(CH3)2], 127.4 (C-4’), 127.7 (2C, C-2’ and C-6’), 
128.2 (2C, C-3’ and C-5’), 131.2 (CH-2), 137.5 (CH-1), 
138.5 (C-1’). 
 
HRESIMS m/z [M+H]+  313.0941 
   (calc. for C15H20O3S2+H, 313.0948) 
 
4.2.47 Preparation of 2-deoxy-4,5-O-isopropylidene-D-threo-pentose 








Method : 127,28,29 
 
To a stirred suspension of lithium aluminium hydride (0.20 g, 4mmol) in 
tetrahydrofuran (30 ml) at 0 oC was added a solution of 2-deoxy-4,5-O-
isopropylidene-D-threo-pent-1-enose diethyl dithioacetal (151) (1.00 g, 4 mmol) 
in tetrahydrofuran (5 ml) over 20 min.  After the addition was complete the 
mixture was allowed to warm to room temperature and was stirred for a further 
3.5 h.  Residual lithium aluminium hydride was quenched by sequential addition 
of water (2 ml), 15% aqueous sodium hydroxide (2 ml) and water (7 ml).  The 
resulting mixture was filtered through a layer of celite, and the collected solid 
was washed with ethyl acetate.  The filtrate was washed with brine and dried 
over magnesium sulfate.  Removal of the solvent in vacuo followed by 
chromatography of the residual oil on silica (elution with 80% hexane/ethyl 
acetate] afforded 2-deoxy-4,5-O-isopropylidene-D-threo pentose diethyl 
dithioacetal (153) (0.60 g, 60%) as colourless oil.   
 
[ ]25Dα    +24° ( c 3.9, CHCl3) [lit.27,28,29 +25.6° ( c 5.0, CHCl3)] 
 
1H NMR (300 MHz, CDCl3) δH:  
1.10 (6H, dt, J=7.2 Hz and 7.5 Hz, 2 x SCH2CH3), 1.20-
1.28 [6H, 2xs, OC(CH3)2], 1.54-1.85 (2H, m, CH2-2), 2.39-
2.58 (4H, m, 2xSCH2CH3), 2.77 (1H, d, J=5.7 Hz, OH), 
3.55-3.90 (4H, m, CH-3, CH-4 and CH2-5), 3.95 (1H, 2 x d, 
J=4.2 Hz and 3.9 Hz, CH-1). 
 
13C NMR (75 MHz, CDCl3) δC:    
14.1/14.2 (2xSCH2CH3), 23.5/24.0/25.0/26.2 [2xSCH2CH3 
and OC(CH3)2], 39.7 (CH2-2), 47.2/65.6/69.1/78.5 (CH-1, 
CH-3, CH-4 and CH2-5), 109.0 [OC(CH3)2]. 
 
HRESIMS m/z [M-H]-  279.1090 
   calc. for C12H24O3S2-H, 279.1089) 
IR νmax (cm-1): 3447. 
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Method : 227,28,29 
 
A solution of Red-Al (1 ml, 4 mmol, 3.4 M solution in toluene) was added a cold 
solution (0 oC) of purified 2-deoxy-4,5-O-isopropylidene-D-threo-pent-1-enose 
diethyl dithioacetal (151) (1.00 g, 4 mmol) in dry toluene (10 ml) in the course of 
15 min.  After an hour stirring at 0 oC, the reaction was quenched with 15% 
aqueous sodium hydroxide solution.  The reaction mixture was diluted with 
ether (50 ml) and the aqueous phase was discarded.  The organic phase was 
washed with water (30 ml), brine (30 ml), and then dried over magnesium 
sulfate.  The chromatography of the residue on silica (elution with 70% 
hexane/ethyl acetate) afforded 2-deoxy-4,5-O-isopropylidene-D-threo-
pentose diethyl dithioacetal (153) (0.90 g, 90%) as a colourless oil. 
 
[ ]25Dα    +24° ( c 3.9, CHCl3) [lit.27,28,29 +25.6° ( c 5.0, CHCl3)] 
 
1H NMR (300 MHz, CDCl3) δH:  
1.10 (6H, dt, J=7.2 Hz and 7.5 Hz, 2xSCH2CH3), 1.20-1.28 
[6H, 2xs, OC(CH3)2], 1.54-1.85 (2H, m, CH2-2), 2.39-2.58 
(4H, m, 2xSCH2CH3), 2.77 (1H, d, J=5.7 Hz, OH), 3.55-
3.90 (4H, m, CH-3, CH-4 and CH2-5), 3.95 (1H, 2xd, J=4.2 
Hz and 3.9 Hz, CH-1). 
 
13C NMR (75 MHz, CDCl3) δC:    
14.1/14.2 (2xSCH2CH3), 23.5/24.0/25.0/26.2 [2xSCH2CH3 
and OC(CH3)2], 39.7 (CH2-2), 47.2/65.6/69.1/78.5 (CH-1, 
CH-3, CH-4 and CH2-5), 109.0 [OC(CH3)2]. 
 
HRESIMS m/z [M-H]-  279.1090 
   (calc. for C12H24O3S2-H, 279.1089) 













The 2-deoxy-4,5-O-isopropylidene-D-threo pentose diethyl dithioacetal (153) 
(1.00 g, 4 mmol) was hydrolysed for 24 h in triflouroacetic acid (15 ml, 0.01 M) 
at 4 oC.  Upon completion of the reaction by TLC monitoring for consumption of 
starting material, the acidic mixture was diluted by addition of water (10 ml) and 
the solution was evaporated to dryness by removal of the solvent in vacuo.  The 
resulting 2-deoxy-D-threo-pentose diethyl dithioacetal (157), (0.75 g, 75%) 
as a sticky brown gum was utilised without further purification. 
 
1H NMR (300 MHz, DMSO-d6) δH:  
0.95-1.00 (6H, dt, J=7.2 Hz and 7.5 Hz, 2xSCH2CH3), 1.52-
1.67 (2H, m, CH2-2), 2.31-2.44 (4H, m, 2xSCH2CH3), 3.08-
3.59 (4H, m, CH-3, CH-4, CH2-5), 3.80-3.85 (1H, m, CH-1), 
4.15 (3H, s, 3 x OH). 
 
13C NMR (75 MHz, DMSO-d6) δC:    
14.7 (2xSCH2CH3), 23.2/24.0 (2xSCH2CH3), 47.9 (CH2-2), 
62.7/67.2/68.1/74.1 (CH-1, CH-3, CH-4 and CH2-5). 
 
HRESIMS m/z [M-H]-  239.0782 
   (calc. for C9H20O3S2-H, 239.0776) 



















To a solution of 2-deoxy-D-threo-pentose diethyl dithioacetal (157) (1.00 g, 4 
mmol) in dry dichloromethane (10 ml) was added pyridine (0.3 ml, 4 mmol) and 
cooled the resulting solution to 0 oC.  A solution of p-toluenesulfonyl chloride 
(0.9 g, 5 mmol) in dry dichloromethane (5 ml) was added dropwise for 15 min.  
The mixture was then stirred at room temperature overnight and diluted with 
dichloromethane (30 ml), washed with aqueous sodium bicarbonate (30 ml) and 
water (30 ml).  The organic phase was dried over magnesium sulfate, 
concentrated in to syrup which upon chromatography of the residue on silca 
(elution with 70% hexane/ethyl acetate) afforded 2-deoxy-5-O-tosyl-D-threo-
pentose diethyl dithioacetal (158) (0.60 g, 60%) as a white solid. 
 
Mp:   690–73 oC from 98% hexane/ethylacetate  
[ ]25Dα    +89.7° ( c 0.9, CHCl3)  
 
1H NMR (300 MHz, CDCl3) δH:  
0.96 (6H, 2xt, J=7.2 Hz and 7.5 Hz, 2xSCH2CH3), 1.48-1.86 
(2H, m, CH2-2), 2.17 (3H, s, CH3-tosyl), 2.25-2.50 (4H, m, 
2xSCH2CH3), 3.12-3.87 (5H, m, CH-1, CH-3, CH-4 and 








13C NMR (75 MHz, CDCl3) δC:    
14.2 (2xSCH2CH3), 21.3 (CH3-Tosyl), 23.6/24.0 
(2xSCH2CH3), 39.2/47.6/68.4/70.9/71.2 (CH-1, CH-2, CH-3, 
CH-4 and CH2-5), 127.7 (2C, C-2’ and C-6’), 129.7 (2C, C-
3 and C-5), 132.1 (C-4’), 144.8 (C-1). 
 
HRESIMS m/z [M+H]+ 339.0411 
   (calc. for C12H18O5S3+H, 339.0413) 
 
IR νmax (cm-1): 3426. 
 
4.2.50 Preparation of 2-deoxy-3,4-O-isopropylidene-5-O-tosyl-D-threo- 













To a suspension of 2-deoxy-5-O-tosyl-D-threo-pentose diethyl dithioacetal (158) 
(1.00 g, 3 mmol) in anhydrous acetone (100 ml) at 0 oC was added 
concentrated sulfuric acid (1 ml).  The resulting solution was warmed to room 
temperature and was stirred for 16 h.  The acidic mixture was neutralised by 
addition of calcium hydroxide (4.00 g).  The precipitated solid was removed by 
filtration and washed with acetone (50 ml).  The filtrate was concentrated in 
vacuo to leave brown oil which was taken up in diethyl ether and washed with a 
saturated solution of sodium bicarbonate (50 ml), and then brine (50 ml).  The 
organic extract was dried over magnesium sulfate and concentrated in vacuo.  
The chromatography of the residue on silica [elution with 90% hexane/ethyl 
acetate) afforded 2-deoxy-3,4-O-isopropylidene-5-O-tosyl-D-threo-pentose 
diethyl dithioacetal (159) (0.95 g, 95%) as a yellowish oil. 
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[ ]25Dα    -30.7° ( c 2.4, CHCl3)  
 
1H NMR (300 MHz, CDCl3) δH:  
1.17 (6H, 2xt, J=7.5 Hz, 2xSCH2CH3), 1.03/1.28 [6H, 2xs, 
OC(CH3)2], 1.77-2.03 (2H, m, CH2-2), 2.46-2.65 (4H, m, 
2xSCH2CH3), 3.78 (2H, m, CH2-5), 3.88 (1H, dd, J=4.2 Hz, 
CH-4), 4.02 (1H, dd, J=5.1 Hz, CH-3), 4.16 (1H, m, CH-1). 
 
13C NMR (75 MHz, CDCl3) δC:    
14.2/14.3 (2xSCH2CH3), 21.4 (CH3-tosyl), 23.6/24.2 
[OC(CH3)2], 26.5/27.1 (2xSCH2CH3), 
39.8/47.6/68.9/75.3/76.9 (CH-1, CH-2, CH-3, CH-4, and 
CH2-5), 109.6 [OC(CH3)2], 127.8 (2C, CH-2’ and CH-6’), 
129.7 (2C, CH-3’ and CH-5’), 132.3 (CH-4), 144.9 (CH-1). 
 
HRESIMS m/z [M+H]+ 379.0725 
   (calc. for C15H22O5S3+H, 379.0728) 
 
4.2.51 Preparation of 2-deoxy-3,4-O-isopropylidene-5-iodo-D-threo- 







The 2-deoxy-3,4-O-isopropylidene-5-O-tosyl-D-threo-pentose diethyl 
dithioacetal (159) (1.00 g, 2 mmol) was dissolved in anhydrous acetone and 
sodium iodide (1.7 g, 12 mmol) was added.  The mixture was refluxed for 20 h 
until the reaction is complete.  The mixture was then cooled, precipitated 
sodium p-toluenesulfonate was filtered off, and the filtrate concentrated to 
dryness.  The residue was partitioned between water (30 ml) and chloroform 
(30 ml).   
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The organic layer was washed with aqueous sodium sulfite (20 ml) and water 
(20 ml), dried over anhydrous magnesium sulfate and concentrated in vacuo.   
The chromatography of the residue on silica (elution with 90% hexane/ethyl 
acetate) afforded 2-deoxy-5-iodo-D-threo-pentose diethyl dithioacetal (160) 
(0.90 g, 90%) as a colourless oil. 
 
Mp:   69–73 oC from 98% hexane/ethylacetate  
 
[ ]25Dα    -89.7° ( c 0.9, CHCl3)  
 
1H NMR (300 MHz, CDCl3) δH:  
1.21 (6H, 2xt, J=7.5 Hz, 2xSCH2CH3), 1.33/1.37 [6H, 2xs, 
OC(CH3)2], 1.93-2.08 (2H, m, CH2-2), 2.48-2.71 (4H, m, 
2xSCH2CH3), 3.19 (2H, d, J=5.7 Hz, CH2-5), 3.70 (1H, dd, 
J=6Hz, CH-4), 3.93 (1H, dd, J=5 Hz, CH-3), 4.11 (1H, m, 
CH-1). 
 
13C NMR (75 MHz, CDCl3) δC:    
5.5 (CH2-I), 14.3 (2xSCH2CH3), 23.6/24.4 [OC(CH3)2], 
27.3/27.5 (2xSCH2CH3), 40.6/47.8/78.7/79.5 (CH-1, CH-2, 
CH-3, CH-4), 109.3 [OC(CH3)2]. 
 
HRESIMS m/z [M+H]+ 334.9653 
   (calc. for C8H15IO2S2+H, 334.9655) 
 











To a solution of D-arabinose (161) (20.00 g, 0.1 mol) in 6 M hydrochloric acid 
(200 ml) was added dropwise ethyl mercaptan (10 ml, 0.1 mol) over 20 minutes.  
After being stirred for 2.5 h, the mixture was cooled to 0 oC and filtered.  The 
collected solid was washed with cold water (200 ml) and air-dried to give D-
arabinose diethyl dithioacetal (162) (12.00 g, 60%) as colourless plates. 
 
Mp:   120–123 oC from hexane (lit.28,31 124–126 oC) 
 
[ ]25Dα    +70.5° ( c 1.2, MeOH) 
 
1H NMR (300 MHz, d6-DMSO) δH:  
1.05 (6H, t, J=7.2 Hz and 7.5 Hz, 2xSCH2CH3), 2.08 (1H, 
OH) 2.56-2.66 (4H, m, 2xSCH2CH3), 3.56-4.00 (6H, m, CH-
1, CH-2, CH-3, CH-4 and CH2-5), 4.29-4.42 (1H, 2xs, OH), 
4.72 (1H, s, OH). 
 
13C NMR (75 MHz, d6-DMSO) δC:  
14.3 (2xSCH2CH3), 24.1/25.0 (2xSCH2CH3), 
54.7/63.6/70.5/71.4/71.7 (CH-1, CH-2, CH-3, CH-4 and 
CH2-5). 
 
HRESIMS m/z [M-H]-  255.0737 
   (calc. for C9H20O4S2-H, 255.0725) 
 
IR νmax (cm-1): 3310. 
 










To a suspension of D-arabinose diethyl dithioacetal (162) (4.00 g, 20 mmol) in 
anhydrous acetone (100 ml) at 0 oC was added concentrated sulfuric acid (1 
ml).  The resulting solution was warmed to room temperature and was stirred 
for 16 h.  The acidic mixture was neutralised by addition of calcium hydroxide 
(4.00 g).  The precipitated solid was removed by filtration and washed with 
acetone (50 ml).  The filtrate was concentrated in vacuo to leave brown oil 
which was taken up in diethyl ether and washed with a saturated solution of 
sodium bicarbonate (50 ml), and then brine (50 ml).  The organic extract was 
dried over magnesium sulfate and concentrated in vacuo.  The chromatography 
of the residue on silica (elution with 90% hexane/ethyl acetate) afforded 2,3:4,5-
di-O-isopropylidene-D-arabinose diethyl dithioacetal (163) (3.20 g, 80%) as 
a yellowish oil. 
 
[ ]25Dα    +82.5° ( c 1.2, MeOH) [lit.28,31 +83.3° ( c 1.4, MeOH)] 
 
1H NMR (300 MHz, CDCl3) δH:  
1.12-1.19 (6H, t, J=7.2 Hz and 7.5 Hz, 2xSCH2CH3), 1.22-
1.32 [12H, 4xs, 2xOC(CH3)2] 2.56-2.68 (4H, m, 
2xSCH2CH3), 3.82-4.20 (6H, m, CH-1, CH-2, CH-3, CH-4 
and CH2-5). 
 
13C NMR (75 MHz, CDCl3) δC:  
14.2 (2xSCH2CH3), 24.7/24.9/25.1/26.5/26.9/27.2 
[2xSCH2CH3 and 2xOC(CH3)2], 52.2/67.6/76.9/78.9/84.4 
(CH-1, CH-2, CH-3, CH-4, CH2-5), 109.5/109.9 
[2xOC(CH3)2]. 
 
HRESIMS m/z [M+H]+ 337.1504 







4.2.54 Preparation of 2-deoxy-4,5-O-isopropylidene-D-erythro-pent-1-









To a solution of potassium tert-butoxide (1.50 g, 13 mmol) in tetrahydrofuran 
(70 ml) and dimethyl sulfoxide (25 ml) at rt was added dropwise over 15 
minutes a solution of 2,3:4,5-di-O-isopropylidene-D-arabinose diethyl 
dithioacetal (163) (3.00 g, 9 mmol) in tetrahydrofuran (5 ml).  The mixture was 
stirred for 1 h and was poured on to ice (500 g).  The aqueous mixture was 
extracted with chloroform (3 x 25 ml), and the combined extracts were washed 
with cold water (3 x 20 ml), dried over anhydrous magnesium sulfate.  Removal 
of the solvent in vacuo followed by chromatography of the residual oil on silica 
(elution with 90% hexane/ethyl acetate) afforded 2-deoxy-4,5-O-
isopropylidene-D-erythro-pent-1-enose diethyl dithioacetal (164) (2.46 g, 
82%) as a pale yellow oil.   
 
[ ]25Dα    +62.5° ( c 0.9, CHCl3) [lit.28,31 +49.2° ( c 0.9, CHCl3)] 
 
1H NMR (300 MHz, CDCl3) δH:  
1.11-1.17 (6H, t, J=7.2 Hz and 7.5 Hz, 2xSCH2CH3), 1.25-
1.32 [6H, 2xs, OC(CH3)2] 2.58-2.80 (5H, m, 2xSCH2CH3 
and OH), 3.76-3.88 (2H, 2xdd, J=8.1 Hz and 8.4 Hz, CH2-
5), 4.02-4.08 (1H, td, J=6.6 Hz, CH-4), 4.74-4.79 (1H, m, 
CH-3), 5.82 (1H, d, J=8.1 Hz, CH-2). 
 
13C NMR (75 MHz, CDCl3) δC:  
14.7/14.8 (2xSCH2CH3), 25.0/26.1/26.7/27.2 [2xSCH2CH3 
and OC(CH3)2], 65.0 (CH-5), 69.3 (CH-4), 77.8 (CH-3), 
109.1 [OC(CH3)2], 133.1 (CH-2), 134.1 (CH-1). 
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HRESIMS m/z [M+H]+ 279.1085 
   (calc. for C12H22O3S2+H, 279.1089) 
 
IR νmax (cm-1): 3228. 
 
4.2.55 Preparation of 2-deoxy-4,5-O-isopropylidene-D-erythro-pentose 








Method : 130,31 
 
To a stirred suspension of lithium aluminium hydride (0.20 g, 4 mmol) in 
tetrahydrofuran (30 ml) at 0 oC was added a solution of 2-deoxy-4,5-O-
isopropylidene-D-erythro-pent-1-enose diethyl dithioacetal (164) (1.00 g, 4 
mmol) in tetrahydrofuran (5 ml) over 20 min.  After the addition was complete 
the mixture was allowed to warm to room temperature and was stirred for a 
further 3.5 h.  Residual lithium aluminium hydride was quenched by sequential 
addition of water (2 ml), 15% aqueous sodium hydroxide (2 ml) and water (7 
ml).  The resulting mixture was filtered through a layer of celite, and the 
collected solid was washed with ethyl acetate.  The filtrate was washed with 
brine and dried over magnesium sulfate.  Removal of the solvent in vacuo 
followed by chromatography of the residual oil on silica (elution with 80% 
hexane/ethyl acetate) afforded 2-deoxy-4,5-O-isopropylidene-D-erythro-
pentose diethyl dithioacetal (165) (0.60 g, 60 %) as a colourless oil.   
 





1H NMR (300 MHz, CDCl3) δH:  
1.14-1.18 (6H, dt, J=7.2 Hz and 7.5 Hz, 2xSCH2CH3), 1.24-
1.31 [6H, 2xs, OC(CH3)2] 1.74-1.90 (2H, m, CH2-2), 2.45-
2.85 (5H, m, 2xSCH2CH3 and OH), 3.81-4.00 (5H, m, CH-1, 
CH-3, CH-4 and CH2-5). 
 
13C NMR (75 MHz, CDCl3) δC:  
14.2/14.3 (2xSCH2CH3), 23.4/24.1/25.0/26.3 (2xSCH2CH3 
and OC(CH3)2), 38.8 (CH2-2), 47.9/65.4/69.4/78.2 (CH-1, 
CH-3, CH-4 and CH2-5), 109.0 [OC(CH3)2]. 
 
HRESIMS m/z [M+H]+ 281.1244 
   (calc. for C12H24O3S2+H, 281.1246) 
 
IR νmax (cm-1): 3215. 
 
Method : 228 
 
A solution of Red-Al (1 ml, 4 mmol, 3.4 M solution in toluene) was added a cold 
solution (0 oC) of purified 2-deoxy-4,5-O-isopropylidene-D-erythro-pent-1-enose 
diethyl dithioacetal (164) (1.00 g, 4 mmol) in dry toluene (10 ml) in the course of 
15 min.  After an hour stirring at 0 oC, the reaction was quenched with a 15% 
aqueous sodium hydroxide solution.  Work-up and chromatograph of the 
residue (elution with 70% hexane/ethyl acetate) afforded 2-deoxy-4,5-O-
isopropylidene-D-erythro-pentose diethyl dithioacetal (165) (0.60 g, 60 %) 
as a colourless oil. 
 







1H NMR (300 MHz, CDCl3) δH:  
1.14-1.18 (6H, dt, J=7.2 Hz and 7.5 Hz, 2xSCH2CH3), 1.24-
1.31 [6H, 2xs, OC(CH3)2] 1.74-1.90 (2H, m, CH2-2), 2.45-
2.85 (5H, m, 2xSCH2CH3 and OH), 3.81-4.00 (5H, m, CH-1, 
CH-3, CH-4 and CH2-5). 
 
13C NMR (75 MHz, CDCl3) δC:    
14.2/14.3 (2xSCH2CH3), 23.4/24.1/25.0/26.3 [2xSCH2CH3 
and OC(CH3)2], 38.8 (CH2-2), 47.9/65.4/69.4/78.2 (CH-1, 
CH-3, CH-4 and CH2-5), 109.0 [OC(CH3)2]. 
 
HRESIMS m/z [M+H]+ 281.1244 
   (calc. for C12H24O3S2+H, 281.1246) 
 
IR νmax (cm-1): 3215. 
 








The 2-deoxy-4,5-O-isopropylidene-D-erythro-pentose diethyl dithioacetal (165) 
(1.00 g, 4 mmol) was hydrolysed for 24 h in triflouroacetic acid (15 ml, 0.01 M) 
at 4 oC.  The acidic mixture was neutralised by addition of water (10 ml) and the 
solution was evaporated to dryness by removal of the solvent in vacuo.  The 
resulting 2-deoxy-D-erythro-pentose diethyl dithioacetal (166) (0.70 g, 70%) 





1H NMR (300 MHz, DMSO-d6) δH:  
1.09-1.14 (6H, dt, J=7.2 Hz and 7.5 Hz, 2xSCH2CH3), 1.68-
1.89 (2H, m, CH2-2), 2.42-2.58 (5H, m, 2xSCH2CH3), 3.15-
3.58 (5H, m, CH-1, CH-3, CH2-5 and OH), 3.99-4.03 (1H, 
dd, J=3 Hz, CH-4), 4.42 (2H, s, 2xOH). 
 
13C NMR (75 MHz, DMSO-d6) δC:    
14.2/14.3 (2xSCH2CH3), 22.6/23.6 (2xSCH2CH3), 47.4 
(CH2-2), 63.1/66.8/68.4/74.7 (CH-1, CH-3, CH-4 and CH2-
5). 
 
HRESIMS m/z [M-H]-  239.0782 
   (calc. for C9H20O3S2-H, 239.0776) 
 
IR νmax (cm-1): 3388. 
 













To a solution of 2-deoxy-D-erythro-pentose diethyl dithioacetal (166) (1.00 g, 4 
mmol) in dry dichloromethane (10 ml), pyridine (0.3 ml, 4 mmol) was added and 
the resulting solution cooled to 0 oC.  A solution of p-toluenesulfonyl chloride 
(0.9 g, 5 mmol) in dry dichloromethane (5 ml) was added dropwise for 15 min.   
The mixture was then stirred at room temperature overnight and diluted with 
dichloromethane (30 ml), washed with aqueous sodium bicarbonate (30 ml) and 
water (30 ml).   
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The organic phase was dried over magnesium sulfate, concentrated in to syrup 
which upon chromatography of the residue on silca (elution with 70% 
hexane/ethyl acetate) afforded 2-deoxy-5-O-tosyl-D-erythro-pentose diethyl 
dithioacetal (167) (0.60 g, 60%) as a white solid. 
 
Mp:   89–92 oC from 98% hexane/ethylacetate  
 
[ ]25Dα    +90.7° ( c 0.9, CHCl3)  
 
 
1H NMR (300 MHz, CDCl3) δH:  
1.12 (6H, 2xt, J=7.2 Hz and 7.5 Hz, 2xSCH2CH3), 1.17-1.23 
(2H, m, CH2-2), 2.42 (3H, s, CH3-tosyl), 2.46-2.75 (4H, m, 
2xSCH2CH3), 3.70-4.46 (5H, m, CH-1, CH-3, CH-4 and 
CH2-5), 7.30 (2H, dd, J=8 Hz, Ar-H), 7.69 (2H, dd, J=8 Hz, 
Ar-H). 
 
13C NMR (75 MHz, CDCl3) δC:    
14.3 (2xSCH2CH3), 21.6 (CH3-Tosyl), 23.6/24.3 
(2xSCH2CH3), 38.9/47.7/67.1/67.9/80.7 (CH-1, CH-2, CH-3, 
CH-4 and CH2-5), 127.9 (2C, C-2’ and C-6’), 129.9 (2C, C-
3 and C-5), 132.0 (C-4’), 145.2 (C-1). 
 
HRESIMS m/z [M+H]+ 339.0411 
   (calc. for C12H18O5S3+H, 339.0413) 
 







4.2.58 Attempted preparation of 5-(4-benzyloxy-3-methoxybenzene)-2,5-









Method : 132 
 
To a solution of 1-benzyloxy-4-bromo-2-methoxybenzene (133) (1.00 g, 3 
mmol) in either anhydrous THF or diethyl ether (20 ml) cooled to -78 oC was 
added dropwise via a syringe n-butyllithium (4 ml, 7 mmol, 1.6 M in hexane) or 
LDA (2.5 ml, 7 mmol) or tert-butyllithium (4 ml, 7 mmol, 1.7 M in pentane) over a 
period of 20 minutes.  The solution was allowed to warm to room temperature 
for 30 minutes, dropped back to -78 oC and a catalytic amount of either cuprous 
iodide (0.3 g, 2 mmol) or cuprous bromide (0.2 g, 2 mmol) in solution of either 
THF or diethyl ether (5 ml) was added.  Then a solution of 2-deoxy-3,4-O-
isopropylidene-5-iodo-D-threo-pentose diethyl dithioacetal (160) (1.14 g, 3 
mmol) in either THF or diethyl ether (5 ml) at the same temperature dropwise 
over 10 minutes.  After stirring at -78 oC for an additional 2 h followed by stirring 
at room temperature for 1 h, the mixture was treated with saturated solution of 
ammonium chloride (10 ml).  The phases were separated and the aqueous 
phase is extracted with ethyl acetate (3 x 20 ml).  The combined organic layers 
were washed with water (20 ml), brine (20 ml), dried over anhydrous 
magnesium sulfate, filtered off and concentrated in vacuo.  The chromatography 
of the residue (elution with 90% hexane/ethyl acetate) afforded an oil in 







Method : 233,34,35 
 
To a stirred solution of 2-deoxy-3,4-O-isopropylidene-5-iodo-D-threo-pentose 
diethyl dithioacetal (160) (1.14 g, 3 mmol) in either anhydrous THF or diethyl 
ether (20 ml) and catalytic amount of either cuprous iodide (0.3 g, 1 mmol) or 
iron (III) chloride (0.2 g, 1 mmol) or cerium (III) chloride (0.4 g, 1 mmol) was 
added dropwise at 0 oC (1-benzyloxy-2-methoxyphenyl)-4-magnesium bromide 
(170) [freshly prepared from refluxing 1-benzyloxy-4-bromo-2-methoxybenzene 
(0.9 g, 3 mmol) with magnesium turnings (0.4 g, 15 mmol), catalytic amount of 
iodine (0.08 g, 0.3 mmol) in either dry THF or diethyl ether (5 ml)].  After stirring 
overnight at room temperature followed by refluxing for 5 h, the reaction mixture 
was added at room temperature saturated solution of ammonium chloride (10 
ml) and the solvent was removed under reduced pressure.  The residue was 
extracted with ethyl acetate (3 x 20 ml).  The combined organic layers were 
washed with water (20 ml), brine (20 ml), dried over anhydrous magnesium 
sulfate, filtered off and concentrated in vacuo.  The chromatography of the 
residue (elution with 90% hexane/ethyl acetate) afforded an oil in absentia of 
the desired product. 
 
4.2.59 Preparation of 5-O-tert-butyldimethylsilyl-2-deoxy-D-threo-pentose 











To a solution of 2-deoxy-D-threo-pentose diethyl dithioacetal (157) (1.00 g, 4 
mmol) in dry THF (5 ml) was added to a suspension of sodium hydride (0.2 g, 4 
mmol) in dry THF (15 ml) and the mixture was stirred at room temperature for 
2.5 h.  Tert-butyldimethylsilyl chloride (0.6 g, 4 mmol) in dry THF (5 ml) was 
added and the mixture was stirred at room temperature until the consumption of 
the starting material.   
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The reaction was added aqueous potassium carbonate (20 ml) and the mixture 
was extracted with diethyl ether (3 x 20 ml).  The combined organic layers were 
washed with water (20 ml), brine (20 ml), dried over anhydrous magnesium 
sulfate, filtered off and concentrated in vacuo.  The chromatography of the 
residue (elution with 80% hexane/ethyl acetate) afforded a colourless oil of 5-O-
tert-butyldimethylsilyl-2-deoxy-D-threo-pentose diethyl dithioacetal (171) 
(0.80 g, 80%). 
 
1H NMR (300 MHz, CDCl3) δH:  
0.04 [6H, s, Si(CH3)2C(CH3)3], 0.86 [9H, s, 
Si(CH3)2C(CH3)3], 1.21 (6H, t, J=7.2 Hz and 7.5 Hz, 
2xSCH2CH3), 1.79-2.10 (2H, m, CH2-2), 2.50-2.79 (6H, m, 
2xSCH2CH3 and 2xOH), 3.44 (1H, dd, J=3.9 Hz and 4.8 
Hz, CH-4), 3.68 (2H, m, CH2-5), 4.00 (2H, m, CH-3 and 
CH-1). 
 
13C NMR (75 MHz, CDCl3) δC:    
-5.5 [Si(CH3)2C(CH3)3], 14.4 (2xSCH2CH3), 18.1 
[Si(CH3)2C(CH3)3], 23.9/24.2 (2xSCH2CH3), 25.8 
[Si(CH3)2C(CH3)3], 40.0 (CH-2), 47.8 (CH2-5), 65.4 (CH-4), 
69.8 (CH-3), 73.1 (CH-1). 
 
HRESIMS m/z [M+H]+ 299.1180 
   (calc. for C11H26O3S2Si+H, 299.1187) 
 









4.2.60 Preparation of 5-O-tert-butyldimethylsilyl-2-deoxy-3,4-O-












To a stirred solution of 5-O-tert-butyldimethylsilyloxy-2-deoxy-D-threo-pentose 
diethyl dithioacetal (171) (0.50 g, 1 mmol) and 2,2-dimethoxypropane (0.3 ml, 2 
mmol) in dry dichloromethane (10 ml) was added a catalytic amount of 
pyridinium para-toluenesulfonate (0.1 g, 0.4 mmol).  The mixture was stirred at 
room temperature until the consumption of the starting material.  The reaction 
was added saturated aqueous sodium hydrogen carbonate (20 ml) and the 
mixture was extracted with dichloromethane (3 x 20 ml).  The combined organic 
layers were washed with water (20 ml), brine (20 ml), dried over anhydrous 
magnesium sulfate, filtered off and concentrated in vacuo.  The crude of 5-O-
tert-butyldimethylsilyloxy-2-deoxy-3,4-O-isopropylidene-D-threo-pentose 
diethyl dithioacetal (172) (0.45 g, 90%) was obtained and was utilised in the 
next step without further purification. 
 
4.2.61 Preparation of 5-O-tert-butyldimethylsilyl-2-deoxy-3,4-O-
















pentose diethyl dithioacetal (172) (1.00 g, 3 mmol) was dissolved in warm 
solution of anhydrous methanol (50 oC) (20 ml) and yellow mercuric oxide (2.20 
g, 8 mmol) in anhydrous methanol (5 ml) was added to the hot vigorously stirred 
mixture over a period of about 2 minutes.  The stirring was continued for 15 
minutes in refluxing methanol.  The solids were removed by hot filtration and 
washed with warm methanol and the combined filtrate and washings were 
concentrated under reduced pressure into syrup containing small amounts of 
mercuric oxide.  The traces of mercuric oxide were dissolved in 
dichloromethane and filtered.  The filtrate was washed with water (20 ml), 10% 
potassium iodide (2 x 20 ml), brine (20 ml), dried over magnesium sulfate and 
concentrated in vacuo.  The chromatography of the residue (elution with 90% 
hexane/ethyl acetate) afforded a colourless oil of 5-O-tert-
butyldimethylsilyloxy-2-deoxy-3,4-O-isopropylidene-D-threo-pentose 
dimethylacetal (173) (0.60 g, 60%). 
 
1H NMR (300 MHz, CDCl3) δH:  
0.02 [6H, s, Si(CH3)2C(CH3)3], 0.85 [9H, s, 
Si(CH3)2C(CH3)3], 1.34 [6H, 2xs, OC(CH3)2], 1.76-1.94 (2H, 
m, CH2-2), 3.29 (6H, s, 2xOCH3), 3.68 (3H, m, CH2-5 and 
CH-4), 3.93 (1H, m, CH-3), 4.56 (1H, dd, J=3.3 Hz and 3.6 
Hz, CH-1). 
 
13C NMR (75 MHz, CDCl3) δC:    
-5.5 [Si(CH3)2C(CH3)3], 18.3 [Si(CH3)2C(CH3)3], 25.9 
[Si(CH3)2C(CH3)3], 26.9/27.3 [OC(CH3)2], 36.7 (CH-2), 52.8 
(OCH3), 63.5 (CH2-5), 75.2 (CH-4), 80.9 (CH-3), 101.9 (CH-
1), 108.6 [OC(CH3)2]. 
 
HRESIMS m/z [M+H]+ 335.2269 
   (calc. for C16H34O5Si+H, 335.2271) 
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To a solution of 2-deoxy-5-O-tert-butyldimethylsilyloxy-3,4-O-isopropylidene-D-
threo-pentose dimethylacetal (173) (0.50 g, 1.5 mmol) in THF (20 ml) was 
added tetra-n-butylammonium fluoride (4.5 ml, 4.5 mmol, 1 M solution in THF) 
and the mixture was stirred at room temperature until the consumption of the 
starting material.  The mixture was concentrated in vacuo, partitioned between 
water (20 ml) and ethyl acetate (20 ml) and the aqueous layer was extracted 
with ethyl acetate (3 x 20 ml).  The combined organic layers were washed with 
water (20 ml), brine (20 ml), dried over anhydrous magnesium sulfate, filtered 
off and concentrated in vacuo.  The chromatography of the residue (elution with 
80% hexane/ethyl acetate) afforded a colourless oil of 2-deoxy-3,4-O-
isopropylidene-D-threo-pentose dimethylacetal (174) (0.45 g, 90%). 
 
1H NMR (300 MHz, CDCl3) δH:  
1.39 [6H, s, OC(CH3)2], 1.87 (3H, t, J=6 Hz, CH2-2 and 
OH), 3.32 (6H, 2xs, 2xOCH3), 3.61 (1H, 2xd, J=5.4 Hz, CH-
4), 3.76 (2H, 2xd, J=4.5 Hz, CH2-5), 3.95 (1H, sept, CH-3), 
4.55 (1H, t, J=5.4 Hz and 5.7 Hz, CH-1). 
 
13C NMR (75 MHz, CDCl3) δC:    
26.9/27.2 [OC(CH3)2], 36.5 (CH-2), 52.9/53.5 (OCH3), 64.2 
(CH2-5), 74.3 (CH-4), 78.7 (CH-3), 101.9 (CH-1), 109.3 
[OC(CH3)2]. 
 
HRESIMS m/z [M+H]+ 221.1399 
   (calc. for C10H20O5+H, 221.1401) 
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IR νmax (cm-1): 3442. 
 
4.2.63 Preparation of 3-O-tert-butyldiphenylsilyl-2-deoxy-4,5-O-










To a stirred solution of 2-deoxy-4,5-O-isopropylidene-D-threo-pentose diethyl 
dithioacetal (153) (2.00 g, 7 mmol) in THF at -20 oC under nitrogen, was added 
potassium tert-butoxide (0.96 g, 9 mmol).  The mixture was stirred at the same 
temperature for 1 h under nitrogen atmosphere.  Then a solution of tert-
butylchlorodiphenylsilane (2 ml, 9 mmol) in THF (3 ml) was added dropwise.  
The solution was allowed to warm to 15 oC over 6 h and was stirred for 16 h.  
The solvent was removed and the residue was partitioned between ethyl 
acetate (20 ml) and water (20 ml).  The aqueous layer was extracted with ethyl 
acetate (3 x 20 ml).  The combined organic extracts were washed with brine (20 
ml), dried over anhydrous magnesium sulfate and concentrated in vacuo.  The 
chromatography of the residue (elution with 80% hexane/ethyl acetate) afforded 
a colourless oil of 3-O-tert-butyldiphenylsilyloxy-2-deoxy-4,5-O-
isopropylidene-D-threo-pentose diethyl dithioacetal (177) (1.8 g, 90%). 
 
1H NMR (400 MHz, CDCl3) δH:  
1.10 [9H, s, Si(Ph)2C(CH3)3], 1.17 (6H, t, J=7.2 Hz and 7.5 
Hz, 2xSCH2CH3), 1.33 [6H, s, OC(CH3)2], 2.01 (1H, m, 
CH2-2), 2.44 (4H, m, 2xSCH2CH3), 2.59 (1H, m, CH2-2), 
3.84-3.97 (3H, m, CH2-5 and CH-4), 4.15 (1H, dd, J=3.3 Hz 




13C NMR (100 MHz, CDCl3) δC:    
14.4 (2xSCH2CH3), 19.5 [Si(Ph)2C(CH3)3], 23.0/23.9 
(2xSCH2CH3), 26.2/26.6 [OC(CH3)2], 27.1 
[Si(CH3)2C(CH3)3], 38.8 (CH-2), 48.0 (CH2-5), 65.2 (CH-4), 
71.6 (CH-3), 76.8 (CH-1), 109.2 [OC(CH3)2], 127.5 (2C, C-
3’ and C-5’), 127.5 (2C, C-3’’ and C-5’’), 129.6 (C-2’ and C-
6’), 129.6 (C-2’’ and C-6’’), 133.9 (C-4’), 134.8 (C-4’’), 136.0 
(C-1’), 136.0 (C-1’’). 
 
HRESIMS m/z [M+H]+ 519.8570 
   (calc. for C28H42O3S2Si+H, 519.8573) 
 








Method : 139,40 
 
To a solution of n-butyllithium ((2 ml, 3.7 mmol, 1.6 M in hexane) in anhydrous 
THF (10 ml) at -78 oC was added 1-benzyloxy-4-bromo-2-methoxy-benzene 
(133) (1.00 g, 3.4 mmol) in THF (5 ml).  The reaction mixture was stirred for 90 
minutes with warming up to -20 oC gradually.  Then the mixture was cooled 
down to -78 oC, treated with a solution of 1,2-epoxybutane (0.3 ml, 3.4 mmol) in 
THF (2 ml) followed by addition of boron triflouride etherate (0.5 ml, 3.7 mmol) 
or cerium choride (0.8 g, 3.4 mmol) and the mixture was continuously stirred at -
78 oC for 2 h before being added a saturated solution of ammonium chloride (10 
ml).  The mixture was warmed to room temperature, added water (20 ml) and 
extracted with ethyl acetate (3x 20 ml).  The combine organic extracts were 
washed with brine (20 ml), dried over anhydrous magnesium sulfate and 
concentrated in vacuo.   
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The chromatography of the residue (elution with 90% hexane/ethyl acetate) 
afforded a yellowish oil with the presence of the starting materials and absence 
of the desired product 182. 
 
Method : 233,34 
 
To a solution of Grignard reagent 170 (13 ml, 26 mmol, 0.5 M) [prepared from 
activated magnesium (0.40 g, 17 mmol) and 1-benzyloxy-4-bromo-2-methoxy-
benzene (133) (1.00 g, 3.4 mmol) in refluxing THF (20 ml)] was added 
N’,N’,N’,N’-tetramethylene-diamine (0.3 ml, 20.4 mmol) and 1,2-epoxybutane 
(181) (1.8 ml, 20.4 mmol) and the mixture cooled to -78 oC.  Then a 0.1 M 
solution of iron (iii) chloride in THF (0.5 ml, 5%) was added at the same 
temperature.  The resulting solution was warmed up and stirred for 30 minutes 
at 0 oC.  Alternately to the prepared Grignard reagent 170 (13 ml, 26 mmol, 0.5 
M) was added cerium (iii) chloride (6.50 g, 26 mmol) and 1,2-epoxybutane (181) 
(1.8 ml, 20.4 mmol) at -78 oC.  The mixture was warmed to room temperature 
and stirred for 2 h.  A saturated solution of ammonium chloride (10 ml) was 
added to the reaction mixture followed by ethyl acetate (20 ml) and water (20 
ml) and separated the two layers.   
 
The aqueous phase was extracted with ethyl acetate (3 x 20 ml) and the 
combine organic extracts were washed with brine (20 ml), dried over anhydrous 
magnesium sulfate and concentrated in vacuo.  The chromatography of the 
residue (elution with 90% hexane/ethyl acetate) afforded a yellowish oil with the 
presence of the starting materials and absence of the desired product 182. 
 
Method : 321 
 
To a stirring solution of guaiacol (135) (1 ml, 9 mmol) in dry dichloromethane 
(20 ml) under argon atmosphere at 0 oC was added tin (iv) chloride (1.2 ml, 11 
mmol).  The reaction mixture was stirred for 45 minutes at room temperature.  
The 1,2-epoxybutane (181) (0.9 ml, 11 mmol) was added in small portions to 
the suspension, followed by nitromethane (3 ml).   
 162
The mixture was stirred for 10 h at room temperature and then quenched with 
cold water (10 ml) and ethyl acetate (20 ml) and separated the two layers.  The 
aqueous phase was extracted with ethyl acetate (3 x 20 ml) and the combine 
organic extracts were washed with brine (20 ml), dried over anhydrous 
magnesium sulfate and concentrated in vacuo.  The chromatography of the 
residue (elution with 90% hexane/ethyl acetate) afforded a yellowish oil with the 
presence of the starting materials and absence of the desired product 182. 
 















To a suspension of D-ascorbic acid (189) (1.00 g, 5.6 mmol) in acetone was 
added 2,2-dimethoxypropane (1.2 ml, 9.7 mmol) and catalytic amount of 10-
camphorsulfonic acid (CSA) (0.07 g, 0.3 mmol).  The mixture was stirred for 1 h 
at room temperature after which the reaction was quenched with addition of 
triethylamine (0.04 ml, 0.3 mmol).  The solvent was removed by filtration and 
the remaining solid was washed with cold acetone and dried under vacuum to 
give the crude white solid.  The chromatography of the residue (elution with 
99% ethyl acetate/acetic acid) afforded a white crystals of 5,6-O-
isopropylidene-D-ascorbic acid (194) (0.95 g, 95%). 
 
Mp:    195-198 oC (lit.32 218-219 oC)  
 
1H NMR (500 MHz, D2O) δH:  
1.32 [6H, s, OC(CH3)2], 4.12 (1H, dd, J=5 Hz, CHb-6), 4.26 
(1H, dd, J=7.2 Hz, CHa-6), 4.53 (1H, dtd, J=2.3 Hz, CH-5), 
4.86 (1H, d, J=2.3 Hz, CH-4). 
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13C NMR (125 MHz, D2O) δC:    
24.1/25.0 [OC(CH3)2], 65.2 (C-6), 73.1 (C-5), 76.0 (C-4), 
111.0 [OC(CH3)2], 118.0 (C-2), 155.8 (C-3), 173.6 (C-1). 
 
HRESIMS m/z [M+H]+ 231.0879 
   (calc. for C10H14O6+H, 231.0881) 
IR νmax (cm-1): 3418, 1640. 
 










To a solution of 5,6-O-isopropylidene-D-ascorbic acid (194) (1.00g, 4.6 mmol) 
and distilled water (25 ml) was added aqueous 30% NaOH (30 ml) and the 
reaction mixture was stirred to become a clear solution.  To the clear solution 
was added sodium hydrogen carbonate (1.00 g, 12 mmol) and hydrogen 
peroxide (0.3 ml, 9 mmol, 35% v/v) dropwise and the resulting mixture was 
stirred for further 1 h at room temperature.  The temperature was slowly raised 
to 40 oC and after 4 h, activated carbon (2.6 g) and catalytic amount of 10% 
palladium on activated carbon (0.15g) were added and the mixture was heated 
at 85 oC until a negative peroxide test was obtained.  The resulting suspension 
was filtered and the aqueous HCl (100 ml, 0.3 M) was added until pH equals to 
three was reached.  Then several attempts were made to extract the product 
(196) from aqueous phase using dichlromethane (4 x 20 ml) and ethyl acetate 
(4 x 20 ml).  The combined organic phases were pooled, dried over magnesium 
sulfate and concentrated in vacuo to obtain a yellowish oil which upon 
characterisation reveals no presence of the desired threonic acid (196). 
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The compound 183 was synthesised in two steps in situ.  To an ice-cold 
solution of 3-benzyloxy-4,5-dimethoxybenzaldehyde (138) (1.00 g, 4 mmol) in 
ethanol was added sodium borohydride (0.3 g,9mmol) in portions.  The solution 
was stirred for 1.5 h at room temperature and the excess reagent was 
destroyed by addition of 10% aq. HCl (10 ml).  The volatiles were removed and 
the product was partitioned between water (20 ml) and ethyl acetate (20 ml) and 
extracted with ethyl acetate (3 x 20 ml).  The combine organic extracts were 
washed with brine (20 ml), dried over anhydrous magnesium sulfate and 
concentrated in vacuo to yield crude colourless oil in almost 90% yield.  The 
crude residue (1.00 g, 4 mmol) in anhydrous chloroform (5 ml) was added 
dropwise to a solution of anhydrous chloroform (10 ml) and thionyl chloride (0.3 
ml, 4.4 mmol) and the solution was stirred at room temperature for 1.5 h.  The 
Then ice-cold water (15 ml) was added to the reaction and extracted with 
chloroform (3 x 20 ml).  The combine organic extracts were washed with brine 
(20 ml), dried over anhydrous magnesium sulfate and concentrated in vacuo.  
The chromatography of the residue (elution with 80% hexane/ethyl acetate) 
afforded a yellowish oil of 1-benzyloxy-5-chloromethyl-2,3-
dimethoxybenzene (183) (0.98 g, 98%). 
 
1H NMR (500 MHz, CDCl3) δH:  
3.84 (6H, 2xs, 2xOCH3), 4.51 (2H, s, CH2Cl), 5.23 (2H, s, 





13C NMR (125 MHz, CDCl3) δC:  
56.0 (2xOCH3), 60.7 (CH2Cl), 71.8 (OCH2Bn), 107.5 (C-6), 
109.8 (C-2), 1279 (2C, C-2’ and C-6’), 128.9 (2C, C-3’ and 
C-5’), 130.9 (C-4’), 132.5 (C-1), 137.29 (C-4), 144.2 (C-1’), 
144.5 (C-3), 148.7 (C-5). 
 
HRESIMS m/z [M+H]+ 293.0958 
   (calc. C16H17ClO3+H, 293.0960) 
 








Firstly compound 201 was prepared in situ in a separate flask.  A suspension of 
octyne (200) (0.1 ml, 0.55 mmol) and zirconocene chloride hydride (0.10 g, 0.55 
mmol) in anhydrous THF (2 ml) were stirred under argon in the dark until a clear 
solution is obtained for about 30 minutes.  In a separate flask, the benzyl 
chloride (183) (0.13 g, 0.4 mmol) was added to a solution of Ni(PPh3)4 (0.1 g, 
0.55 mmol) [prepared from n-BuLi (0.01 ml, 0,55 mmol, 1.6 M solution in 
hexane) added in a suspension of Ni(PPh3)2Cl2 (0.02 g, 0.02 mmol), PPh3 (0.02 
g, 0.55 mmol) and stirred for 5 minutes and utilised as required].  After stirring 
for 5 to 10 minutes the mixture was added to vinylzirconocene (201) using 
cannula.  The mixture was allowed to stir at room temperature for 1.5 h.  The 
hydrogen peroxide (0.09 ml, 30% v/v) was added and the mixture stirred for 10 
minutes and filtered off.  The filtrate was added 5% aqueous HCl and extracted 
with ethyl acetate (3 x 10 ml).  The combined organic layers were washed with 
water (15 ml) and brine (15 ml), dried over magnesium sulfate and concentrated 
in vacuo.  The chromatography of the residue (elution with 90% hexane/ethyl 
acetate) afforded yellowish oil with the absence of the desired compound 202. 
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To a solution of 3-O-tert-butyldiphenylsilyloxy-2-deoxy-4,5-O-isopropylidene-D-
threo-pentose diethyl dithioacetal (177) (1.00 g, 2 mmol) in a mixture of 
acetone/water/acetonitrile 2:1:2 (v/v/v) was added mercury oxide (0.70 g, 3 
mmol) and mercury chloride (0.80 g, 3 mmol) and the mixture was stirred at 60 
oC for 18 h.  Salts were removed by filtration and washed with acetone.  The 
reaction mixture was concentrated under reduced pressure and the residue was 
dissolved in dichloromethane (20 ml).  The organic solution was consecutively 
washed with potassium iodide solution (10 ml), saturated aqueous sodium 
thiosulfate, water (20 ml), brine (20 ml) and dried over magnesium sulfate and 
concentrated in vacuo.  The chromatographic purification of the residue (elution 
with 90% hexane/ethyl acetate) afforded a yellowish oil of 3-O-tert-
butyldiphenylsilyloxy-2-deoxy-4,5-O-isopropylidene-D-threo-pentanal 
(203) (0.90 g, 90%). 
 
[ ]25Dα    +12.9 (c 3.7, CHCl3)  
 
1H NMR (400 MHz, CDCl3) δH:  
0.96 [9H, s, Si(Ph)2C(CH3)3], 1.13/1.23 [6H, 2xs, 
OC(CH3)2], 2.30-2.53 (2H, m, CH2-2), 3.82 (1H, dd, J=2.5 
Hz, CH-4), 4.02 (2H, 2xdd, J=6.1 Hz and 7.1 Hz, CH2-5), 
4.32 (1H, dd, J=5.4, CH-3), 7.24-7.62 (10H, m, Ar-H), 9.56 




13C NMR (100 MHz, CDCl3) δC:    
19.3 [Si(Ph)2C(CH3)3], 26.9 [Si(CH3)2C(CH3)3], 27.0 
[OC(CH3)2], 46.4 (CH-2), 48.0 (CH2-5), 65.0 (CH-4), 68.8 
(CH-3), 76.9 (CH-1), 109.8 [OC(CH3)2], 127.8 (2C, C-3’ and 
C-5’), 129.6 (2C, C-3’’ and C-5’’), 134.9 (C-2’ and C-6’), 
131.0 (C-2’’ and C-6’’), 133.9 (C-4’), 134.8 (C-4’’), 135.3 (C-
1’), 135.9 (C-1’’), 200.7 (CHO). 
 
HRESIMS m/z [M+H]+ 411.1990 
   (calc. for C24H31O4Si-H, 411.1992) 
 
IR νmax (cm-1): 2890, 1654. 
 












Method : 124 
 
Potassium bis(trimethylsilyl)amide (0.60 g, 3 mmol) was added at -78 oC to a 
solution of aldehyde (203) (1.00 g, 2.4 mmol) and the sulfone (146) (1.36 g, 2.9 
mmol) in THF or 1,2-dimethoxyethane (20 ml) under an atmosphere of dry 
argon.  The mixture was stirred for 16 h, maintaining the flask at -78 oC with 
warming slowly to room temperature.  The reaction was added saturated 
solution of ammonium chloride and extracted with diethyl ether (3 x 20 ml).  The 
combined organic layers were washed with water (15 ml) and brine (15 ml), 
dried over magnesium sulfate and concentrated in vacuo.   
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The chromatography of the residue (elution with 90% hexane/ethyl acetate) 
afforded yellowish oil with the absence of the desired compound 211. 
 
Method : 224 
 
A suspension of cesium carbonate (2.40 g, 7.3 mmol), aldehyde (203) (1.00 g, 
2.4 mmol) and sulfone (146) (1.47 g, 3 mmol) in DMF/THF (20 ml, 1:3) were 
heated at 70 oC for 16 h.  After cooling to room temperature, the solution was 
added ice-cold water (20 ml) and extracted with ethyl acetate (3 x 20 ml).  The 
combined organic layers were washed with water (15 ml) and brine (15 ml), 
dried over magnesium sulfate and concentrated in vacuo.   
The chromatography of the residue (elution with 90% hexane/ethyl acetate) 
afforded yellowish oil with the absence of the desired compound 211 but 
decomposed starting material. 
 
Method : 345 
 
To a suspension of phosphonium iodide (143) (3.30 g, 5 mmol) in mixture of 
THF/hexamethyl phosphoroustriamide (HMPT) (15 ml, 2:1)was added 
butyllithium (3 ml, 5 mmol, 1.6 M in hexane) at -78 oC and the mixture was 
warmed to room temperature with stirring for 0.5 h.  After cooling back to -78 
oC, the aldehyde (203) (1.00 g, 2.4 mmol) in THF (5 ml) was added dropwise 
under nitrogen atmosphere.  After 12 h of stirring the reaction was cooled back 
to -78 oC and added methanol (10 ml) and stirred for 20 minutes at room 
temperature.  The reaction was added saturated solution of ammonium chloride 
and extracted with ethyl acetate (3 x 20 ml).  The combined organic layers were 
washed with water (15 ml) and brine (15 ml), dried over magnesium sulfate and 
concentrated in vacuo.  The chromatography of the residue (elution with 90% 
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